NL-03-0918, Southern Nuclear Operating Co, Inc. Annual Radioactive Effluent Release Reports for 2002, Enclosure 3, Appendix a, Chapters 3 - 10

Southern Nuclear Operating Co, Inc. Annual Radioactive Effluent Release Reports for 2002, Enclosure 3, Appendix a, Chapters 3 - 10

ML031210446
Person / Time
Site:	Hatch, Vogtle, Farley
Issue date:	04/28/2003
From:	Beasley J Southern Nuclear Operating Co
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
NL-03-0918
Download: ML031210446 (175)

Text

{{#Wiki_filter:* - ,. - Chapter 3 - Gaseous - Effluents \ 9 9 )

3.1

)  3

VEGP ODCM CHAPTER 3 GASEOUS EFFLUENTS 3.1 LIMITS OF OPERATION The following Limits of Operation implement requirements established by Technical Specifications Section 5.0. Terms printed in all capital letters are defined in Chapter 10. 3.1.1 Gaseous Effluent Monitorina Instrumentation Control In accordance with Technical Specification 5.5.4.a, the radioactive gaseous effluent monitoring instrumentation channels shown in Table 3-1 shall be OPERABLE with their alarm/trip setpoints set to ensure that the limits of Section 3.1.2.a are not exceeded. The alarm/trip setpoints of these channels shall be determined in accordance with Section 3.3. 3.1.1.1 Applicability These limits apply as shown in Table 3-1. 3.1.1.2 Actions With a radioactive gaseous effluent monitoring instrumentation channel alarm/trip setpoint less conservative than required by the above control, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel, declare the channel inoperable, or restore the setpoint to a value that will ensure that the limits of Section 3.1.2.a are met. With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table 3-1. Restore the inoperable instrumentation to operable status within 30 days, or if unsuccessful, explain in the next Radioactive Effluent Release Report, per Technical Specification 5.6.3, why this inoperability was not corrected in a timely manner. This control does not affect shutdown requirements or MODE changes. 3.1.1.3 Surveillance Requirements Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL OPERATIONAL TEST operations at the frequencies shown in Table 3-2. Rev. 18 3-1 Rev. 18

VEGP ODCM 3.1.1.4 Basis The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The Alarml/Trip Setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in Section 3.3 to ensure that the alarm/trip will occur prior to exceeding the limits of Section 3.1.2.a. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. Rev. 18 3-2 Rev. 18

VEGP ODCM Table 3-1. Radioactive Gaseous Effluent Monitoring Instrumentation OPERABILITY Requirements Minimum Instrument Channels OPERABLE Applicability ACTION

1. GASEOUS RADWASTE TREATMENT SYSTEM (Common)

a. Noble Gas Activity Monitor, with Alarm and Automatic Termination of Release (ARE-0014) 1 During releasesa 45

b. Effluent System Flowrate Measuring Device (AFT-0014) 1 During releases8 46

2. Turbine Building Vent (Each Unit)

a. Noble Gas Activity Monitor (RE-12839C) 1 During releasesa 47

b. Iodine and Particulate Samplers (RE-12839A & B) 1 During releases8 51

c. Flowrate Monitor (FT-12839 or FIS-12 862)b 1 During releases8 46

d. Sampler Flowrate Monitor (Fl-1 3211) 1 During releasesa 46

3. Plant Vent (Each Unit) l

a. Noble Gas Activity Monitor (RE-12442C or RE-12444C) 1 At all times 47,48

b. Iodine Sampler/Monitor (RE-12442B or RE-12444B) 1 At all times 51

c. Particulate Sampler/Monitor (RE-12442A or RE-12444A) 1 At all times 51

d. Flowrate Monitor (FT-12442 or 12835) 1 At all times 46

e. Sampler Flowrate Monitor (FI-12442 or FI-12444) 1 At all times 46

4. Radwaste Processing Facility Vent (Common)

a. Particulate Monitor (ARE-1 6980) 1 During Releasesa 51

a. "During releases" means "During radioactive releases via this pathway."

b. During emergency filtration.

3-3 Rev. 19

VEGP ODCM Table 3-1 (contd). Notation for Table 3 ACTION Statements ACTION 45- With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, the contents of the tank(s) may be released to the environment for up to 14 days provided that prior to initiating the release:

a. At least two independent samples of the tank's contents are analyzed, and

b. At least two technically qualified members of the Facility Staff independently verify the discharge line valving, and verify the release rate calculations.

Otherwise, suspend release of radioactive effluents via this pathway. ACTION 46- With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided the flowrate is estimated at least once per 4 hours. ACTION 47- With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided grab samples are taken at least once per 12 hours and these samples are analyzed for radioactivity within 24 hours. ACTION 48- With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, immediately suspend containment purging of radioactive effluents via this pathway. ACTION 49- (Not Used) ACTION 50- (Not Used) ACTION 51 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via the affected pathway may continue provided samples are continuously collected with auxiliary sampling equipment. Rev. 18 3-4 3-4 Rev. 18

VEGP ODCM Table 3-2. Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements Surveillance Requirements CHANNEL CHANNEL OPERA-Instrument CHANNEL SOURCE CALIBRA- TIONAL CHECK CHECK TION TEST MODESC

1. GASEOUS RAD WASTE TREATMENT SYSTEM (Common)

a. Noble Gas Activity Monitor, with Alarm and Automatic Termination of Release During (ARE-0014) P P Rb Qa(1) Release

b. Effluent System Flowrate Measuring Device During (AFT-0014) P NA R NA Release

2. Turbine Building Vent (Each Unit)

a. Noble Gas Activity Monitor During (RE-12839C) D M R Qa(2) Release

b. Iodine and Particulate During Samplers (RE-12839A&B) Wd NA NA NA Release

c. Flowrate Monitor During (FT-12839 or FIS-12862) D NA R NA Release

d. Sampler Flowrate Monitor During (Fl-1 321 1) D NA R a Release

3. Plant Vent (Each Unit)

a. Noble Gas Activity Monitor (RE-12442C or RE-12444C) D M Rb Qa( 2) All

b. Particulate and Iodine Monitors (RE-12442A&B) Wd NA R (a(2) All

c. Particulate and Iodine Samplers (RE-12444A&B) Wd NA NA NA All

d. Flowrate Monitor (FT-12442 or 12835) D NA R NA All

e. Sampler Flowrate Monitor (Fl-12442 or Fl-12444) D NA R a All

4. Radwaste Processing Facility Vent (Common)

a. Particulate Monitor I11_____Release Wd l Re N/A During (AE-i16980) 3-5 Rev. 19

VEGP ODCM Table 3-2 (contd). Notation for Table 3-2

a. In addition to the basic functions of a CHANNEL OPERATIONAL TEST (Section 10.2):

(1) The CHANNEL OPERATIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room annunciation occurs (for item a. below only); and control room CRT indication occurs (if any of the following conditions exist): (a) Instrument indicates measured levels above the alarm/trip setpoint; (b) Instrument indicates an "Equipment Trouble" alarm; (c) Instrument indicates a "Low" alarm; or (d) Instrument indicates channel "Deactivated." (2) The CHANNEL OPERATIONAL TEST shall also demonstrate that control room annunciation occurs (for item a. below only); and that control room CRT indication occurs (if any of the following conditions exist): (a) Instrument indicates measured levels above the alarm/trip setpoint; (b) Instrument indicates an "Equipment Trouble" alarm; (c) Instrument indicates a "Low" alarm; or (d) Instrument indicates channel "Deactivated." ("Loss of counts for ARE-1 6980 only)

b. The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology, or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For any subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

c. MODES in which surveillance is required. "All" means "At all times." "During release" means "During radioactive release via this pathway."

d. The channel check shall consist of visually verifying that the collection device (i.e.,

particulate filter or charcoal cartridge, etc.) is in place for sampling.

e. The CHANNEL CALIBRATION verifies proper operation of the CHANNEL OPERATIONAL TEST requirements described in Notation a(2) above.

Rev. 19 3-6 Rev. 19

VEGP ODCM 3.1.2 Gaseous Effluent Dose Rate Control In accordance with Technical Specifications 5.5.4.c and 5.5.4.g, the licensee shall conduct operations so that the dose rates due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY are limited as follows:

a. For noble gases: Less than or equal to a dose rate of 500 mrem/y to the total body and less than or equal to a dose rate of 3000 mremly to the skin, and

b. For lodine-131, lodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: Less than or equal to a dose rate of 1500 mrem/y to any organ.

3.1.2.1 Applicability This limit applies at all times. 3.1.2.2 Actions With a dose rate due to radioactive material released in gaseous effluents exceeding the limit stated in Section 3.1.2, immediately decrease the release rate to within the stated limit. These limits do not affect shutdown requirements or MODE changes. 3.1.2.3 Surveillance Requirements The dose rates due to radioactive materials in areas at or beyond the SITE BOUNDARY due to releases of gaseous effluents shall be determined to be within the above limits, in accordance with the methods and procedures in Section 3.4.1, by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table 3-3. 3.1.2.4 Basis This control is provided to ensure that gaseous effluent dose rates will be maintained within the limits that historically have provided reasonable assurance that radioactive material discharged in gaseous effluents will not result in a dose to a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, exceeding the limits specified in Appendix I of 10 CFR Part 50, while allowing operational flexibility for effluent releases. For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of the MEMBER OF THE PUBLIC will be sufficiently low to compensate for any increase in the atmospheric diffusion factor above that for the SITE BOUNDARY. The dose rate limit for lodine-131, lodine-1 33, tritium, and radionuclides in particulate form with half-lives greater than 8 days specifically applies to dose rates to a child via the inhalation pathway. This control applies to the release of gaseous effluents from all reactors at the site. 3-7 Rev. 18

VEGP ODCM Table 3-3. Radioactive Gaseous Waste Sampling and Analysis Program Sampling and Analysis Requirementsa MINIMUM DETECTABLE Minimum CONCENTRA-Gaseous Sampling Analysis Type of Activity TION (MDC) Release Type FREQUENCY FREQUENCY Analysis (iCi/mL) Waste Gas P P Noble Gas 1 E-4 Decay Tank Each Tank Grab Each Tank PRINCIPAL (Common) Sample . GAMMA EMITTERS PC Noble Gas 1 E-4 Containment pCEach Purge PRINCIPAL Purge Each Purge GAMMA EMITTERS 24"c orn14) Grab Sample M H-3 (Oxide) 1 E-6 (Each Unit) Noble Gas 1 E-4 Plant Vent MCdf M 0 PRINCIPAL (Each Unit) Grab Sample M GAMMA EMITTERS H-3 (Oxide) 1 E-6 Condenser Air Noble Gas 1 E-4 Ejector& A PRINCIPAL Steam Packing Grab Sample M GAMMA EMITTERS Exhaust GrbSml (Each Unit)b H-3 (Oxide) 1 E-6 we 1-131 1 E-12 CONTINUOUS9 Charcoal or Silver Zeolite Sample we Particulate 1 E-11 CONTINUOUS Particulate PRINCIPAL Sample GAMMA EMITTERS Plant Vent, M Gross Alpha 1 E-11 Condenser Air COMPOSITE Ejector & C Particulate Steam Packing CNIU S Sample Exhaust (Each Unit)_ Q Sr-89, Sr-90 1 E-11 C UCOMPOSITE Particulate l_ Sample l Radwaste Wh Particulate 1 E-11 Processing Particulate PRINCIPAL Facility Vent Sample GAMMA EMITTERS (Common) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Rev. 19 3-8 3-8 Rev. 19

VEGP ODCM Table 3-3 (contd). Notation for Table 3-3

a. Terms printed in all capital letters are defined in Chapter 10.

b. The turbine building vent is the release point for the condenser air ejector and steam packing exhaust. All sampling and analyses may be omitted for this vent, provided the absence of a primary to secondary leak has been demonstrated, that is, if the gamma activity in the secondary water does not exceed background by more than 20%.

c. Sampling and analysis shall also be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a one-hour period. This requirement does not apply if (1) analysis shows that the DOSE EQUIVALENT 1-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the noble gas monitor shows that effluent activity has not increased more than a factor of 3.

d. Tritium grab samples shall be taken at least once per 24 hours when the refueling cavity is flooded.

e. Samples shall be changed at least once per 7 days and analyses shall be completed within 48 hours after changing (or after removal from sampler). Sampling shall also be performed at least once per 24 hours for at least 7 days following each shutdown, startup, or THERMAL POWER change exceeding 15% of RATED THERMAL POWER in one hour, and analyses shall be completed within 48 hours of changing. When samples collected for 24 hours are analyzed, the corresponding MDC may be increased by a factor of 10. This requirement does not apply if (1) analysis shows that the DOSE EQUIVALENT 1-131 concentration in the primary coolant has not increased more than a factor of 3; and (2)the noble gas monitor shows that effluent activity has not increased more than a factor of 3.

f. Tritium grab samples shall be taken at least once per 7 days from the Unit 1 plant vent, whenever spent fuel is in the spent fuel pool (Unit 1 plant vent only).

9. The ratio of the sample flowrate to the sampled stream flowrate shall be known for the time period covered by each dose or dose rate calculation made in accordance with controls specified in Sections 3.1.2, 3.1.3, and 3.1.4.

h. Samples shall be changed at least once per 7 days and analyses shall be completed within 48 hours after changing (or removal of sampler).

Rev. 19 3-9 3-9 Rev. 19

VEGP ODCM 3.1.3 Gaseous Effluent Air Dose Control In accordance with Technical Specifications 5.5.4.e and 5.5.4.h, the air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. During any calendar quarter: Less than or equal to 5 mrad for gamma radiation and less than or equal to 10 mrad for beta radiation, and

b. During any calendar year: Less than or equal to 10 mrad for gamma radiation and less than or equal to 20 mrad for beta radiation.

3.1.3.1 Applicability This limit applies at all times. 3.1.3.2 Actions With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, prepare and submit to the Nuclear Regulatory Commission within 30 days a special report which identifies the cause(s) for exceeding the limit(s); defines the corrective actions that have been taken to reduce the releases; and defines the proposed corrective actions to be taken to assure that subsequent releases of radioactive noble gases in gaseous effluents will be in compliance with the limits of Section 3.1.3. This control does not affect shutdown requirements or MODE changes. 3.1.3.3 Surveillance Requirements Cumulative air dose contributions from noble gas radionuclides released in gaseous effluents from each unit to areas at and beyond the SITE BOUNDARY, for the current calendar quarter and current calendar year, shall be determined in accordance with Section 3.4.2 at least once per 31 days. 3.1.3.4 Basis This control is provided to implement the requirements of Sections ll.B, III.A and IV.A of Appendix I, 10 CFR Part 50. Section 3.1.3 implements the guides set forth in Section ll.B of Appendix I. The ACTION statements in Section 3.1.3.2 provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I, assuring that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The Surveillance requirements in Section 3.1.3.3 implement the requirements in Section IIL.A of Appendix I, which require that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The dose calculations established in Section 3.4.2 for calculating the doses due to the actual releases of noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109 (Reference 3), and Regulatory Guide 1.111 (Reference 5). The equations in Section 3.4.2 provided for determining the air doses at the SITE BOUNDARY are based upon the historical annual average atmospheric conditions. Rev. 18 3-10 3-10 Rev. 18

VEGP ODCM 3.1.4 Control on Gaseous Effluent Dose to a Member of the Public In accordance with Technical Specifications 5.5.4.e and 5.5.4.i, the dose to a MEMBER OF THE PUBLIC from 1-131,1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released, from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. During any calendar quarter: Less than or equal to 7.5 mrem to any organ, and

b. During any calendar year: Less than orequal to 15 mrem to any organ.

3.1.4.1 Applicability This limit applies at all times. 3.1.4.2 Actions With the calculated dose from the release of 1-131, 1-133, tritium, or radionuclides in particulate form with half-lives greater than 8 days, in gaseous effluents exceeding any of the above limits, prepare and submit to the Nuclear Regulatory Commission within 30 days a special report which identifies the cause(s) for exceeding the limit; defines the corrective actions that have been taken to reduce the releases of radioiodines and radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents; and defines proposed corrective actions to assure that subsequent releases will be in compliance with the limits stated in Section 3.1.4. This control does not affect shutdown requirements or MODE changes. 3.1.4.3 Surveillance Requirements Cumulative organ dose contributions to a MEMBER OF THE PUBLIC from 1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days released in gaseous effluents from each unit to areas at and beyond the SITE BOUNDARY, for the current calendar quarter and current calendar year, shall be determined in accordance with Section 3.4.3 at least once per 31 days. 3.1.4.4 Basis This control is provided to implement the requirements of Section II.C, III.A and IV.A of Appendix I, 10 CFR Part 50. The limits stated in Section 3.1.4 are the guides set forth in Section II.C of Appendix I. The ACTION statements in Section 3.1.4.2 provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The calculational methods specified in the Surveillance Requirements of Section 3.1.4.3 implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The calculational methods in Section 3.4.3 for calculating the doses due to the actual releases of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109 (Reference 3), and Regulatory Guide 1.111 (Reference 5). These equations provide for determining the actual doses 3-11 Rev. 18

VEGP ODCM based upon the historical annual average atmospheric conditions. The release specifications for radioiodines, radioactive materials in particulate form and radionuclides other than noble gases are dependent on the existing radionuclide pathways to man, in the areas at and beyond the SITE BOUNDARY. The pathways which were examined in the development of these calculations were:

1) individual inhalation of airborne radionuclides, 2) deposition of radionuclides onto green leafy garden vegetation with subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.

3.1.5 Gaseous Radwaste Treatment System Control In accordance with Technical Specification 5.5.4.f, the GASEOUS WASTE PROCESSING SYSTEM and the VENTILATION EXHAUST TREATMENT SYSTEM shall be OPERABLE. The appropriate portions of the GASEOUS WASTE PROCESSING SYSTEM and the VENTILATION EXHAUST TREATMENT SYSTEM shall be used to reduce radioactive materials in gaseous wastes prior to their discharge when the projected doses in 31 days due to gaseous effluent releases, from each reactor unit, to areas at and beyond the SITE BOUNDARY would exceed 0.2 mrad to air from gamma radiation, 0.4 mrad to air from beta radiation, or 0.3 mrem to any organ of a MEMBER OF THE PUBLIC. 3.1.5.1 Applicability These limits apply at all times. 3.1.5.2 Actions With gaseous waste being discharged without treatment and in excess of the limits in Section 3.1.5, prepare and submit to the Nuclear Regulatory Commission within 30 days a special report which includes the following information:

a. Identification of any inoperable equipment or subsystem and the reason for inoperability,

b. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

c. Summary description of action(s) taken to prevent a recurrence.

This control does not affect shutdown requirements or MODE changes. 3.1.5.3 Surveillance Requirements Doses due to gaseous releases from each unit to areas at and beyond the SITE BOUNDARY shall be projected at least once per 31 days, in accordance with Section 3.5.1, when the GASEOUS WASTE PROCESSING SYSTEM or the VENTILATION EXHAUST TREATMENT SYSTEM is not being fully utilized. The GASEOUS WASTE PROCESSING SYSTEM and the VENTILATION EXHAUST TREATMENT SYSTEM shall be demonstrated OPERABLE: Rev. 18 3-12 Rev. 18

VEGP ODCM by meeting the controls of Sections 3.1.2, and either 3.1.3 (for the GASEOUS WASTE PROCESSING SYSTEM) or 3.1.4 (for the VENTILATION EXHAUST TREATMENT SYSTEM). 3.1.5.4 Basis The OPERABILITY of the GASEOUS WASTE PROCESSING SYSTEM ensures that the system will be available for use whenever gaseous effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." This control implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section I.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the system were specified as a suitable fraction of the dose design objectives set forth in Section ll.B and lI.C of Appendix I, 10 CFR Part 50, for gaseous effluents. This control applies to the release of radioactive materials in gaseous effluents from each unit at the site. For units with shared radwaste treatment systems, the gaseous effluents from the shared system are proportioned among the units sharing that system. 3.1.6 Maior Changes to Gaseous Radioactive Waste Treatment Systems Licensee initiated MAJOR CHANGES TO GASEOUS RADIOACTIVE WASTE TREATMENT SYSTEMS:

a. Shall be reported to the Nuclear Regulatory Commission in the Radioactive Effluents Release Report for the period in which the change was implemented. The discussion of each change shall contain the information described in Section 7.2.2.7.

b. Shall become effective upon review and approval by the General Manager - Nuclear Plant.

3-13 Rev. 18

it? 3.2 ) ) )

VEGP ODCM 3.2 GASEOUS WASTE PROCESSING SYSTEM At Plant Vogtle, there are six potential points where radioactivity may be released to the atmosphere in gaseous discharges. These six potential release pathways are the Unit 1 and Unit 2 Plant Vents; the Unit 1 and Unit 2 Turbine Building Vents; the Radwaste Processing Facility Vent; and the Dry Active Waste Processing Building Vent. However, the Turbine Building Vents are not normal release pathways unless a primary-to-secondary leak exists. The Radwaste Processing Facility Vent is not a normal release pathway unless a spill occurs. The figures on the following pages give schematic diagrams of the Gaseous Waste Treatment System and the Ventilation Exhaust Treatment Systems (Reference 11). The Unit 1 Plant Vent release pathway includes two release sources that are common to the two units: ventilation air from the Fuel Handling Building, and discharges from the GASEOUS WASTE PROCESSING SYSTEM. Otherwise, discharges from the two reactor units are separated. Reactor Containment Building ventilation releases are through the respective plant vents. The Turbine Building Vent serves as the discharge point for both the condenser air ejector and the steam packing exhauster system. The Radwaste Processing Facility Vent includes sources from the Radwaste Processing Facility Process area. Releases from the two Turbine Building Vents, the Radwaste Processing Facility Vent, and the Dry Active Waste Processing Building Vent are considered to be ground-level releases, whereas releases from the two Plant Vents are considered mixed-mode releases. Chapter 8 discusses the calculation of atmospheric dispersion parameters using the ground-level and mixed-mode (i.e., split-wake) models. All six potential release pathways are considered to be continuous (as opposed to batch) in nature. Rev. 19 3-14 3-14 Rev. 19

VEGP ODCM Figure 3-1. Schematic Diagram of the Gaseous Radwaste Treatment System 3-15 Rev. 18

VEGP ODCM Plant Vent Radioactivity Monitor 1RE12442AB,C l HEPA ll HEPA ll HEPAl l I Radioactivity HC HC Monitor RE0039A AME ME Auxiliaryxv Building Radioactivity Monitor

                                                          , RE565ABC 1                  Fuel Handling Building (Shared)*

Radioactivity Reactor Containment MonitorRecoCotimn ARE-0014 Building From Waste Gas Processing Area and System HEPA - High-Efficiency Particulate Air Filter CF - Activated Charcoal Filter HC - Heating Coil ME - Moisture Eliminator

• Prior to treatment by the Fuel Handling Building Ventilation Exhaust Treatment System, Exhaust from Unit 1 Spent Fuel Pool Area is monitored by ARE2532B and ARE2533B; exhaust from Unit 2 Spent Fuel Pool Area is monitored by ARE2532A and ARE2533A.

Figure 3-2. Schematic Diagram of the Unit 1 Plant Vent Release Pathway 3-16 Rev. 18

VEGP ODCM Plant Vent Radioactivity Monitor 2RE1 2442A,B,C Auxiliary Building Radioactivity Monitor 2RE2565A.B,C Reactor Containment Building HEPA - High-Efficiency Particulate Air Filter CF - Activated Charcoal Filter HC - Heating Coil ME - Moisture Eliminator Figure 3-3. Schematic Diagram of the Unit 2 Plant Vent Release Pathway 3-17 Rev. 18

VEGP ODCM Figure 3-4. Schematic Diagram of the Turbine Building Vent Release Pathway (Typical of Both Units) Rev. 18 3-18 Rev. 18

VEGP ODCM Dry Active Waste Processing Building Vent Radioactivity Monitor ARE 13256 Rooms Trash Compactor Figure 3-5. Schematic Diagram of the Dry Active Waste Processing Building Ventilation Release Pathway 3-19 Rev. 18

VEGP ODCM Figure 3-6. Schematic Diagram of the Radwaste Processing Facility Ventilation Release Pathway Rev. 19 3-1 9a 3-19a Rev. 19

3.3 , 3 )1)

VEGP ODCM 3.3 GASEOUS EFFLUENT MONITOR SETPOINTS 3.3.1 General Provisions Regarding Noble Gas Monitor Setpoints Noble gas radioactivity monitor setpoints calculated in accordance with the methodology presented in this section are intended to ensure that the limits of Section 3.1.2.a are not exceeded. They will be regarded as upper bounds for the actual high alarm setpoints. That is, a lower high alarm setpoint may be established or retained on the monitor, if desired. Intermediate level setpoints should be established at an appropriate level to give sufficient warning prior to reaching the high alarm setpoint. If no release is planned for a given pathway, or if there is no detectable activity in the gaseous stream being evaluated for release, the setpoint should be calculated in accordance with the methods presented below, based on an assumed concentration of Kr-88 that leads to a practical setpoint. A practical setpoint in this context is one which prevents spurious alarms, and yet produces an alarm should a significant inadvertent release occur. Section 3.1.1 establishes the requirements for gaseous effluent monitoring instrumentation, and Section 3.2 describes the VENTILATION EXHAUST TREATMENT SYSTEM and the GASEOUS WASTE PROCESSING SYSTEM. From those Sections, it can be seen that certain monitors are located on final release pathways, that is, streams that are being monitored immediately before being discharged from the plant; the setpoint methodology for these monitors is presented in Section 3.3.2. Other monitors are located on source streams, that is, streams that merge with other streams prior to passing a final monitor and being discharged; the setpoint methodology for these monitors is presented in Section 3.3.3. Table 3-4 identifies which of these setpoint methodologies applies to each monitor. Some additional monitors with special setpoint requirements are discussed in Section 3.3.5. As established in Section 3.1.1, gaseous effluent monitor setpoints are requiredonly for the noble gas monitors on certain potential release streams: the two Plant Vents, the two Turbine Building Vents, and the GASEOUS WASTE PROCESSING SYSTEM discharge. However, because of the potential significance of releases from other sources, Section 3.3 discusses setpoint methodologies for certain additional monitors, as well. Rev. 18 3-20 3-20 Rev. 18

VEGP ODCM Table 3-4. Applicability of Gaseous Monitor Setpoint Methodologies Final Release Pathways with no Monitored Source Streams Setpoint Method: Section 3.3.2 Release Elevation: Ground-level Unit 1 or Unit 2 Turbine Building Vent Monitor: 1RE-12839C/2RE-12839C Maximum Flowrate: 900 cfm (4.25 E+05 mU/s) Dry Active Waste Building Vent Monitor: ARE-13256 Maximum Flowrate: 2,200 cfm (1.04 E+06 mL's) Final Release Pathways with One or More Monitored Source Streams Release Elevation: Mixed-Mode Unit 1 Plant Vent Monitors: 1RE-12442C, 1RE-12444C Maximum Flowrate: 187,000 cfm (8.83 E+07 mUs) Setpoint Method: Section 3.3.2 Release Type: CONTINUOUS Source Stream: Unit 1 Reactor Containment Purae Monitor: 1RE-2565C Maximum Flowrate: release-dependent Setpoint Method: Section 3.3.3 Release Type: BATCH Source Stream: Gaseous Waste Treatment System Monitor: ARE-0014 Maximum Flowrate: release-dependent Setpoint Method: Section 3.3.3 Release Type: BATCH Unit 2 Plant Vent Monitors: 2RE-12442C, 2RE-12444C Maximum Flowrate: 112,500 cfm (5.31 E+07 mUs) Setpoint Method: Section 3.3.2 Release Type: CONTINUOUS Source Stream: Unit 2 Reactor Containment Purae Monitor: 2RE-2565C Maximum Flowrate: release-dependent Setpoint Method: Section 3.3.3 Release Type: BATCH (XIQ,,b Values for Use in Setpoint Calculations Ground-Level Releases: 2.55 x 10 4 s/rM3 [NE Sector] Mixed-Mode Releases: 4.62 x 107 s/M3 [NE Sector] Maximum flowrate values are from Reference 11, Table 11.5.2-1 and Table 11.5.5-1. Rev. 18 3-21 3-21 Rev. 18

VEGP ODCM 3.3.2 Setooint for the Final Noble Gas Monitor on Each Release Pathway 3.3.2.1 Overview of Method Gaseous effluent radioactivity monitors are intended to alarm prior to exceeding the limits of Section 3.1.2.a. Therefore, their alarm setpoints are established to ensure compliance with the following equation: c=the lesser AG-SF X-Rt (3.1) where: c = the setpoint, in gCVmL, of the radioactivity monitor measuring the concen-tration of radioactivity in the effluent line prior to release. The setpoint represents a concentration which, if exceeded, could result in dose rates exceeding the limits of Section 3.1.2.a at or beyond the SITE BOUNDARY. AG = an administrative allocation factor applied to divide the release limit among all the gaseous release pathways at the site. SF = the safety factor selected to compensate for statistical fluctuations and errors of measurement. X = the noble gas concentration for the release under consideration. R. = the ratio of the dose rate limit for the total body, 500 mrem/y, to the dose rate to the total body for the conditions of the release under consideration. Rk = the ratio of the dose rate limit for the skin, 3000 mremly, to the dose rate to the skin for the conditions of the release under consideration. Equation (3.1) shows the relationships of the critical parameters that determine the setpoint. However, in order to apply the methodology presented in the equation to a mixture of noble gas radionuclides, radionuclide-specific concentrations and dose factors must be taken into account under conditions of maximum flowrate for the release point and annual average meteorology. The basic setpoint method presented below is applicable to the radioactivity monitor nearest the point of release for the release pathway. For monitors measuring the radioactivity in source streams that merge with other streams prior to subsequent monitoring and release, the modifications presented in Section 3.3.3 must be applied. 3.3.2.2 Setpoint Calculation Steps Step 1: Determine the concentration, X4, of each noble gas radionuclide i in the gaseous stream v being considered for release, in accordance with the sampling and analysis requirements of Section 3.1.2. Then sum these concentrations to determine the total noble gas concentration, 1:XN. Rev. 18 3-22 3-22 Rev. 18

VEGP ODCM Step 2: Determine R., the ratio of the dose rate limit for the total body, 500 mrem/y, to the total body dose rate due to noble gases detected in the release under consideration, as follows: Rt= 500 (3.2) (XI/Q) Vb [K *Q"] where: 500 = the dose rate limit for the total body, 500 mrem/y. (X/Q),b = the highest annual average relative concentration at the SITE BOUNDARY for the discharge point of release pathway v. Table 3-4 includes an indication of what release elevation is applicable to each release pathway; release elevation determines the appropriate value of (X/Q),b K, = the total-body dose factor due to gamma emissions from noble gas radio-nuclide i, in (mrem/y)/(iCVm 3 ), from Table 3-5. Q1 = the release rate of noble gas radionuclide i from the release pathway under consideration, in jiCis, calculated as the product of XN and f8,, where: X = the concentration of noble gas radionuclide i for the particular release, in gCLmL. faV = the maximum anticipated flowrate for release pathway v during the period of the release under consideration, in mUs. SteD 3: Determine Rk, the ratio of the dose rate limit for the skin, 3000 mrem/y, to the skin dose rate due to noble gases detected in the release under consideration, as follows: Rk 3000 (3.3) (Q)vb[(Li + 1. 1M). Q(3] where: 3000 = the dose rate limit for the skin, 3000 mrem/y. L = the skin dose factor due to beta emissions from noble gas radionuclide i, in (mrem/y)/(gCVm3), from Table 3-5. Ml = the air dose factor due to gamma emissions from noble gas radionuclide i, in (mrad/y)/(pCVm3), from Table 3-5. 1.1 = the factor to convert air dose in mrad to skin dose in mrem. All other terms were defined previously. 3-23 Rev. 18

VEGP ODCM Step 4: Determine the maximum noble gas radioactivity monitor setpoint concentration. Based on the values determined in previous steps, the radioactivity monitor setpoint for the planned release is calculated to ensure that the limits of Section 3.1 .2.a will not be exceeded. Because the radioactivity monitor responds primarily to radiation from noble gas radionuclides, the monitor setpoint c,, (in iCVmL) is based on the concentration of all noble gases in the waste stream, as follows: where: Cv = the calculated setpoint, in gCVmL, for the noble gas monitor serving gaseous release pathway v. AGV. SF

• X, v Rt c,,v =the lesser of i (3.4)

AGV.SF*X 1 ,,Rk i AGV = the administrative allocation factor for gaseous release pathway v, applied to divide the release limit among all the gaseous release pathways at the site. The allocation factor may be assigned any value between 0 and 1, under the condition that the sum of the allocation factors for all simultaneously-active final release pathways at the entire plant site does not exceed 1. Alternative methods for determination of AG, are presented in Section 3.3.4. SF = the safety factor selected to compensate for statistical fluctuations and errors of measurement. The value for the safety factor must be between 0 and 1. A value of 0.5 is reasonable for gaseous releases; a more precise value may be developed if desired. X = the measured concentration of noble gas radionuclide i in gaseous stream v, as defined in Step 1, in p.CVmL. The values of Rt and Rk to be used in the calculation are those which were determined in Steps 2 and 3 above. Step 5: Determine whether the release is permissible, as follows: If cr, Ž>IXN, the release is permissible. However, if c, is within about 10 percent of :XN,, it may be impractical to use this value of cr,. This situation indicates that measured concentrations are approaching values which would cause the limits of Section 3.1.2.a to be exceeded. Therefore, steps should be taken to reduce contributing source terms of gaseous radioactive material, or to adjust the allocation of the limits among the active release points. The setpoint calculations (steps 1-4) must then be repeated with parameters that reflect the modified conditions. 3-24 Rev. 18

VEGP ODCM If c, < Y:X4, the release may not be made as planned. Consider the alternatives discussed in the paragraph above, and calculate a new setpoint based on the results of the actions taken. 3.3.2.3 Use of the Calculated Setpoint The setpoint calculated above is in the units gCimL. The monitor actually measures a count rate, subtracts a predetermined background count rate, and multiplies by a calibration factor to convert from count rate to gCVmL Initial calibration by the manufacturer and Georgia Power Company of the gaseous effluent monitors specified in Section 3.1.1 utilized at least one NIST-traceable gaseous radionuclide source in the exact geometry of each production monitor. The point and gaseous sources used covered the beta particle end point energy range from 0.293 MeV to at least 1.488 MeV. The calibration factor is a function of the radionuclide mix in the gas to be released, and normally will be calculated for the monitor based on the results of the sample results from the laboratory gamma-ray spectrometer system. The mix-dependent calibration factor will be used as the gain factor in the PERMS monitor, or used to modify the calculated base monitor setpoint so that the default calibration factor in the PERMS monitor can be left unchanged. Notwithstanding the initial calibration, monitor calibration data for conversion between count rate and concentration may include operational data obtained from determining the monitor response to stream concentrations measured by sample analysis. In all cases, monitor background must be controlled so that the monitor is capable of responding to concentrations in the range of the setpoint value. Contributions to the monitor background may include any or all of the following factors: ambient background radiation, plant-related radiation levels at the monitor location (which may change between shutdown and power conditions), and internal background due to contamination of the monitor's sample chamber. 3.3.3 Setooints for Noble Gas Monitors on Effluent Source Streams Table 3-4 lists certain gaseous release pathways as being source streams. As may be seen in the figures of Section 3.2, these are streams that merge with other streams, prior to passing a final radioactivity monitor and being released. Unlike the final monitors, the source stream monitors measure radioactivity in effluent streams for which flow can be terminated; therefore, the source stream monitors have control logic to terminate the source stream release at the alarm setpoint. 3.3.3.1 Setpoint of the Monitor on the Source Stream Step 1: Determine the concentration Xis of each noble gas radionuclide i in source stream s (in h+/-CVmL) according to the results of its required sample analyses [see Section 3.1.2]. Sten 2: Determine rt, the ratio of the dose rate limit for the total body, 500 mrem/y, to the total body dose rate due to noble gases detected in the source stream under consideration. Use the XIs values and the maximum anticipated source stream 3-25 Rev. 18

VEGP ODCM flowrate fas in equation (3.2) to determine the total body dose rate for the source stream, substituting rt for Rt. The SITE BOUNDARY relative dispersion value used in Steps 2 and 3 for the source stream is the same as the (X/Q),t that applies to the respective merged stream. This is because the (X/Q) value is determined by the meteorology of the plant site and the physical attributes of the release point, and is unaffected by whether or not a given source stream is operating. SteD 3: Determine rk, the ratio of the dose rate limit for the skin, 3000 mrem/y, to the skin dose rate due to noble gases detected in the source stream under consideration. Use the X, values and the maximum anticipated source stream flow rate f55 in equation (3.3) to determine the skin dose rate for the source stream, substituting rk for Rk-SteD 4: Determine the maximum noble gas radioactivity monitor setpoint concentration, as follows: AG, *SF *- Xis *r, C,= the lesser of i (3.5) AGS *SF - Xi, *r, where: c,, = the calculated setpoint (in iCVmL) for the noble gas monitor serving gaseous source stream s. AG, = the administrative allocation factor applied to gaseous source stream s. For a given final release point v, the sum of all the AG, values for source streams contributing to the final release point must not exceed the release point's allocation factor Ag,. X4 = the measured concentration of noble gas radionuclide i in gaseous source stream s, as defined in Step 1, in giCi/mL. The values of rt and rk to be used in the calculation are those which were determined in Steps 2 and 3 above. The safety factor, SF, was defined previously. Step 5: Determine whether the release is permissible, as follows: If cns > 7X5, the release is permissible. However, if cq is within about 10 percent of X,5, it may be impractical to use this value of c,,. This situation indicates that measured concentrations are approaching values which would cause the limits of Section 3.1.2.a to be exceeded. Therefore, steps should be taken to reduce contributing source terms of gaseous radioactive material, or to adjust the allocation of the limits among the active release points. The setpoint calculations (steps 1-4) must then be repeated with parameters that reflect the modified conditions. Rev. 18 3-26 3-26 Rev. 18

VEGP ODCM If cn, < YX,, the release may not be made as planned. Consider the alternatives discussed in the paragraph above, and calculate a new setpoint based on the results of the actions taken. 3.3.3.2 Effect on the Setpoint of the Monitor on the Merged Stream Before beginning a release from a monitored source stream, a setpoint must be determined for the source stream monitor as presented in Section 3.3.3.1. In addition, whether or not the source stream has its own effluent monitor, the previously-determined maximum allowable setpoint for the downstream final monitor on the merged stream must be redetermined. This is accomplished by repeating the steps of Section 3.3.2, with the following modifications. Modification 1: The new maximum anticipated flowrate of the merged stream is the sum of the old merged stream maximum flowrate, and the maximum flowrate of the source stream being considered for release. (fav )new = (av ld +fa (3.6) Modification 2: The new concentration of noble gas radionuclide i in the merged stream includes both the contribution of the merged stream without the source stream, andthe source stream being considered for release. (x1 ) = (fa'V )old (Xi )old + LI + Xi, (.fav )3ew 3.3.4 Determination of Allocation Factors. AG When simultaneous gaseous releases are conducted, an administrative allocation factor must be applied to divide the release limit among the active gaseous release pathways. This is to assure that the dose rate limit for areas at and beyond the SITE BOUNDARY (see Section 3.1.2) will not be exceeded by simultaneous releases. The allocation factor for any pathway may be assigned any value between 0 and 1, under the following two conditions:

1. The sum of the allocation factors for all simultaneously-active final release paths at the plant site may not exceed 1.

2. The sum of the allocation factors for all simultaneously-active source streams merging into a given final release pathway may not exceed the allocation factor of that final release pathway.

Any of the following three methods may be used to assign the allocation factors to the active gaseous release pathways:

1. For ease of implementation, AG, may be equal for all release pathways:

                                                     =1                                        (3.8)

N 3-27 Rev. 18

VEGP ODCM where: N = the number of simultaneously active gaseous release pathways.

2. AG, for a given release pathway may be selected based on an estimate of the portion of the total SITE BOUNDARY dose rate (from all simultaneous releases) that is contributed by the release pathway. During periods when a given building or release pathway is not subject to gaseous radioactive releases, it may be assigned an allocation factor of zero.

3. AG, for a given release pathway may be selected based on a calculation of the portion of the total SITE BOUNDARY dose rate that is contributed by the release pathway, as follows:

                                               )vb,       (ffiQ,,)

AGv _N i (3.9) E [E~rb (K,Q,,) where: (X/Q0)b = the annual average SITE BOUNDARY relative concentration applicable to the gaseous release pathway v for which the allocation factor is being determined, in s/M3. K, = the total-body dose factor due to gamma emissions from noble gas radio-nuclide i, in (mrem/y)(pgCVm 3), from Table 3-5. al = the release rate of noble gas radionuclide i from release pathway v, in gCi/s, calculated as the product of X4 and f,,where: Xv = the concentration of noble gas radionuclide i applicable to the gaseous release pathway v for which the allocation factor is being determined, in pCVmL fav = the discharge flowrate applicable to gaseous release pathway v for which the allocation factor is being determined, in mULs. (X/Q),b = the annual average SITE BOUNDARY relative concentration applicable to active gaseous release pathway r, in s/M3 . air = the release rate of noble gas radionuclide i applicable to active release pathway r, in pCi/s, calculated as the product of X,, and far, where: Xir = the concentration of noble gas radionuclide i applicable to active gaseous release pathway r, in gCimL far = the discharge flowrate applicable to active gas6ous release pathway r, in mL/s. Rev. 18 3-28 Rev. 18

VEGP ODCM N = the number of simultaneously active gaseous release pathways (including pathway v that is of interest). NOTE: Although equations (3.8) and (3.9) are written to illustrate the assignment of the allocation factors for final release pathways, they may also be used to assign allocation factors to the source streams that merge into a given final release pathway. 3.3.5 SetDoints for Noble Gas Monitors with Special Requirements At present, VEGP has no noble gas monitors for which setpoint methodologies are to be presented in the ODCM, and that require methods other than those in Section 3.3.2 or Section 3.3.3. 3.3.6 Setpoints for Particulate and Iodine Monitors In accordance with Section 5.1.1 of NRC NUREG-0133 (Reference 1), the effluent controls of Section 3.1.1 do not require that the ODCM establish setpoint calculation methods for particulate and iodine monitors. Therefore, the following is provided for information only: Initial setpoints for the particulate channels of effluent monitors RE-12442, RE-2565, and ARE-1 3256 were determined as described in Reference 13. Rev. 18 3-29 3-29 Rev. 18

I 3.4 k I 9 ) )

VEGP ODCM 3.4 GASEOUS EFFLUENT COMPLIANCE CALCULATIONS 3.4.1 Dose Rates at and Beyond the Site Boundary Because the dose rate limits for areas at and beyond the SITE specified in Section 3.1.2 are site limits applicable at any instant in time, the summations extend over all simultaneously active gaseous final release pathways at the plant site. Table 3-4 identifies the gaseous final release pathways at the plant site, and indicates the (X/Q),b value for each. 3.4.1.1 Dose Rates Due to Noble Gases For the purpose of implementing the controls of Section 3.1 .2.a, the dose rates due to noble gas radionuclides in areas at or beyond the SITE BOUNDARY, due to releases of gaseous effluents, shall be calculated as follows: For total body dose rates: DR =1 {(XQ)Vb X[K 1Q1V]} (3.10) For skin dose rates: DRk =I {- Q)vb S[(L, + -. imj)QxV (3.11) where: DRt = the total body dose rate at the time of the release, in mrem/y. DRk = the skin dose rate at the time of the release, in mrem/y. ON = the release rate of noble gas radionuclide i, in gCis, equal to the product of ft and X4, where: f = the actual average flowrate for release pathway v during the period of the release, in mUs. All other terms were defined previously. 3.4.1.2 Dose Rates Due to lodine-131, lodine-133, Tritium, and Radionuclides in Particulate Form with Half-Lives Greater than 8 Days For the purpose of implementing the controls of Section 3.1.2.b, the dose rates due to lodine-1 31, lodine-1 33, tritium, and all radionuclides in particulate form with half-lives greater than 8 days, in areas at or beyond the SITE BOUNDARY, due to releases of gaseous effluents, shall be calculated as follows: DR. =X{ )lvb [pio QivI} (3.12) Rev. 18 3-30 3-30 Rev. 18

VEGP ODCM where: DR, = the dose rate to organ o at the time of the release, in mrem/y. P, = the site-specific dose factor for radionuclide i and organ o, in (mrem/y)/(giCi/m 3 ). Since the dose rate limits specified in Section 3.1.2.b apply only to the child age group exposed to the inhalation pathway, the values of P10 may be obtained from Table 3-9, URapj for Inhalation Pathway, Child Age Group.' Q', = the release rate of radionuclide i from gaseous release pathway v, in IpCis. For the purpose of implementing the controls of Section 3.1 .2.b, only 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days should be included in this calculation. All other terms were defined previously. 3.4.2 Noble Gas Air Dose at or Beyond Site Boundary For the purpose of implementing the controls of Section 3.1.3, air doses in areas at or beyond the SITE BOUNDARY due to releases of noble gases from each unit shall be calculated as follows (adapted from Reference 1, page 28, by including only long-term releases): X

                                       <=3.17xJO8X{      b [N  1 .Qi}                          (3.13)

Dr=3.17X10-(8 -{()b [MQ](3.14) where: 3.17 x 1OF = a units conversion factor 1 y/(3.15 x 107 s). Do = the air dose due to beta emissions from noble gas radionuclides, in mrad. Dr = the air dose due to gamma emissions from noble gas radionuclides, in mrad. N, = the air dose factor due to beta emissions from noble gas radionuclide i (mrad/y)/(CVm3 ), from Table 3-5. Mi = the air dose factor due to gamma emissions from noble gas radionuclide i (mrad/y)/(CVm3 ), from Table 3-5.

        .,,      =  the cumulative release of noble gas radionuclide i from release pathway v (gCi), during the period of interest.

and all other terms are as defined above. 3-31 Rev. 18

VEGP ODCM Because the air dose limit is on a per-reactor-unit basis, the summations extend over all gaseous final release pathways for a given unit. For a release pathway discharging materials originating in both reactor units, the activity discharged from the release point may be apportioned to the two units in any reasonable manner, provided that all activity released via the particular shared release pathway is apportioned to one or the other unit. The gaseous final release pathways at the plant site, and the (X/Q)b for each, are identified in Table 3-4. Rev. 18 3-32 Rev. 18

VEGP ODCM Table 3-5. Dose Factors for Exposure to a Semi-Infinite Cloud of Noble Gases y- Body (K) , - Skin (L) y- Air (M) P - Air (N) Nuclide (mrem/y) per (mrem/y) per (mrad/y) per (mrad/y) per (mCi/M3) (pCi/m 3) (pCi/m 3) (pCi/m 3) Kr-83m 7.56 E-02 0.00 E+00 1.93 E+01 2.88 E+02 Kr-85m 1.17 E+03 1.46 E+03 1.23 E+03 1.97 E+03 Kr-85 1.61 E+01 1.34 E+03 1.72 E+01 1.95 E+03 Kr-87 5.92 E+03 9.73 E+03 6.17 E+03 1.03 E+04 Kr-88 1.47 E+04 2.37 E+03 1.52 E+04 2.93 E+03 Kr-89 1.66 E+04 1.01 E+04 1.73 E+04 1.06 E+04 Kr-90 1.56 E+04 7.29 E+03 1.63 E+04 7.83 E+03 Xe-131m 9.15 E+01 4.76 E+02 1.56 E+02 1.11 E+03 Xe-1 33m 2.51 E+02 9.94 E+02 3.27 E+02 1.48 E+03 Xe-1 33 2.94 E+02 3.06 E+02 3.53 E+02 1.05 E+03 Xe-135m 3.12 E+03 7.11 E+02 3.36 E+03 7.39 E+02 Xe-135 1.81 E+03 1.86 E+03 1.92 E+03 2.46 E+03 Xe-137 1.42 E+03 1.22 E+04 1.51 E+03 1.27 E+04 Xe-138 8.83 E+03 4.13 E+03 9.21 E+03 4.75 E+03 Ar-41 8.84 E+03 2.69 E+03 9.30 E+03 3.28 E+03 All values in this table were obtained from Reference 3 (Table B-1), with units converted. 3-33 Rev. 18

VEGP ODCM Table 3-6. Dose Factors for Exposure to Direct Radiation from Noble Gases in an Elevated Finite Plume The contents of this table are not applicable to VEGP. 3-34 Rev. 18

VEGP ODCM 3.4.3 Dose to a Member of the Public at or Beyond Site Boundary The dose received by an individual due to gaseous releases from each reactor unit, to areas at or beyond the SITE BOUNDARY, depends on the individual's location, age group, and exposure pathways. The MEMBER OF THE PUBLIC expected to receive the highest dose in the plant vicinity is referred to as the controlling receptor. The dosimetrically-significant attributes of the currently-defined controlling receptor are presented in Table 3-7. Doses to a MEMBER OF THE PUBLIC due to gaseous releases of 1-131, 1-133, tritium, and all radionuclides in particulate form from each unit shall be calculated as follows (equation adapted from Reference 1, page 29, by considering only long-term releases): Dja =3.17x10-8X{XRaipj Y.[Wvp *Q-.]} (3.15) P I v where: D, = the dose to organ j of an individual in age group a, due to gaseous releases of 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days, in mrem. 3.17 x 10 =a units conversion factor: 1 y/(3.15 x 10 7 s). Rajp, = the site-specific dose factor for age group a, radionuclide i, exposure pathway p, and organ j. For the purpose of implementing the controls of Section 3.1.4, the exposure pathways applicable to calculating the dose to the currently-defined controlling receptor are included in Table 3-7; values of Rap for each exposure pathway and radionuclide applicable to calculations of dose to the controlling receptor are included in Tables 3-8 through 3-12. A detailed discussion of the methods and parameters used for calculating Rao for the plant site is presented in Chapter 9. That information may be used for recalculating the Raipi values if the underlying parameters change, or for calculating Rao values for special radionuclides and age groups when performing the assessments discussed in Section 3.4.4 below. W = the annual average relative dispersion or deposition at the location of the controlling receptor, for release pathway v, as appropriate to exposure pathway p and radionuclide i. For all tritium pathways, and for the inhalation of any radionuclide: Wp is (X/Q)p, the annual average relative dispersion factor for release pathway v, at the location of the controlling receptor (s/M3). For the ground-plane exposure pathway, and for all in estion-related pathways for radionuclides other than tritium: Wvo is (D/Q)vp, the annual average relative deposition factor for release pathway v, at the location of the controlling receptor (m-2). Values of (X/Q)vp and (D/Q),p for use in calculating the dose to the currently-defined controlling receptor are included in Table 3-7. 3-35 Rev. 18

VEGP ODCM QV = the cumulative release of radionuclide i from release pathway v, during the period of interest (lCi). For the purpose of implementing the controls of Section 3.1.4, only 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days should be included in this calculation. In any dose assessment using the methods of this sub-section, only radio-nuclides detectable above background in their respective samples should be included in the calculation. Because the member of the public dose limit is on a per-unit basis, the summations extend over all gaseous final release pathways for a given unit. For a release pathway discharging materials originating in both reactor units, the activity discharged from the release point may be apportioned between the two units in any reasonable manner, provided that all activity released from the plant site is apportioned to one or the other unit. The gaseous final release pathways at the plant site, and the release elevation for each, are identified in Table 3-4. Rev. 18 3-36 Rev. 18

VEGP ODCM Table 3-7. Attributes of the Controlling Receptor The locations of members of the public in the vicinity of the plant site, and the exposure pathways associated with those locations, are determined in the Annual Land Use Census. Dispersion and deposition values were calculated based on site meteorological data collected for the period January 1, 1985 through December 31, 1987. Based on an analysis of this information, the current controlling receptor for the plant site is described as follows (References 15 and 22). Sector: SSW Distance: 4.7 miles Age Grouo: Child Exposure Pathways: Inhalation, ground plane, cow meat, and garden vegetation Dispersion Factors (X/Q),p: Ground-Level release points: 7.78 x 1-O s/iM 3 Mixed-Mode release points: 3.78 x 108 s/iM 3 Derosition Factors (D/Q).: Ground-Level release points: 3.43 x 10.1'0m 2 2 Mixed-Mode release points: 1.99 x 101 0 m 3-37 Rev. 18

VEGP ODCM 3.4.4 Dose Calculations to SuDmort Other Requirements Case 1: A radiological impact assessment may be required to support evaluation of a reportable event. Dose calculations may be performed using the equations in Section 3.4.3, with the substitution of the dispersion and deposition parameters [(X/Q) and (D/Q)] for the period covered by the report, and using the appropriate pathway dose factors (Raip) for the receptor of interest. Methods for calculating (X/Q) and (D/Q) from meteorological data are presented in Chapter 8. Values of Rap other than those presented in Tables 3-8 through 3-12 may need to be calculated. Methods and parameters for calculating values of Ras are presented in Chapter 9. When calculating Rao for evaluation of an event, pathway and usage factors specific to the receptor involved in the event may be used in place of the values in Chapter 9, if the specific values are known. Case 2: A dose calculation is required to evaluate the results of the Land Use Census, under the provisions of Section 4.1.2. In the event that the Land Use Census reveals that exposure pathways have changed at previously-identified locations, or if new locations are identified, it may be necessary to calculate doses at two or more locations to determine which should be designated as the controlling receptor. Such dose calculations may be performed using the equations in Section 3.4.3, with the substitution of the annual average dispersion and deposition values [m) and (MAO)] for the locations of interest, and using the appropriate pathway dose factors (Raw) for the receptors of interest. Methods for calculating (X/Q) and (D/Q) from meteorological data are presented in Chapter 8. The values of Ratp other than those presented in Tables 3-8 through 3-12 may need to be calculated. Methods and parameters for calculating values of Ra8p are presented in Chapter 9. Case 3: Under Section 5.2, a dose calculation may be required to support the determination of a component of the total dose to a receptor other than that currently defined as the controlling receptor. Dose calculations would be performed using the equations in Section 3.4.3, with the dispersion and deposition parameters and appropriate values of (Rao) for the receptor of interest. Appropriate values of the dispersion and deposition parameters, if not found in Table 3-7, would need to be calculated. Methods for calculating (XIQ) and (D/Q) from meterological data are presented in Chapter 8. Appropriate values of Rap, if not found in Tables 3-8 through 3-12, would need to be calculated. Methods and parameters for calculating values of Rao are presented in Chapter 9. Rev. 18 3-38 Rev. 18

VEGP ODCM Table 3-8. Rapj for Ground Plane Pathway, All Age Groups Nuclide T. Body l Skin H-3 0.00 0.00 C-14 0.00 0.00 P-32 0.00 0.00 Cr-51 4.66E+06 5.51 E+06 Mn-54 1.39E+09 1.63E+09 Fe-55 0.00 0.00 Fe-59 2.73E+08 3.21 E+08 Co-58 3.79E+08 4.44E+08 Co-60 2.15E+10 2.53E+10 Ni-63 0.00 0.00 Zn-65 7.47E+08 8.59E+08 Rb-86 8.99E+06 1.03E+07 Sr-89 2.16E+04 2.51 E+04 Sr-90 0.00 0.00 Y-91 1.07E+06 1.21 E+06 Zr-95 2.45E+08 2.84E+08 Nb-95 1.37E+08 1.61 E+08 Ru-103 1.08E+08 1.26E+08 Ru-106 4.22E+08 5.07E+08 Ag-11 Om 3.44E+09 4.01 E+09 Sb-124 5.98E+08 6.90E+08 Sb-125 2.34E+09 2.64E+09 Te-125m 1.55E+06 2.13E+06 Te-127m 9.16E+04 1.08E+05 Te-129m 1.98E+07 2.31 E+07 1-131 1.72E+07 2.09E+07 1-133 2.45E+06 2.98E+06 Cs-134 6.86E+09 8.OOE+09 Cs-136 1.51 E+08 1.71 E+08 Cs-137 1.03E+10 1.20E+10 Ba-140 2.05E+07 2.35E+07 Ce-141 1.37E+07 1.54E+07 Ce-144 6.95E+07 8.04E+07 Pr-143 0.00 0.00 Nd-147 8.39E+06 1.01 E+07

1. Units are m2_(mrem/yr)/(gCis).

2. The values in the Total Body column also apply to the Bone, Liver, Thyroid, Kidney, Lung, and GI-LLI organs.

3. This table also supports the calculations of section 6.2.

3-39 Rev. 18

VEGP ODCM Table 3-9. Ranpj for Inhalation Pathway, Child Age Group lNuclide Bone l Liver lT. Body Thyroid Kidney Lung GI-LLI H-3 0.00 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 C-14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 P-32 2.60E+06 1.14E+05 9.88E+04 0.00 0.00 0.00 4.22E+04 Cr-51 0.00 0.00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 1.08E+03 Mn-54 0.00 4.29E+04 9.51 E+03 0.00 1.OOE+04 1.58E+06 2.29E+04 Fe-55 4.74E+04 2.52E+04 7.77E+03 0.00 0.00 1.11 E+05 2.87E+03 Fe-59 2.07E+04 3.34E+04 1.67E+04 0.00 0.00 1.27E+06 7.07E+04 Co-58 0.00 1.77E+03 3.16E+03 0.00 0.00 1.11 E+06 3.44E+04 Co-60 0.00 1.31 E+04 2.26E+04 0.00 0.00 7.07E+06 9.62E+04 Ni-63 8.21 E+05 4.63E+04 2.80E+04 0.00 0.00 2.75E+05 6.33E+03 Zn-65 4.26E+04 1.13E+05 7.03E+04 0.00 7.14E+04 9.95E+05 1.63E+04 Rb-86 0.00 1.98E+05 1.14E+05 0.00 0.00 0.00 7.99E+03 Sr-89 5.99E+05 0.00 1.72E+04 0.00 0.00 2.16E+06 1.67E+05 Sr-90 1.01 E+08 0.00 6.44E+06 0.00 0.00 1.48E+07 3.43E+05 Y-91 9.14E+05 0.00 2.44E+04 0.00 0.00 2.63E+06 1.84E+05 Zr-95 1.90E+05 4.18E+04 3.70E+04 0.00 5.96E+04 2.23E+06 6.11 E+04 Nb-95 2.35E+04 9.18E+03 6.55E+03 0.00 8.62E+03 6.14E+05 3.70E+04 Ru-103 2.79E+03 0.00 1.07E+03 0.00 7.03E+03 6.62E+05 4.48E+04 Ru-106 1.36E+05 0.00 1.69E+04 0.00 1.84E+05 1.43E+07 4.29E+05 Ag-11im 1.69E+04 1.14E+04 9.14E+03 0.00 2.12E+04 5.48E+06 1.OOE+05 Sb-124 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sb-125 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Te-125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 0.00 4.77E+05 3.38E+04 Te-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 Te-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 1-131 4.81 E+04 4.81 E+04 2.73E+04 1.62E+07 7.88E+04 0.00 2.84E+03 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 0.00 5.48E+03 Cs-134 6.51 E+05 1.01 E+06 2.25E+05 0.00 3.30E+05 1.21 E+05 3.85E+03 Cs-136 6.51 E+04 1.71 E+05 1.16E+05 0.00 9.55E+04 1.45E+04 4.18E+03 Cs-1 37 9.07E+05 8.25E+05 1.28E+05 0.00 2.82E+05 1.04E+05 3.62E+03 Ba-140 7.40E+04 6.48E+01 4.33E+03 0.00 2.11 E+01 1.74E+06 1.02E+05 Ce-141 3.92E+04 1.95E+04 2.90E+03 0.00 8.55E+03 5.44E+05 5.66E+04 Ce-144 6.77E+06 2.12E+06 3.61 E+05 0.00 1.17E+06 1.20E+07 3.89E+05 Pr-143 1.85E+04 5.55E+03 9.14E+02 0.00 3.OOE+03 4.33E+05 9.73E+04 Nd-147 1.08E+04 8.73E+03 6.81 E+02 0.00 4.81 E+03 3.28E+05 8.21 E+04

1. Units are (mrem/yr)/(gCVm 3 ) for all radionuclides.

2. This table also supports the calculations of section 6.2.

3-40 Rev. 18

VEGP ODCM Table 3-10. Raipi for Inhalation Pathway, Adult Age Group lNuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 0.00 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 C-14 1.82E+04 3.41 E+03 3.41 E+03 3.41 E+03 3.41 E+03 3.41 E+03 3.41 E+03 P-32 1.32E+06 7.71 E+04 5.01 E+04 0.00 0.00 0.00 8.64E+04 Cr-51 0.00 0.00 1.OOE+02 5.95E+01 2.28E+01 1.44E+04 3.32E+03 Mn-54 0.00 3.96E+04 6.30E+03 0.00 9.84E+03 1.40E+06 7.74E+04 Fe-55 2.46E+04 1.70E+04 3.94E+03 0.00 0.00 7.21 E+04 6.03E+03 Fe-59 1.18E+04 2.78E+04 1.06E+04 0.00 0.00 1.02E+06 1.88E+05 Co-58 0.00 1.58E+03 2.07E+03 0.00 0.00 9.28E+05 1.06E+05 Co-60 0.00 1.15E+04 1.48E+04 0.00 0.00 5.97E+06 2.85E+05 Ni-63 4.32E+05 3.14E+04 1.45E+04 0.00 0.00 1.78E+05 1.34E+04 Zn-65 3.24E+04 1.03E+05 4.66E+04 0.00 6.90E+04 8.64E+05 5.34E+04 Rb-86 0.00 1.35E+05 5.90E+04 0.00 0.00 0.00 1.66E+04 Sr-89 3.04E+05 0.00 8.72E+03 0.00 0.00 1.40E+06 3.50E+05 Sr-90 9.92E+07 0.00 6.1 OE+06 0.00 0.00 9.60E+06 7.22E+05 Y-91 4.62E+05 0.00 1.24E+04 0.00 0.00 1.70E+06 3.85E+05 Zr-95 1.07E+05 3.44E+04 2.33E+04 0.00 5.42E+04 1.77E+06 1.50E+05 Nb-95 1.41 E+04 7.82E+03 4.21 E+03 0.00 7.74E+03 5.05E+05 1.04E+05 Ru-103 1.53E+03 0.00 6.58E+02 0.00 5.83E+03 5.05E+05 1.1OE+05 Ru-106 6.91 E+04 0.00 8.72E+03 0.00 1.34E+05 9.36E+06 9.12E+05 Ag-i1 Om 1.08E+04 1.OOE+04 5.94E+03 0.00 1.97E+04 4.63E+06 3.02E+05 Sb-124 3.12E+04 5.89E+02 1.24E+04 7.55E+01 0.00 2.48E+06 4.06E+05 Sb-125 6.61 E+04 7.13E+02 1.33E+04 5.87E+01 0.00 2.20E+06 1.01 E+05 Te-125m 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 Te-127m 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50E+05 Te-129m 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 1-131 2.52E+04 3.58E+04 2.05E+04 1.19E+07 6.13E+04 0.00 6.28E+03 1-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 0.00 8.88E+03 Cs-134 3.73E+05 8.48E+05 7.28E+05 0.00 2.87E+05 9.76E+04 1.04E+04 Cs-136 3.90E+04 1.46E+05 1.1 OE+05 0.00 8.56E+04 1.20E+04 1.17E+04 Cs-137 4.78E+05 6.21 E+05 4.28E+05 0.00 2.22E+05 7.52E+04 8.40E+03 Ba-1 40 3.90E+04 4.90E+01 2.57E+03 0.00 1.67E+01 1.27E+06 2.18E+05 Ce-141 1.99E+04 1.35E+04 1.53E+03 0.00 6.26E+03 3.62E+05 1.20E+05 Ce-144 3.43E+06 1.43E+06 1.84E+05 0.00 8.48E+05 7.78E+06 8.16E+05 Pr-143 9.36E+03 3.75E+03 4.64E+02 0.00 2.16E+03 2.81 E+05 2.OOE+05 Nd-147 5.27E+03 6.1OE+03 3.65E+02 0.00 3.56E+03 2.21 E+05 1.73E+05

1. Units are (mremlyr)/(p.Ci/m 3 ) for all radionuclides.

2. This table is included to support the calculations of section 6.2.

3-41 Rev. 18

VEGP ODCM Table 3-11. R.,,, for Cow Meat Pathway, Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 0.00 2.34E+02 2.34E+02 2.34E+02 2.34E+02 2.34E+02 2.34E+02 C-14 5.29E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 P-32 7.41 E+09 3.47E+08 2.86E+08 0.00 0.00 0.00 2.05E+08 Cr-51 0.00 0.00 8.79E+03 4.88E+03 1.33E+03 8.91 E+03 4.66E+05 Mn-54 0.00 8.01 E+06 2.13E+06 0.00 2.25E+06 0.00 6.72E+06 Fe-55 4.57E+08 2.42E+08 7.51 E+07 0.00 0.00 1.37E+08 4.49E+07 Fe-59 3.76E+08 6.09E+08 3.03E+08 0.00 0.00 1.77E+08 6.34E+08 Co-58 0.00 1.64E+07 5.02E+07 0.00 0.00 0.00 9.58E+07 Co-60 0.00 6.93E+07 2.04E+08 0.00 0.00 0.00 3.84E+08 Ni-63 2.91 E+10 1.56E+09 9.91 E+08 0.00 0.00 0.00 1.05E+08 Zn-65 3.75E+08 1.OOE+09 6.22E+08 0.00 6.30E+08 0.00 1.76E+08 Rb-86 0.00 5.77E+08 3.55E+08 0.00 0.00 0.00 3.71 E+07 Sr-89 4.82E+08 0.00 1.38E+07 0.00 0.00 0.00 1.87E+07 Sr-90 1.04E+1 0 0.00 2.64E+09 0.00 0.00 0.00 1.40E+08 Y-91 1.80E+06 0.00 4.82E+04 0.00 0.00 0.00 2.40E+08 Zr-95 2.66E+06 5.85E+05 5.21 E+05 0.00 8.38E+05 0.00 6.11 E+08 Nb-95 3.1 OE+06 1.21 E+06 8.62E+05 0.00 1.13E+06 0.00 2.23E+09 Ru-103 1.55E+08 0.00 5.96E+07 0.00 3.90E+08 0.00 4.01 E+09 Ru-106 4.44E+09 0.00 5.54E+08 0.00 5.99E+09 0.00 6.90E+1 0 Ag-11Dm 8.39E+06 5.67E+06 4.53E+06 0.00 1.06E+07 0.00 6.74E+08 Sb-124 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sb-125 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Te-125m 5.69E+08 1.54E+08 7.59E+07 1.60E+08 0.00 0.00 5.49E+08 Te-127m 1.77E+09 4.78E+08 2.11 E+08 4.24E+08 5.06E+09 0.00 1.44E+09 Te-129m 1.79E+09 5.OOE+08 2.78E+08 5.77E+08 5.26E+09 0.00 2.18E+09 1-131 1.65E+07 1.66E+07 9.46E+06 5.50E+09 2.73E+07 0.00 1.48E+6 1-133 5.67E-01 7.02E-01 2.66E-01 1.30E+02 1.17E+00 0.00 2.83E-01 Cs-134 9.22E+08 1.51 E+09 3.19E+08 0.00 4.69E+08 1.68E+08 8.16E+06 Cs-1 36 1.62E+07 4.46E+07 2.88E+07 0.00 2.37E+07 3.54E+06 1.57E+06 Cs-137 1.33E+09 1.28E+09 1.88E+08 0.00 4.16E+08 1.50E+08 7.99E+06 Ba-140 4.38E+07 3.84E+04 2.56E+06 0.00 1.25E+04 2.29E+04 2.22E+07 Ce-141 2.22E+04 1.11 E+04 1.64E+03 0.00 4.86E+03 0.00 1.38E+07 Ce-144 2.32E+06 7.26E+05 1.24E+05 0.00 4.02E+05 0.00 1.89E+08 Pr-143 3.34E+04 1.OOE+04 1.66E+03 0.00 5.43E+03 0.00 3.60E+07 Nd-147 1.1 7E+04 9.47E+03 7.33E+02 0.00 5.19E+03 0.00 1.50E+07 Units are (mrem/yr)/(iCVm 3) for tritium, and m2_(mrem/yr)/(jiCi/s) for all other radionuclides. Rev. 18 3-42 3-42 Rev. 18

VEGP ODCM Table 3-12. Raip, for Garden Vegetation Pathway, Child Age Group Nuclide Bone Liver [ T.Body l Thyroid [ Kidney Lung GI-LLI H-3 0.00 4.01 E+03 4.01 E+03 4.01 E+03 4.01 E+03 4.01 E+03 4.01 E+03 C-14 8.89E+08 1.78E+08 1.78E+08 1.78E+08 1.78E+08 1.78E+08 1.78E+08 P-32 3.37E+09 1.58E+08 1.30E+08 0.00 0.00 0.00 9.31 E+07 Cr-51 0.00 0.00 1.17E+05 6.50E+04 1.78E+04 1.19E+05 6.21 E+06 Mn-54 0.00 6.65E+08 1.77E+08 0.00 1.86E+08 0.00 5.58E+08 Fe-55 8.01 E+08 4.25E+08 1.32E+08 0.00 0.00 2.40E+08 7.87E+07 Fe-59 3.98E+08 6.43E+08 3.20E+08 0.00 0.00 1.86E+08 6.70E+08 Co-58 0.00 6.44E+07 1.97E+08 0.00 0.00 0.00 3.76E+08 Co-60 0.00 3.78E+08 1.12E+09 0.00 0.00 0.00 2.1OE+09 Ni-63 3.95E+10 2.11 E+09 1.34E+09 0.00 0.00 0.00 1.42E+08 Zn-65 8.13E+08 2.16E+09 1.35E+09 0.00 1.36E+09 0.00 3.80E+08 Rb-86 0.00 4.52E+08 2.78E+08 0.00 0.00 0.00 2.91 E+07 Sr-89 3.60E+10 0.00 1.03E+09 0.00 0.00 0.00 1.39E+09 Sr-90 1.24E+12 0.00 3.15E+11 0.00 0.00 0.00 1.67E+10 Y-91 1.86E+07 0.00 4.99E+05 0.00 0.00 0.00 2.48E+09 Zr-95 3.86E+06 8.48E+05 7.55E+05 0.00 1.21 E+06 0.00 8.85E+08 Nb-95 4.1 OE+05 1.60E+05 1.14E+05 0.00 1.50E+05 0.00 2.96E+08 Ru-1 03 1.53E+07 0.00 5.90E+06 0.00 3.86E+07 0.00 3.97E+08 Ru-106 7.45E+08 0.00 9.30E+07 0.00 1.01 E+09 0.00 1.16E+10 Ag-1 Om 3.21 E+07 2.17E+07 1.73E+07 0.00 4.04E+07 0.00 2.58E+09 Sb-124 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sb-125 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Te-125m 3.51 E+08 9.50E+07 4.67E+07 9.84E+07 0.00 0.00 3.38E+08 Te-127m 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3.77E+09 0.00 1.07E+09 Te-129m 8.41 E+08 2.35E+08 1.31 E+08 2.71 E+08 2.47E+09 0.00 1.03E+09 1-131 1.43E+08 1.44E+08 8.17E+07 4.75E+10 2.36E+08 0.00 1.28E+07 1-133 3.53E+06 4.37E+06 1.65E+06 8.11 E+08 7.28E+06 0.00 1.76E+06 Cs-134 1.60E+10 2.63E+10 5.55E+09 0.00 8.15E+09 2.93E+09 1.42E+08 Cs-136 8.24E+07 2.27E+08 1.47E+08 0.00 1.21 E+08 1.80E+07 7.96E+06 Cs-1 37 2.39E+10 2.29E+1 0 3.38E+09 0.00 7.46E+09 2.68E+09 1.43E+08 Ba-1 40 2.77E+08 2.42E+05 1.61 E+07 0.00 7.89E+04 1.45E+05 1.40E+08 Ce-141 6.56E+05 3.27E+05 4.86E+04 0.00 1.43E+05 0.00 4.08E+08 Ce-144 1.27E+08 3.98E+07 6.78E+06 0.00 2.21 E+07 0.00 1.04E+1 0 Pr-1 43 1.46E+05 4.37E+04 7.23E+03 0.00 2.37E+04 0.00 1.57E+08 Nd-147 7.15E+04 5.79E+04 4.48E+03 0.00 3.18E+04 0.00 9.17E+07 Units are (mrem/yr)/(gCi/m 3) for tritium, and m2_(mrem/yr)/(RCi/s) for all other radionuclides. 3-43 Rev. 18

3.5 ) ) I

VEGP ODCM 3.5 GASEOUS EFFLUENT DOSE PROJECTIONS 3.5.1 Thirty-One Day Dose Proiections In order to meet the requirements of the limit for operation of the gaseous radwaste treatment system (see Section 3.1.5), dose projections must be made at least once each 31 days; this applies during periods in which a discharge to areas at or beyond the SITE BOUNDARY of gaseous effluents containing radioactive materials occurs or is expected. Projected 31-day air doses and doses to individuals due to gaseous effluents may be determined as follows: For air doses: D =l x 31 + Da (3.16) DWp = x 31 + Dp For individual doses: Dop = -oc x31+D (3.17) where: Dop = the projected air dose due to beta emissions from noble gases, for the next 31 days of gaseous releases. Djk = the cumulative air dose due to beta emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration. Do = the anticipated air dose due to beta emissions from noble gas releases, contributed by any planned activities during the next 31-day period, if those activities will result in gaseous releases that are in addition to routine gaseous effluents. If only routine gaseous effluents are anticipated, DA, may be set to zero. DW = the projected air dose due to gamma emissions from noble gases for the next 31 days of gaseous releases. D' = the cumulative air dose due to gamma emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration. DI = the anticipated air dose due to gamma emissions from noble gas releases, contributed by any planned activities during the next 31-day period, if those activities will result in gaseous releases that are in addition to routine 3-44 3Rev. 18

VEGP ODCM gaseous effluents. If only routine gaseous effluents are anticipated, D. may be set to zero. Dop = the projected dose to the total body or organ o, due to releases of 1-131, 1-133, tritium, and particulates for the next 31 days of gaseous releases. Doe = the cumulative dose to the total body or organ o, due to releases of 1-131, 1-133, tritium, and particulates that have occurred in the elapsed portion of the current quarter, plus the release under consideration. Dot = the anticipated dose to the total body or organ o, due to releases of 1-131, 1-133, tritium, and particulates, contributed by any planned activities during the next 31-day period, if those activities will result in gaseous releases that are in addition to routine gaseous effluents. If only routine gaseous effluents are anticipated, Doa may be set to zero. t = the number of whole or partial days elapsed into the current quarter, including the time to the end of the release under consideration (even if the release continues into the next quarter). 3.5.2 Dose Proiections for Specific Releases Dose projections may be performed for a particular release by performing a pre-release dose calculation assuming that the planned release will proceed as anticipated. For air dose and individual dose projections due to gaseous effluent releases, follow the methodology of Section 3.4, using sample analysis results for the gaseous stream to be released, and parameter values expected to exist during the release period. 3-45 Rev. 18

II 3.6 I ) ) 3

VEGP ODCM 3.6 DEFINITIONS OF GASEOUS EFFLUENT TERMS Section of Term Definition Initial Use AG = the administrative allocation factor for gaseous streams, applied to divide the gaseous release limit among all the release pathways [unitless]. 3.3.2.1 AG, = the administrative allocation factor for gaseous source stream s, applied to divide the gaseous release limit among all the release pathways [unitless]. 3.3.3 AG, = the administrative allocation factor for gaseous release pathway v, applied to divide the gaseous release limit among all the release pathways [unitless]. 3.3.2.2 c= the setpoint of the radioactivity monitor measuring the concentration of radioactivity in the effluent line prior to release [fjCVmL]. 3.3.2.1 Cas = the calculated noble gas effluent monitor setpoint for gaseous source stream s [IiCVmL]. 3.3.3 c,, = the calculated noble gas effluent monitor setpoint for release pathway v [gCVmL]. 3.3.2.2 D,, = the dose to organ j of an individual in age group a, due to gaseous releases of 1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days [mrem]. 3.4.3 Doa = the anticipated dose to organ o due to releases of non-noble-gas radionuclides, contributed by any planned activities during the next 31-day period [mrem]. 3.5.1 D,, = the cumulative dose to organ o due to releases of non-noble-gas radionuclides that have occurred in the elapsed portion of the current quarter, plus the release under consideration [mrem]. 3.5.1 Dop = the projected dose to organ o due to the next 31 days of gaseous releases of non-noble-gas radionuclides [mrem]. 3.5.1 Dp= the air dose due to beta emissions from noble gas radionuclides [mrad]. 3.4.2 D,= the anticipated air dose due to beta emissions from noble gas releases, contributed by any planned activities during the next 31-day period [mrad). 3.5.1 Rev. 18 3-46 3-46 Rev. 18

VEGP ODCM Section of Term Definition Initial Use D, = the cumulative air dose due to beta emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration [mrad]. 3.5.1 Do = the projected air dose due to beta emissions from noble gases, for the next 31 days of gaseous releases [mrad]. 3.5.1 Do= the air dose due to gamma emissions from noble gas radionuclides [mrad]. 3.4.2 Dza = the anticipated air dose due to gamma emissions from noble gas releases, contributed by any planned activities during the next 31-day period [mrad]. 3.5.1 Dr = the cumulative air dose due to gamma emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration [mrad]. 3.5.1 Dyp = the projected air dose due to gamma emissions from noble gases, for the next 31 days of gaseous releases [mrad]. 3.5.1 (D/Q)v = the annual average relative deposition factor for release pathway v, at the location of the controlling receptor, from Table 3-7 [mr 2]. 3.4.3 DRk = the skin dose rate at the time of the release [mrem/y]. 3.4.1.1 DR, = the dose rate to organ o at the time of the release [mrem/y]. 3.4.1.2 DRt = the total body dose rate at the time of the release [mrem/y]. 3.4.1.1 f" = the maximum anticipated actual discharge flowrate for release pathway v during the period of the planned release [mUs]. 3.3.2.2 f's = the maximum anticipated actual discharge flowrate for gaseous source stream s during the period of the planned release [mUs]. 3.3.3 K, = the total body dose factor due to gamma emissions from noble gas radionuclide i, from Table 3-5 [(mrem/y)/(gCVm 3 )]. 3.3.2.2 L= the skin dose factor due to beta emissions from noble gas radio-nuclide i, from Table 3-5 [(mrem/y)/(jiCim 3)]. 3.3.2.2 M= the air dose factor due to gamma emissions from noble gas radionuclide i, from Table 3-5 [(mrad/y)/(gCifm 3 )]. 3.4.2 Rev. 18 3-47 Rev. 18

VEGP ODCM Section of Term Definition Initial Use N= the number of simultaneously active gaseous release pathways [unitless]. 3.3.4 N.= the air dose factor due to beta emissions from noble gas radio-nuclide i, from Table 3-5 [(mrad/y)I(gCim 3)]. 3.4.2 PO = the site-specific dose factor for radionuclide i (1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days) and organ o. The values of Pi are equal to the site-specific Ra., values presented in Table 3-9 [(mremfy)/(CVm3)]. 3.4.1.2 0,, = the release rate of noble gas radionuclide i from release pathway v during the period of interest [giC/s]. 3.3.2.2 the release rate of radionuclide i (1-131, 1-133, tritium, and radio-nuclides in particulate form with half-lives greater than 8 days) from gaseous release pathway v during the period of interest [gCVs]. 3.4.1.2

   =  the cumulative release of noble gas radionuclide i from release pathway v during the period of interest [gCi].                                 3.4.2 the cumulative release of non-noble-gas radionuclide i from release pathway v, during the period of interest [FCi].                        3.4.3 Ra.p = the site-specific dose factor for age group a, radionuclide i, exposure pathway p, and organ j. Values and units of RaI for each exposure pathway, age group, and radionuclide that may arise in calculations for implementing Section 3.1.4 are listed in Table 3-8 through Table 3-9.                                                   3.4.3 Rk =   the ratio of the skin dose rate limit for noble gases, to the skin dose rate due to noble gases in the release under consideration

[unitless]. 3.3.2.1 Rt= the ratio of the total body dose rate limit for noble gases, to the total body dose rate due to noble gases in the release under consideration [unitless]. 3.3.2.1 rk = the ratio of the skin dose rate limit for noble gases, to the skin dose rate due to noble gases in the source stream under consideration [unitless]. 3.3.3.1 r= the ratio of the total body dose rate limit for noble gases, to the total body dose rate due to noble gases in the source stream under consideration [unitless]. 3.3.3.1 3-48 Rev. 18

VEGP ODCM Section of Term Definition Initial Use SF= the safety factor used in gaseous setpoint calculations to compensate for statistical fluctuations and errors of measurement [unitless]. 3.3.2.2 t= the number of whole or partial days elapsed in the current quarter, including the period of the release under consideration. 3.5.1 the annual average relative dispersion [(X/Qp] or deposition [(D/Q),p] at the location of the controlling receptor, for release pathway v, as appropriate to exposure pathway p and radionuclide i. 3.4.3 X= the noble gas concentration for the release under consideration [5CVmLJ. 3.3.2.1 the concentration of radionuclide i applicable to active gaseous release pathway r [gCVmL]. 3.3.4 Xir = the measured concentration of radionuclide i in gaseous source stream s [giCGmL]. 3.3.3 X1v = the measured concentration of radionuclide i in gaseous stream v [4CVmL]. 3.3.2.2 (X/Q) = the highest relative concentration at any point at or beyond the SITE BOUNDARY [s/mn3 . 3.3.2.1 (XIQ).b = the annual average SITE BOUNDARY relative concentration applicable to active gaseous release pathway r [s/m3 ]. 3.3.4 (X/Q)Vb = the highest annual average relative concentration at the SITE BOUNDARY for the discharge point of release pathway v, from Table 3-4 [s/m3 ]. 3.3.2.2 (X/Q)p = annual average relative dispersion factor for release pathway v, at the location of the controlling receptor, from Table 3-7 [s/mr3 . 3.4.3 Rev. 18 3-49 3-49 Rev. 18

                                       ,~ ~ I',~ ,    '. . r @

Chapter 4 - Radiological Environ- \ mental Monitoring Program V .11 ) 3 3

4.1

)  ) 3

VEGP ODCM CHAPTER 4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 4.1 LIMITS OF OPERATION The following limits are the same for both units at the site. Thus, a single program including monitoring, land use survey, and quality assurance serves both units. 4.1.1 Radiological Environmental Monitorina The Radiological Environmental Monitoring Program (REMP) shall be conducted as specified in Table 4-1. 4.1.1.1 Applicability This control applies at all times. 4.1.1.2 Actions 4.1.1.2.1 With the REMP not being conducted as specified in Table 4-1, submit to the Nuclear Regulatory Commission (NRC), in the Annual Radiological Environmental Operating Report, a description of the reasons for not conducting the program as required and the plans for preventing a recurrence. Deviations from the required sampling schedule are permitted if specimens are unobtainable due to hazardous conditions, unavailability, inclement weather, equipment malfunction, or other just reasons. If deviations are due to equipment malfunction, efforts shall be made to complete corrective action prior to the end of the next sampling period. 4.1.1.2.2 With the confirmed' measured level of radioactivity as a result of plant effluents in an environmental sampling medium specified in Table 4-1 exceeding the reporting levels of Table 4-2 when averaged over any calendar quarter, submit within 30 days a special report to the NRC. The special report shall identify the cause(s) for exceeding the limit(s) and define the corrective action(s) to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of Sections 2.1.3, 3.1.3, and 3.1.4. The methodology and parameters used to estimate the potential annual dose to a MEMBER OF THE PUBLIC shall be indicated in the special report. When more than one of the radionuclides in Table 4-2 are detected in the sampling medium, this report shall be submitted if: concentration(1) concentration (2)

                                                +-                     +---  2 1.0 reportinglevel (1)    reporting level (2)

When radionuclides other than those in Table 4-2 are detected and are the result of plant effluents, this special report shall be submitted if the potential annual dose to a MEMBER OF THE Defined as confirmed by reanalysis of the original sample, or analysis of a duplicate or new sample, as appropriate. The results of the confirmatory analysis shall be completed at the earliest time consistent with the analysis. Rev. 18 4-1 4-1 Rev. 18

VEGP ODCM PUBLIC is equal to or greater than the calendar year limits stated in Sections 2.1.3, 3.1.3, and 3.1.4. This special report is not required if the measured level of radioactivity was not the result of plant effluents; however, in such an event, the condition shall be described in the Annual Radiological Environmental Operating Report. The levels of naturally-occurring radionuclides which are not included in the plant's effluent releases need not be reported. 4.1.1.2.3 If adequate samples of milk, or during the growing season, grass or leafy vegetation, can no longer be obtained from one or more of the sample locations required by Table 4-1, or if the availability is frequently or persistently wanting, efforts shall be made: to identify specific locations for obtaining suitable replacement samples; and to add any replacement locations to the REMP given in the ODCM within 30 days. The specific locations from which samples became unavailable may be deleted from the REMP. Pursuant to Technical Specification 5.5.1, documentation shall be submitted in the next Radioactive Effluent Release Report for the change(s) in the ODCM, including revised figure(s) and table(s) reflecting the changes to the location(s), with supporting information identifying the cause of the unavailability of samples and justifying the selection of any new location(s). 4.1.1.2.4 This control does not affect shutdown requirements or MODE changes. 4.1.1.3 Surveillance Requirements The REMP samples shall be collected pursuant to Table 4-1 from the locations described in Section 4.2, and shall be analyzed pursuant to the requirements of Table 4-1 and Table 4-3. Required detection capabilities for thermoluminescent dosimeters used for environmental measurements shall be in accordance with the recommendations of Regulatory Guide 4.13. Program changes may be initiated based on operational experience. Analyses shall be performed in such a manner that the stated MINIMUM DETECTABLE CONCENTRATIONs (MDCs) will be achieved under routine conditions. Occasionally background fluctuations, unavoidable small sample sizes, the presence of interfering radionuclides, or other uncontrollable circumstances may render these MDCs unachievable. In such cases, the contributing factors will be identified and described in the Annual Radiological Environmental Operating Report. 4.1.1.4 Basis The REMP required by this control provides representative measurements of radiation and of radioactive materials in those exposure pathways, and for those radionuclides, which lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the plant operation. The REMP implements Section IV.B.2, Appendix I, 10 CFR 50, and thereby supplements the radiological effluent monitoring program by measuring concentrations of radioactive materials and levels of radiation, which may then be compared with those expected on the basis of the effluent measurements and modeling of the environmental exposure pathways. The detection capabilities required by Table 4-3 are within state-of-the-art for routine environmental measurements in industrial laboratories. Rev. 18 4-2 4-2 Rev. 18

( Exposure Number of Representative Samples and Sample Sampling and Type and -4 (D I Pathway Loain~)Collection Frequency of and/or Sample tnFrequency Analysis

1. DIRECT RADIATION M

                                                                                                                   -L Direct Radia- Thirty-six or more routine monitoring stations, either  Quarterly.          Gamma dose tion(2)       with two or more dosimeters, or with one instrument                         quarterly.          0.

0 for measuring and recording dose rate continuously, Co placed as follows: 0 0 An inner ring of stations, one in each meteorological m sector in the general area of the site boundary. An outer ring of stations, one in each meteorological 3(D sector at approximately 5 miles from the site. X Ca, The balance of the stations to be placed In special _3 0 Interest areas such as population centers, nearby 0 residences, schools, and in one or more areas to M. serve as control stations. ___._ _._.

                                                                                                                  -U

2. AIRBORNE Radiolodine Samples from 5 or more locations as follows: Continuous Radioiodine 0 (a

and Partic- sampler operation Canister: 1-131 ~1 ulates Three or more samples from close to the three site with sample analysis weekly. 3 boundary locations, in different sectors. collection weekly, or more frequently Particulate One sample from the vicinity of a community having if required by dust Sampler: Gross the highest calculated annual average ground-level loading. beta radioactivity D/Q. analysis following filter change, and One sample from a control location, as, for example, gamma isotopic CD a population center 10 to 20 miles distant and In the analysis of M a, least prevalent wind direction. composite (by G)

                                                                                                                       -U location)                0 quarterly.(3)(4)         C.

( ( ( Exposure Number of Representative Samples Sampling and Collection Type and Frequency of Pathway n and Sample Locations(1) Frequency Analysis and/or Sample 11_ _ _ _ _ _ _ _ _ _ _ _

3. WATERBORNE Surface(5) One sample upstream. Composite sample over 1- Gamma Isotopic analysis month period.(6) monthly; composite for One sample downstream. tritium analysis quarterly.(4)

Drinking Two samples at each of the one to Composite sample of river 1-131 analysis on each three nearest water treatment plants water near Intake at each sample when the dose that could be affected by discharges water treatment plant over calculated for the from the facility. 2-week consumption of the water period when 1-131 analysis is greater than 1 mrem per Two samples at a control location. Is performed, monthly year. Composite for gross composite otherwise; and beta and gamma isotopic grab sample of finished analyses monthly. water at each water Composite for tritlum treatment plant every 2 analysis quarterly.(4)(7) weeks or monthly, as appropriate.(6) Sediment from One sample from downstream area Semiannually. Gamma isotopic analysis Shoreline with existing or potential recreational semiannually.(4) value. c m G) co 0U 0

( ( ( Exposure Number of Representative Samples and Sample Sampling and Type and Pathway Loain~)Collection Frequency of an/rSample Loaln()Frequency Analysis

4. INGESTION Milk Samples from milking animals In three locations within 3 Semimonthly. Gamma miles distance having the highest dose potential; If there are Isotopic none, then one sample from milking animals In each of three analysis semi-areas between 3 and 5 miles distance where doses are monthly.(4)(8) calculated to be greater than 1 mrem per year.(7)

One sample from milking animals at a control location about 10 miles distant or beyond, and preferably In a wind direction of low prevalence. Fish At least one sample of any commercially and recreatlonally Semiannually. Gamma Important species in vicinity of plant discharge area. Isotopic analyses on 01 At least one sample of any species in areas not influenced edible by plant discharge. portions.(4) At least one sample of any anadromous species in vicinity of During spring Gamma plant discharge. spawning Isotopic season. analyses on edible

                       ._                                                                         portion.(4)

Grass or One sample from two onsite locations near the site Monthly during Gamma Leafy boundary In different sectors. growing season. isotopic.(4)(8) Vegetation One sample from a control location about 15 miles distant. Monthly during Gamma _ growing season. isotopic.(4)(8) 71 m G) 09 0

TABLE NOTATIONS C-(v (1) For each sample location in this table, specific parameters of distance and direction sector from a point midway betwo 8 the center of the two reactors, and additional description where pertinent, are provided in Table 4-4, and in Figure 4-1 , through Figure 4-4 of this ODCM. (2) One or more Instruments, such as a pressurized Ion chamber, for measuring and recording dose rate continuously, n D be used In place of or In addition to Integrating dosimeters. For the purpose of this table, a thermoluminescent dosirrn-(TLD) Is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimete . Film badges shall not be used as dosimeters for measuring direct radiation. 0 (3) Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to all m for radon and thoron daughter decay. If gross beta activity in air particulate samples is greater than 10 times the yea < mean of control samples, gamma isotopic analysis shall be performed on the Individual samples. 0 (4) Gamma Isotopic analysis means the Identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility. 0 (5) The upstream sample shall be taken at a distance beyond significant Influence of the discharge. The downstream M sample shall be taken In an area beyond but near the mixing zone. 0 (6) Composite sample aliquots shall be collected at time Intervals that are very short (e.g., hourly) relative to the composi -U period (e.g., monthly) In order to assure obtaining a representative sample. 0 (7) The dose shall be calculated for the maximum organ and age group, using the methodology and parameters in the 3 ODCM. 8 (8) If gamma isotopic analysis is not sensitive enough to meet the required MDC for 1-131, a separate analysis for 1-131 , be performed. a < CD M

( ( ( Analysis Water (pCi/L) I Airborne Particulate or Fish (pCM(kg, wet) Milk (pCI/L) Grass or Leafy Vegetation _ __ __ __ __ _ _ _ _ _ _ _ Gases (PCI/rn) I_ _ _ _ _ _ __(pC  !/kg, w t H-3 2 E+4( Mn-54 1 E+3 3 E+4 Fe-59 4 E+2 1 E+4 Co-58 1 E+3 3 E+4 Co-60 3 E+2 1 E+4 Zn-65 3 E+2 2 E+4 Zr-95 4 E+2 Nb-95 7 E+2 1-131 2 E+Ob 9 E-1 3 E+O 1 E+2 Cs-134 3 E+1 1 E+1 1 E+3 6 E+1 1 E+3 Cs-137 5 E+1 2 E+1 2 E+3 7 E+1 2 E+3 Ba-140 2 E+2 3 E+2 La-140 1 E+2 _ 4 E+2

a. This is the 40 CFR 141 value for drinking water samples. If no drinking water pathway exists, a value of 3 E+04 pCi/L may be used.

b. If no drinking water pathway exists, a value of 20 pCi/L may be used.

m G) c0 -L -U 0 C-

( ( (

                                                                                                                                   -4 0

Minimum Detectable Concentration MiDC)a 4<> Analysis Water (pCVL) I AIrborne Particulate or3 Fish (pC/kg, wet) Milk MpCL Grass or Leafy Sediment C,, (piI) Gases (pC Vm) JpCgwe) piL) Vegetation (pCVkg, wet) 1(Ckdy (pCIkg, dry) 0 Gross Beta 4 E+O I E-2 H-3 2 E+ 3 b CD Mn-54 1.5 E+1 1.3 E+2 o Fe-59 3 E+1 2.6 E+2 0 Co-58, Co-60 1.5 E+1 1.3 E+2 CD Zn-65 3 E+1 2.6 E+2 Zr-95 3 E+1 =r 2. Nb-95 1.5 E+1 C K a 1-131 1 E+Or 7 E-2 1 E+O 6 E+1 Cs-134 1.5 E+1 5 E-2 1.3 E+2 1.5 E+1 6 E+1 1.5 E+2 CD Cs-137 1.8 E+1 6 E-2 1.5 E+2 1.8 E+1 8 E+1 1.8 E+2 0 0~ Ba-140 6 E+1 6 E+1 o La-140 1.5 E+1 1.5 E+1 _ 0 0 0

a. See the definition of MINIMUM DETECTABLE CONCENTRATION In Section 10.1. Other peaks which are 0

measurable and Identifiable as plant effluents, together with the radionuclides in this table, shall be analyzed and reported In accordance with Section 7.1.

b. If no drinking water pathway exists, a value of 3 E+3 pCVL may be used.

c. If no drinking water pathway exists, a value of 1.5 E+1 pCi/L may be used.

0 c m G) co

                                                                                                                                       -U 0

0

VEGP ODCM 4.1.2 Land Use Census A land use census shall be conducted and shall identify the following within a distance of 5 miles in each of the 16 meteorological sectors: the location of the nearest milk animal,' the nearest permanent residence, and the nearest garden of greater than 500 square feet producing broad leafy vegetation. Land within the Savannah River Site is excluded from this census. 4.1.2.1 Applicability This control applies at all times. 4.1.2.2 Actions 4.1.2.2.1 With a land use census identifying a location(s) which yields a calculated dose or dose commitment greater than values currently being calculated in accordance with Section 3.4.3, identify the new location(s) in the next Radioactive Effluent Release Report. 4.1.2.2.2 With a land use census identifying a location(s) which yields a calculated dose or dose commitment (via the same exposure pathway) 20 percent greater than at a location from which samples are currently being obtained in accordance with Section 4.1.1, add the new location(s) to the REMP within 30 days if samples are available. The sampling location, excluding control station location(s), having the lowest calculated dose or dose commitment (via the same exposure pathway) may be deleted from the REMP if new sampling locations are added. Pursuant to Technical Specification 5.5.1 submit in the next Radioactive Effluent Release Report any change(s) in the ODCM, including the revised figure(s) and table(s) reflecting any new location(s) and information supporting the change(s). 4.1.2.2.3 This control does not affect shutdown requirements or MODE changes. 4.1.2.3 Surveillance Requirements The land use census shall be conducted annually, using that information which will provide good results, such as a door-to-door census, a visual census from automobile or aircraft, consultation with local agriculture authorities, or some combination of these methods, as feasible. Results of the land use census shall be included in the Annual Radiological Environmental Operating Report. 4.1.2.4 Basis This control is provided to ensure that changes in the use of UNRESTRICTED AREAS are identified and that modifications to the REMP are made if required by the results of this census. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 500 ft2 provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 kgly) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the 1 Defined as a cow or goat that is producing milk for human consumption. Rev. 18 4-9 4-9 Rev. 18

VEGP ODCM following assumptions were made: (1) 20 percent of the garden was used for growing broad leaf vegetation (i.e., similar to lettuce and cabbage) and (2) a vegetation yield of 2 kg/M2 was obtained. 4.1.3 Interlaboratorv Comparison Program Analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which satisfies the requirements of Regulatory Guide 4.15, Revision 1, February, 1979. 4.1.3.1 Applicability This control applies at all times. 4.1.3.2 Actions With analyses not being performed as required by Section 4.1.3, report the corrective actions taken to prevent a recurrence in the Annual Radiological Environmental Operating Report. This control does not affect.shutdown requirements or MODE changes. 4.1.3.3 Surveillance Requirements A summary of the results obtained as part of the required Interlaboratory Comparison Program shall be included in the Annual Radiological Environmental Operating Report. 4.1.3.4 Basis The requirement for participation in an approved Interlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring, in order to demonstrate that the results are reasonably valid for the purposes of Section IV.B.2, Appendix 1,10 CFR 50. 4-10 Rev. 18

4.2

   )

VEGP ODCM 4.2 RADIOLOGICAL ENVIRONMENTAL MONITORING LOCATIONS Table 4-4, and Figure 4-1 through Figure 4-4 specify the locations at which the measurements and samples are taken for the REMP required by Section 4.1.1. Rev. 18 4-11 4-11 Rev. 18

VEGP ODCM Table 4-4. Radiological Environmental Monitoring Locations Location Descriptive Location Direction Distance Sample Number (miles) Type(1 ) 1 River Bank N 1.1 D 2 River Bank NNE 0.8 D 3 Discharge Area NE 0.6 A 3 River Bank NE 0.7 D 4 River Bank ENE 0.8 D 5 River Bank E 1.0 D 6 Plant Wilson ESE 1.1 D 7 Simulator Building SE 1.7 D,V,A 8 River Road SSE 1.1 D 9 River Road S 1.1 D 10 Met Tower SSW 0.9 A 10 River Road SSW 1.1 D 11 River Road SW 1.2 D 12 River Road WSW 1.2 D,A 13 River Road W 1.3 D 14 River Road WNW 1.8 D 15 Hancock Landing Road NW 1.5 D,V 16 Hancock Landing Road NNW 1.4 D,A 17 Savannah River Site, River Road N 5.4 D 18 Savannah River Site, D Area NNE 5.0 D 19 Savannah River Site, Road A. NE 4.6 D 20 Savannah River Site, Road A.13.1 ENE 4.8 D 21 Savannah River Site, Road A.17 E 5.3 D 22 River Bank Downstream of Buxton ESE 5.2 D Landing 23 River Road SE 4.6 D 24 Chance Road SSE 4.9 D 25 Chance Road near Highway 23 S 5.2 D 26 Hihway 23 and Ebenezer Church SSW 4.6 D Rev. 18 4-12 4-12 Rev. 18

VEGP ODCM Table 4-4 (contd). Radiological Environmental Monitoring Locations Location Number 1 Descriptive Location (Direction Distance (miles) Sample Type") 27 Highway 23, opposite Boll Weevil SW 4.7 D Road 28 Thomas Road WSW 5.0 D 29 Claxton-Lively Road W 5.1 D 30 Nathaniel Howard Road WNW 5.0 D 31 River Road at Allen's Chapel Fork NW 5.0 D 32 River Bank NNW 4.7 D 35 Girard SSE 6.6 D,A 36 GPC Waynesboro Operating WSW 13.9 D,A Headquarters 37 Substation; Waynesboro, GA WSW 16.7 D,V 43 Employees Recreation Area SW 2.2 D 47 Oak Grove Church SE 10.4 D 48 McBean Cemetery NW 10.2 D 51 SGA School; Sardis, GA S 11.0 D 52 Oglethorp Substation; SW 10.7 D Alexander, GA 80 Augusta Water Treatment Plant NNW 29.0 W(2 ) 81 Savannah River - N 2.5 F(3) S(4 82 Savannah River (RM 151.2) NNE 0.8 R 83 Savannah River (RM 150.4) ENE 0.8 RS(4_ 84 Savannah River (RM 149.5) ESE 1.6 R 85 Savannah River ESE 4.3 F(3) 87 Beaufort - Jasper Water Treatment SE 76.0 WM Plant; Beaufort, SC l 88 Cherokee Hill Water Treatment SSE 72.0 W(6) Plant; Port Wentworth, GA l 98 W.C. Dixon Dairy SE 9.8 M 99 Boyceland Dairy W 20.9 M Rev. 18 4-13 Rev. 18

VEGP ODCM Table 4-4 (cont.) Radiological Environmental Monitoring Locations TABLE NOTATIONS (1) Sample Types: A - Airborne Radioactivity D - Direct Radiation F - Fish M - Milk R - River Water S - River Shoreline Sediment W - Drinking Water (at water treatment plant) V - Vegetation (2) The intake for the Augusta Water Treatment Plant is located on the Augusta Canal. The entrance to this canal is at river mile (RM) 207 on the Savannah River. The canal effectively parallels the river. The intake to the pumping station is about 4 miles down the canal and only 0.1 mile from the river (across land). (3) About a 5-mile stretch of the river is generally needed to obtain adequate fish samples. Samples are normally gathered between RM 153 and 158 for upriver collections and between RMs 144 and 149.4 for downriver collections. (4) Sediment is collected at locations with existing or potential recreational value. High water shifting of the river bottom or other reasons could cause a suitable location for sediment collection to become unavailable or unsuitable. Thus, a stretch of river between RM 148.5 and 150.5 is designated for downriver sediment collections, while a stretch between RM 153 and 154 is designated for upriver collections. In practice, collections are normally made at RM 150.2 for downriver collections and at RM 153.3 for upriver collections. (5) The intake for the Beaufort-Jasper Water Treatment Plant is located at the end of a canal which begins at RM 39.3 on the Savannah River. This intake is about 16 miles by line of sight down the canal from its beginning on the Savannah River. (6) The intake for the Cherokee Hill Water Treatment Plant is located on Abercorn Creek, which is about one and a quarter creek miles from its mouth on the Savannah River at RM 29. Rev. 18 4-14 4-14 Rev. 18

VEGP ODCM Figure 4-1. Terrestrial Stations Near Site Boundary Rev. 18 4-15 4-15 Rev. 18

VEGP ODCM Figure 4-2. Terrestrial Stations and Aquatic Stations, 0-5 Miles Rev. 18 4-16 Rev. 18

VEGP ODCM Figure 4-3. Terrestrial Stations Beyond 5 Miles Rev. 18 4-17 Rev. 18

VEGP ODCM FigureA-4. Drinking Water Stations 4-18 Rev. 18

i Chapter 5 - Total Dose Determinations I 3

5.1

1) 9

VEGP ODCM CHAPTER 5 TOTAL DOSE DETERMINATIONS 5.1 LIMIT OF OPERATION In accordance with Technical Specification 5.5.4.j, the dose or dose commitment to any MEMBER OF THE PUBLIC over a calendar year, due to releases of radioactivity and to radiation from uranium fuel cycle sources, shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem. 5.1.1 Applicability This limit applies at all times. 5.1.2 Actions With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of Section 2.1.3, 3.1.3, or 3.1.4, calculations shall be made according to Section 5.2 methods to determine whether the limits of Section 5.1 have been exceeded. If these limits have been exceeded, prepare and submit a special report to the Nuclear Regulatory Commission within 30 days, which defines the corrective actions to be taken to reduce subsequent releases to prevent recurrence of exceeding the limits of Section 5.1 and includes the schedule for achieving conformance with the limits of Section 5.1. This special report, as defined in 10 CFR 20.2203, shall also include an analysis which estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from uranium fuel cycle sources (including all effluent pathways and direct radiation) for the calendar year that includes the release(s) covered by this report. This special report shall also describe the levels of radiation and concentrations of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose(s) exceeds the limits of Section 5.1, and if the release condition resulting in violation of the provisions of 40 CFR 190 has not already been corrected, the special report shall include a request for variance in accordance with the provisions of 40 CFR 190 and including the specified information of 40 CFR 190.11 (b). Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete. This control does not affect shutdown requirements or MODE changes. 5.1.3 Surveillance Reauirements Cumulative dose contributions from liquid and gaseous effluents and from direct radiation shall be determined in accordance with Section 5.2. This requirement is applicable only under the conditions set forth above in Section 5.1.2. 5.1.4 Basis This control is provided to meet the dose limitations and reporting requirements of 40 CFR 190. The control requires the preparation and submittal of a special report whenever the calculated doses from plant radioactive effluents exceed the limits of Section 5.1. For sites containing up to 4 reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reactors remain within twice the dose design 5-1 Rev. 18

VEGP ODCM objectives of Appendix I and if direct radiation doses from the units, such as direct exposure from outside storage tanks, are kept small. The special report will describe a course of action which should result inthe limitation of dose to a MEMBER OF THE PUBLIC for a calendar year to within the 40 CFR 190 limits. For the purposes of the special report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible with the exception that dose contributions from other uranium fuel cycle facilities at the same site or within a radius of 5 miles must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR 190, the special report with a request for variance (provided the release conditions resulting in violation of 40 CFR 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11 and 10 CFR 20.2203(a) (4), is considered to be a timely request and fulfills the requirements of 40 CFR 190 until NRC staff action is completed. The variance only relates to the limits of 40 CFR 190, and does not apply in any way to the requirements for dose limitation as addressed in other sections of this ODCM. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation which is part of the nuclear fuel cycle. Rev. 18 5-2 Rev. 18

5.2 )

VEGP ODCM 5.2 DEMONSTRATION OF COMPLIANCE There are no other uranium fuel cycle facilities within 5 miles of the plant site. Therefore, for the purpose of demonstrating compliance with the limits of Section 5.1, the total dose to a MEMBER OF THE PUBLIC in the vicinity of the plant site due to uranium fuel cycle sources shall be determined as follows: Dn = DL + DG + DD + DN (5.1) where: DTk= the total dose or dose commitment to the total body or organ k, in mrem. DL = the dose to the same organ due to radioactivity discharged from the plant site in liquid effluents, calculated in accordance with Section 2.4.1, in mrem. DG = the dose to the same organ due to non-noble-gas radionuclides discharged from the plant site in gaseous effluents, calculated for the controlling receptor in accordance with Section 3.4.3, in mrem. DD = the direct radiation dose to the whole body of an individual at the controlling receptor location, due to radioactive materials retained within the plant site, in mrem. Values of direct radiation dose may be determined by measurement, calculation, or a combination of the two. DN = the external whole body dose to an individual at the controlling receptor location, due to gamma ray emissions from noble gas radionuclides discharged from the plant site in gaseous effluents, in mrem. DN is calculated as follows (equation adapted from Reference 1, page 22, by re-casting in cumulative dose form): DN =3.17X10' X{(XQ)VP E[K 1 *Qii} (5.2) where: 3.17 x 1OF8 = a units conversion factor 1 y/(3.15 x 107 s). Q,= the cumulative release of noble gas radionuclide i from release pathway v (lCi), during the period of interest.

                    =         the total-body dose factor due to gamma emissions from noble gas radionuclide i (mrem/y)/(gCim 3), from Table 3-5.

(X/Q)Xp = annual average relative dispersion factor for release pathway v, at the location of the controlling receptor, from Table 3-7 [s/r 3 ]. Rev. 18 5-3 5-3 Rev. 18

VEGP ODCM As defined above, DL and DG are for different age groups, while DD and DN are not age group specific. When a more precise determination of DTk is desired, values of DL and DG may be calculated for all four age groups, and those values used in equation (5.1) to determine age group specific values of DTk; the largest value of DTk for any age group may then be compared to the limits of Section 5.1. Rev. 18 5-4 Rev. 18

Chapter 6 - Potential Doses 3 )1)

VEGP ODCM CHAPTER 6 POTENTIAL DOSES TO MEMBERS OF THE PUBLIC DUE TO THEIR ACTIVITIES INSIDE THE SITE BOUNDARY 6.1 REQUIREMENT FOR CALCULATION To support the reporting requirements of Section 7.2.2.3, an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY shall be performed as specified in Section 6.2, at least once per calendar year. 6.2 CALCULATIONAL METHOD For the purpose of performing the calculations required in Section 6.1, the dose to a member of the public inside the SITE BOUNDARY shall be determined at the locations, and for the receptor age groups, defined in Table 6-1. The dose to such a receptor at any one of the defined locations shall be determined as follows: Dik =[DA +Ds + Dp] F, (6.1) where: Dk = the total dose to the total body or organ k, in mrem. DA = the dose to the same organ due to inhalation of non-noble-gas radionuclides discharged from the plant site in gaseous effluents, calculated in accordance with Section 3.4.3, in mrem. The (X/gLvalue to be used is given for each receptor location in Table 6-1; depleted (X/Q) values may be used in calculations for non-noble-gas radionuclides. Ds = the dose to the same organ due to ground plane deDosition of non-noble-gas radionuclides discharged from the plant site in gaseous effluents, calculated in accordance with Section 3.4.3, in mrem. The (D/Q) value to be used is given for each receptor location in Table 6-1. Dp = the external whole body dose due to gamma ray emissions from noble gas radio-nuclides discharged from the plant site in gaseous effluents, calculated using equation (5.2), in mrem. The (I7 values that are to be used are given for each receptor location in Table 6-1. F0 = the occupancy factor for the given location, which is the fraction of the year that one individual MEMBER OF THE PUBLIC is assumed to be present at the receptor location [unitless]. Values of Fo for each receptor location are included in Table 6-1. Rev. 18 6-1 6-1 Rev. 18

VEGP ODCM Table 6-1. Attributes of Member of the Public Receptor Locations Inside the Site Boundary Location: Visitors Center, SE at 447 meters Age Group: Child Occupancy Factor: 4.57 x 1O4 (based on 4 hours per year) Disnersion and DeDosition Parameters: Parameter Ground-Level l Mixed-Mode Undepleted (X/Q), s/m3 5.93 E-6 7.12 E-7 Depleted (X/Q), s/ 3 5.58 E-6 6.74 E-7 TD/Q), m2 2.28 E-8 5.77 E-9 Rev. 18 6-2 Rev. 18

Chapter 7 - Reports ) 1) )

VEGP ODCM CHAPTER 7 REPORTS 7.1 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 7.1.1 Requirement for Report Inaccordance with Technical Specification 5.6.2, the Annual Radiological Environmental Operating Report covering the REMP activities during the previous calendar year shall be submitted before May 15 of each year. (Asingle report fulfills the requirements for both units.) The material provided shall be consistent with the objectives outlined in section 4.1 and section 7.1.2 of the ODCM, and in Sections IV.B.2, IV.B.3, and IV.C of Appendix I to 10 CFR Part 50. 7.1.2 Report Contents The materials specified in the following sub-sections shall be included in each Annual Radiological Environmental Operating Report: 7.1.2.1 Data The report shall include summarized and tabulated results of all REMP samples required by Table 4-1 taken during the report period, in a format similar to that contained in Table 3 of the Radiological Assessment Branch Technical Position (Reference 19); the results for any additional samples shall also be reported. Inthe event that some results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results; the missing data shall be submitted as soon as possible in a supplementary report. The results for naturally-occurring radionuclides not included in plant effluents need not be reported. 7.1.2.2 Evaluations Interpretations and analyses of trends of the results shall be included in the report, including the following: (as appropriate) comparisons with pre-operational studies, operational controls, and previous environmental reports; and an assessment of any observed impacts of the plant operation on the environment. If the measured level of radioactivity in an environmental sampling medium exceeding the reporting levels of Table 4-2 is not the result of plant effluents, the condition shall be described as required by Section 4.1.1.2.2. 7.1.2.3 Programmatic Information Also to be included in each report are the following: a summary description of the REMP; a map(s) of all sampling locations keyed to a table giving distances and directions from a point midway between the centers of the two reactors; the results of land use censuses required by Section 4.1.2; and the results of licensee participation in the Interlaboratory Comparison Program required by Section 4.1.3. 7.1.2.4 Descriptions of Program Deviations Discussions of deviations from the established program must be included in each report, as follows: Rev. 18 7-1 7-1 Rev. 18

VEGP ODCM 7.1.2.4.1 If the REMP is not conducted as required in Table 4-1, a description of the reasons for not conducting the program as required, and the plans for preventing a recurrence, must be included in the report. 7.1.2.4.2 If the MDCs required by Table 4-3 are not achieved, the contributing factors must be identified and described in the report. 7.1.2.4.3 If Interlaboratory Comparison Program analyses are not performed as required by Section 4.1.3, the corrective actions taken to prevent a recurrence must be included in the report. 7-2 Rev. 18

VEGP ODCM 7.2 RADIOACTIVE EFFLUENT RELEASE REPORT 7.2.1 Requirement for Report In accordance with Technical Specification 5.6.3, the Radioactive Effluent Release Report covering the operation of the units during the previous calendar year of operation shall be submitted in accordance with 10 CFR Part 50.36a. (A single submittal may be made for Units 1 and 2. However, the submittal shall specify the releases of radioactive material in liquid and gaseous effluents from each unit and solid radioactive waste from the site.) The report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the units. The material provided shall be consistent with the objectives outlined throughout this ODCM and the Process Control Program (PCP) and in conformance with 10 CFR Part 50.36a and Section IV.B.1 of Appendix I to 10 CFR Part 50. 7.2.2 Report Contents The materials specified in the following sub-sections shall be included in each Radioactive Effluent Release Report: 7.2.2.1 Quantities of Radioactive Materials Released The report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the units as outlined in NRC Regulatory Guide 1.21, "Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with liquid and gaseous effluent data summarized on a quarterly basis and solid radioactive waste data summarized on a semiannual basis following the format of Appendix B thereof. Unplanned releases of radioactive materials in gaseous and liquid effluents from the site to UNRESTRICTED AREAS shall be included in the report, tabulated either by quarter or by event. For gamma emitters released in liquid and gaseous effluents, in addition to the principal gamma emitters for which MDCs are specifically established in Table 2-3 and Table 3-3, other peaks which are measurable and identifiable also shall be identified and reported. 7.2.2.2 Meteorological Data The report shall include an annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing of wind speed, wind direction, and atmospheric stability, and precipitation (if measured) on magnetic tape; or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability. In lieu of submission with the Radioactive Effluent Release Report, the licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request. 7.2.2.3 Dose Assessments The report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from each unit during the previous calendar year. Historical annual average meteorology or the meteorological conditions concurrent with the time of release of radioactive materials in gaseous effluents (as determined by sampling frequency and measurement) shall be used for determining the gaseous pathway doses. This assessment of Rev. 18 7-3 7-3 Rev. 18

VEGP ODCM radiation doses shall be performed in accordance with Sections 2.1.3, 2.4, 3.1.3, 3.1.4, 3.4.2, 3.4.3, 5.1, and 5.2. If a determination is required by Section 5.1.2, the report shall also include an assessment of radiation doses to the likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR 190, Environmental Radiation Protection Standards for Nuclear Power Operation; this dose assessment must be performed in accordance with Chapter 5. The report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY during the report period; this assessment must be performed in accordance with Chapter 6. All assumptions used in making these assessments (i.e., specific activity, exposure time, and location) shall be included in the report. 7.2.2.4 Solid Radwaste Data For each type of solid waste shipped offsite during the report period, the following information shall be included:

a. Waste volume,

b. Total curie quantity (specify whether determined by measurement of estimate),

c. Principal radionuclides (specify whether determined by measurement or estimate),

d. Type of waste (e.g., spent resin, compacted dry waste, evaporator bottoms),

e. Type of container (e.g., LSA, Type A, Type B, Large Quantity),

f. Solidification agent (e.g., cement, urea formaldehyde) and

9. Class of solid wastes (as defined by 10 CFR Part 61.)

7.2.2.5 Licensee Initiated Document Changes Licensee initiated changes shall be submitted to the Nuclear Regulatory Commission as a part of or concurrent with the Radioactive Effluent Release Report for the period in which any changes were made. Such changes to the ODCM shall be submitted pursuant to Technical Specification 5.5.1. This requirement includes: 7.2.2.5.1 Any changes to the sampling locations in the radiological environmental monitoring program, including any changes made pursuant to Section 4.1.1.2.3. Documentation of changes made pursuant to Section 4.1.1.2.3 shall include supporting information identifying the cause of the unavailability of samples. 7.2.2.5.2 Any changes to dose calculation locations or pathways, including any changes made pursuant to Section 4.1.2.2.2. 7.2.2.6 Descriptions of Program Deviations Discussions of deviations from the established program shall be included in each report, as follows: Rev. 18 7-4 Rev. 18

VEGP ODCM 7.2.2.6.1 The report shall include deviations from the liquid and gaseous effluent monitoring instrumentation operability requirements included in Sections 2.1.1 and 3.1.1, respectively. The report shall include an explanation as to why the inoperability of the liquid or gaseous effluent monitoring instrumentation was not corrected within the specified time requirement. 7.2.2.6.2 The report shall include a description of the events leading to liquid holdup tanks or gas storage tanks exceeding the limits of Technical Specification 5.5.12. 7.2.2.7 Major Changes to Radioactive Waste Treatment Systems As required by Sections 2.1.5 and 3.1.6, licensee initiated MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS (liquid and gaseous) shall be reported to the Nuclear Regulatory Commission in the Radioactive Effluent Release Report covering the period in which the change was reviewed and accepted for implementation.' The discussion of each change shall contain:

a. A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59;

b. Sufficient detailed information to totally support the reason for the change without benefit of additional supplemental information;

c. A detailed description of the equipment, components, and processes involved and the interfaces with other plant systems;

d. An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents that differ from those previously predicted in the license applications and amendments thereto;

e. An evaluation of the change which shows the expected maximum exposures to individuals in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license applications and amendments thereto;

f. A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents, to the actual releases for the period prior to when the changes are to be made;

g. An estimate of the exposure to plant operating personnel as a result of the change; and

h. Documentation of the fact that the change was reviewed and found acceptable by the PRB.

In lieu of inclusion in the Radioactive Effluents Release Report, this same information may be submitted as part of the annual FSAR update. Rev. 18 7-5. 7-5 . Rev. 18

VEGP ODCM 7.3 MONTHLY OPERATING REPORT This ODCM establishes no requirements pertaining to the Monthly Operating Report. 7.4 SPECIAL REPORTS Special reports shall be submitted to the Nuclear Regulatory Commission as required by Sections 2.1.3.2, 2.1.4.2, 3.1.3.2, 3.1.4.2, 3.1.5.2, 4.1.1.2.2, and 5.1.2. Rev. 18 7-6 Rev. 18

Chapter 8 - Meteorological X Models 3 )

VEGP ODCM CHAPTER 8 METEOROLOGICAL MODELS The models presented in this chapter are those which were used to compute the specific values of meteorology-related parameters that are referenced throughout this ODCM. These models should also be used whenever it is necessary to calculate values of these parameters for new locations of interest. Note: Although Plant.Vogtle has no pure elevated releases, the sections on elevated-mode calculations (8.1.2 and 8.2.2) are included for convenience in calculating mixed-mode values, and to preserve section number compatibility with the ODCMs of the other Southern Company nuclear power plants. 8.1 ATMOSPHERIC DISPERSION Atmospheric dispersion may be calculated using the appropriate form of the sector-averaged Gaussian model. Gaseous release elevations may be considered to be either at ground-level, elevated, or mixed-mode. Facility release elevations for each gaseous release point are as indicated in Table 3-4. 8.1.1 Ground-Level Releases Relative concentration calculations for ground-level releases, or for the ground-level portion of mixed-mode releases, shall be made as follows: 1Q) 2.032 Kr [ 1 (. (8.1) Nr where: (XIQ)G = the ground-level sector-averaged relative concentration for a given wind direction (sector) and distance (s/m3). 2.032 = (2n)4" 2 divided by the width in radians of a 22.50 sector, which is 0.3927 radians. 8= the plume depletion factor for all radionuclides other than noble gases at a distance r shown in Figure 8-3. For noble gases, the depletion factor is unity. If an undepleted relative concentration is desired, the depletion factor is unity. Only depletion by deposition is considered since depletion by radioactive decay would be of little significance at the distances considered. K, = the terrain recirculation factor corresponding to a distance r, taken from Appendix A of Reference 15. nk = the number of hours that wind of wind speed class j is directed into the given sector during the time atmospheric stability category k existed. N= the total hours of valid meteorological data recorded throughout the period of interest for all sectors, wind speed classes, and stability categories. Rev. 18 8-1 8-1 Rev. 18

VEGP ODCM u= the wind speed (mid-point of wind speed class j) at ground level (m/s). r= the distance from release point to location of interest (m). L; = the vertical standard deviation of the plume concentration distribution considering the initial dispersion within the building wake, calculated as follows:

                                                              +

21GZk Xzk = the lesser of OR (8.2) l3(azk) C= the vertical standard deviation of the plume concentration distribution (m) for a given distance and stability category k as shown in Figure 8-1. The stability category is determined by the vertical temperature gradient AT/Az (0C/100 m). 71= 3.1416 b= the maximum height of adjacent plant structure (55 m). 8.1.2 Elevated Releases Relative dispersion calculations for elevated releases, or for the elevated portion of mixed-mode releases, shall be made as follows: _h2 (XQ) 2 .O 3 G 2KrX lk (2' (8.3) Nr L 2J^Z where: (XIQ)E = the elevated release sector-averaged relative concentration for a given wind direction (sector) and distance (s/m3 ). k= the plume depletion factor for all radionuclides other than noble gases at a distance r for elevated releases, as shown in Figure 8-4, Figure 8-5, and Figure 8-6. For an elevated release, this factor is stability dependent. For noble gases, the depletion factor is unity. If an undepleted relative concentration is desired, the depletion factor is unity. Only depletion by deposition is considered since depletion by radioactive decay would be of little significance at the distances considered. Rev. 18 8-2 Rev. 18

VEGP ODCM nk = the number of hours that wind of wind speed class j is directed into the given sector during the time atmospheric stability category k existed. u= the wind speed (mid-point of wind speed class j) at the effective release height h (mis). h= the effective height of the release (m), which is calculated as follows: h = h + hp,. -h - c, (8.4) h= the height of the release point (m). ht= the maximum terrain height between the release point and the point of interest (m), from Table 8-1. hp= the additional height due to plume rise (m) which is calculated as follows and limited by hpqma): h = 1.44 d(WV X . (x 1) (8.5) Ud hp,(max) =the lesser of: OR (8.6) 1.5( ) *S_] u d= the inside diameter of the vent (m). c= the correction for low vent exit velocity (m), which is calculated as follows: 03 (.5 -- *d for"-0<1.5 Cv OR (8.7) l °for ->1 .5 U Fm = the momentum flux parameter (m41s2), which is calculated as follows: F. =( *2) (8.8) S= the stability parameter: Rev. 18 8-3 8-3 Rev. 18

VEGP ODCM

                =            8.75x10 s 2 for-0.5<AT< 1.5
                =            1.75x10c3 s72 for1.5<AT<4.0
                =            2.45x10-3s72 forAT>4.0 All other symbols are as previously defined in Section 8.1.1.

8.1.3 Mixed-Mode Releases Relative dispersion calculations for mixed-mode releases shall be made as follows: (XIQ)M =(1 E) -(X/I)E + E - XIOG(89 where: (X/Q)M = the mixed-mode release sector-averaged relative concentration for a given wind direction (sector) and distance (s/rm3). E= the fraction of hours during which releases are considered as ground-level releases, calculated as follows: 1.0 for -O< 1.0 Uj 2.58-1.58. forl.0<W<1.5 E= Uj Uj (8.10) 0.3 - 0.06 - for 1.5 <-< 5.0 Uj )Uj 0 for---> 5.0 Uj All other symbols are as previously defined. 8-4 Rev. 18

VEGP ODCM 8.2 RELATIVE DEPOSITION Plume depletion may be calculated using the appropriate form of the sector-averaged Gaussian model. Gaseous release elevations may be considered to be either at ground-level, elevated, or mixed-mode. Facility release elevations for each gaseous release points are as indicated in Table 3-4. 8.2.1 Ground-Level Releases Relative deposition calculations for ground-level releases, or for the ground-level portion of mixed-mode releases, shall be made as follows: 2.55Dg K r (DI ND2C r Xll (8.11) where: (D/Q)G = the ground-level sector-averaged relative deposition for a given wind direction (sector) and distance (rn 2). 2.55 = the inverse of the number of radians in a 22.50 sector [= (2 /I16r]. Dg = the deposition rate at distance r, taken from Figure 8-7 for ground-level releases (m-'). nk = the number of hours in which the wind is directed into the sector of interest, and during which stability category k exists. All other symbols are as defined previously in Section Section 8.1. 8.2.2 Elevated Releases Relative deposition calculations for elevated releases, or for the elevated portion of mixed-mode releases, shall be made as follows:

• 2.55K (D/ = ' nK D (8.12)

PE Nr k where: (D/Q)E = the elevated-plume sector-averaged relative deposition for a given wind direction (sector) and distance (me). Dek = the elevated plume deposition rate at distance r, taken from Figure 8-8, Figure 8-9, or Figure 8-10, as appropriate to the plume effective release height h defined in Section 8.1.2, for stability class k (m). All other symbols are as defined previously. Rev. 18 8-5 8-5 Rev. 18

VEGP ODCM 8.2.3 Mixed-Mode Releases Relative deposition calculations for mixed-mode releases shall be made as follows: (D/Q)M = (J- E) *(D/Q)E +E *(D/Q)G (8.13) where: (D/Q)M = the mixed-mode release sector-averaged relative deposition for a given wind direction (sector) and distance (m<). E= the fraction of hours during which releases are considered as ground-level releases, defined in Section 8.1.3. All other symbols are as previously defined. 8.3 ELEVATED PLUME DOSE FACTORS These factors are not required in effluent dose calculations for VEGP. Rev. 18 8-6 8-6 Rev. 18

(: ( Dis t . iNNEINE ENE SE I SSE S SSW SW W WNW NW NNW 500 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 8.7 5.7 1.4 5.8 5.7 3.5 1,000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 16.7 13.4 3.3 10.4 11.8 6.8 1,500 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 21.7 18.6 7.3 12.2 14.3 7.3 2,000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 21.7 18.6 7.3 12.2 14.3 7.3 2,500 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 21.7 18.6 7.3 12.2 14.3 7.3 3,000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 23.7 18.6 7.3 12.2 14.3 7.3 3,500 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 24.4 18.6 7.3 12.2 16.9 7.3 4,000 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 4.7 24.4 18.6 7.3 12.2 16.9 7.3 5,000 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 4.7 24.7 18.6 7.3 12.2 16.9 7.3 6,000 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 4.7 26.8 18.6 7.3 12.2 16.9 7.3 7,000 0.0 0.0 0.0 7.8 0.0 0.0 11.1 0.0 3.6 4.7 26.8 18.6 7.3 12.2 16.9 7.3 8,000 0.0 0.0 21.1 13.9 0.0 0.0 11.8 0.0 14.6 4.7 26.8 18.6 7.3 12.2 16.9 7.3 9,000 0.0 0.0 24.4 14.6 0.0 0.0 12.7 7.1 14.6 5.1 26.8 18.6 7.3 12.2 16.9 7.3 10,000 0.0 10.2 24.4 20.2 0.0 0.0 17.1 17.0 14.6 6.8 26.8 18.6 7.3 12.2 16.9 7.3 12,000 0.0 15.9 26.8 20.2 0.0 0.0 17.1 19.5 14.6 6.8 34.1 28.9 13.4 12.2 16.9 7.3 14,000 0.0 15.9 26.8 20.2 0.0 0.0 17.1 19.5 14.6 6.8 34.1 28.9 13.4 16.5 19.7 7.3 16,000 0.0 15.9 26.8 21.7 13.2 0.0 17.1 19.5 14.6 6.8 34.1 28.9 13.4 16.5 25.7 7.3 m Data in this table are obtained from Reference 11. -u G) 0 CD 0 co

VEGP ODCM 1000 r / I I I 11 I1

                                                 /                                   I AI 100 I I jr ur I I It PS o .1                   1.0                    10)

PLUME TRAVEL DISTANCE IKILOMETERS) Range of Vertical Range of Vertical Category Temperature Gradient l Temperature Gradient (OC/100 m) (OF/100 ft) A AT/AZ c -1.9 AT/AZ < -1.0 B -1.9 s AT/AZ < -1.7 -1.0 s AT/AZ < -0.9 C -1.7 s AT/AZ < -1.5 -0.9 s AT/AZ c -0.8 D -1.5 s AT/AZ < -0.5 -0.8 s AT/AZ < -0.3 E -0.5 s AT/Az c 1.5 -0.3 s AT/AZ < 0.8 F 1.5 s AT/AZ c 4.0 0.8 s AT/AZ < 2.2 G 4.0 AT/Az 2.2 s AT/AZ This graph is reproduced from Reference 5 (Figure 1). Figure 8-1. Vertical Standard Deviation of Material in a Plume (ar) 8-8 Rev. 18

VEGP ODCM This figure intentionally left blank. Refer to the definition for K, (terrain recirculation factor) in section 8.1.1 for applicable plant data. Figure 8-2. Terrain Recirculation Factor (Kr) Rev. 18 8-9 Rev. 18

VEGP ODCM 0.9 __ . _ _ RH ilTS 0.3 z 1! 0.7 i OA OA U 0.4 M. 0.2 0.1 __.I IXl I 111l 0.1 1.0 . M0. 10 . 00 PLUME VAWL WINCE WIULmTErm This graph is reproduced from Reference 5 (Figure 2). Figure 8-3. Plume Depletion Effect for Ground Level Releases Rev. 18 8-10 8-10 Rev. 18

VEGP ODCM 1.0 I 0.7 I I CA I h. OA 02 0.1 0.1 10 I0.0 0"0, 0.0 PUBE TAVEL DIETANCE IKUUlMETER This graph is reproduced from Reference 5 (Figure 3). Figure 8-4. Plume Depletion Effect for 3O-Meter Releases 8-1 1 Rev. 18

VEGP ODCM

      ¶.0
      *A If 0.7 I

IC U CA I. Da 0.3 0.2 0.1 0.1 10 10.0 100.0 20 PLUMt TRAVEL DISTANCE (KILOMETERS This graph is reproduced from Reference 5 (Figure 4). Figure 8-5. Plume Depletion Effect for 60-Meter Releases 8-12 Rev. 18

VEGP ODCM oA oi am 0.8 2 0.7 Z! a oh I W. OA 0.2 0.1 0.1 1.0 10O 1l0 au PLUME TRVL DITACE McILOMMTO This graph is reproduced from Reference 5 (Figure 5). Figure 8-6. Plume Depletion Effect for 100-Meter Releases Rev. 18 8-13 Rev. 18

VEGP ODOM 1i- 3

                         .   .           *1*1~~* -      *? ,

IC

     'U   10-6 0
     'U vi
     -J
     'U 10-0.1                  1.0                   10.0        100.0  200.0 PLUME TRAVEL DISTANCE (KILOMETERS)

ThiB graph is reproduced from Reference 5 (Figure 6). Figure 8-7. Relative Deposition for Ground-Level Releases 8-14 Rev. 18

VEGP ODCM as P-sa ou z 0

     °   10-6 0

0. au Ou 10 0.1 1.0 10.0 IOOD 200I0 PLUME TRAVEL DISTANCE (KILOMETERS) This graph is reproduced from Reference S (Figure 7). Figure 8-8. Relative Deposition for 30-Meter Releases 8-15 Rev. 18

VEGP ODCM Figure 8-9. Relative Deposition for 60-Meter Releases Rev. 18 8-16 8-16 Rev. 18

VEGP ODCM 10-5 w U0

    'a A.

I-z o 104 0 w 104 0.1 1.0 10.0 100.0 200.0 PLLUME TRAVEL DISTANCE (KILOMETERS) This graph is reproduced from Reference 5 (Figure 9). Figure 8-10. Relative Deposition for 100-Meter (or Greater) Releases Rev. 18 8-17 8-17 Rev. 18

Chapter 9 - Calculation of Gaseous Effluent ) I 3

9.1 ) )

VEGP ODCM CHAPTER 9 METHODS AND PARAMETERS FOR CALCULATION OF GASEOUS EFFLUENT PATHWAY DOSE FACTORS, Rasp 9.1 INHALATION PATHWAY FACTOR For the inhalation pathway, Raip in (mrem/y) per (pCVm3) is calculated as follows (Reference 1, Section 5.3.1.1): Raipi = K1 -(BR)a * (DFA)0 J (9.1 ) where: K1 = the units conversion factor: 106 pCV/Ci. (BR)a = the breathing rate of receptor age group a, in m3 /y, from Table 9-5. (DFA)aj = the inhalation dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-7 through Table 9-10. Rev. 18 9-1 91 Rev. 18

9.2 3 ) 1)

VEGP ODCM 9.2 GROUND PLANE PATHWAY FACTOR For the ground plane external exposure pathway, R.0 in (m2.mrem/y) per (pCis) is calculated as follows (Reference 1, Section 5.3.1.2): Raipi = K, - K2 (SHF)*(DFG)j f4 ) (9.2) where: K, = the units conversion factor: 106 pCiCi. K2 = the units conversion factor: 8760 h/y. (SHF) = the shielding factor due to structure (dimensionless). The value used for (SHF) is 0.7, from (Reference 3, Table E-15). (DFG), = the ground plane dose factor for radionuclide i and organ j, in (mremlh) per (pCGVm 2), from Table 9-15. Dose factors are the same for all age groups, and those for the total body also apply to all organs other than skin. Ak= the radioactive decay constant for radionuclide i, in s'l. Values of A used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 20. t= the exposure time, in s. The value used for t is 4.73 x 108 s (= 15 y), from (Reference 1, Section 5.3.1.2). Rev. 18 9-2 Rev. 18

9.3 ) ) I)

VEGP ODCM 9.3 GARDEN VEGETATION PATHWAY FACTOR For radionuclides other than tritium in the garden vegetation consumption pathway, R¢, in (m2.mremly) per (.Ci/s) is calculated as follows (Reference 1, Section 5.3.1.5):

                     =K,          + A) -(DFL)aj          L    +                            (9.3) where:

K1 = the units conversion factor 106 pCi/ACi. r= the fraction of deposited activity retained on the edible parts of garden vegetation (dimensionless). The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1). Y' = the areal density (agricultural productivity) of growing leafy garden vegetation, in kg/m , from Table 9-1.

              ,=         the radioactive decay constant for radionuclide i, in s1'. Values of X, used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 20.

X. = the rate constant for removal of activity on leaf and plant surfaces by weathering, in sr, from Table 9-1. (DFL)aI = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14. UaL = the consumption rate of fresh leafy garden vegetation by a receptor in age group a, in kg/y, from Table 9-5. UaS = the consumption rate of stored garden vegetation by a receptor in age group a, in kg/y, from Table 9-5. fL = the fraction of the annual intake of fresh leafy garden vegetation that is grown locally (dimensionless), from Table 9-1. fg = the fraction of the annual intake of stored garden vegetation that is grown locally (dimensionless), from Table 9-1. tL = the average time between harvest of fresh leafy garden vegetation and its consumption, in s, from Table 9-1. th= the average time between harvest of stored garden vegetation and its consumption, in s, from Table 9-1. Rev. 18 9-3 9-3 Rev. 18

VEGP ODCM 3 For tritium in the garden vegetation consumption pathway, Ra in (mrem/y) per (pCVm ) is calculated as follows (Reference 1, Section 5.3.1.5), based on the concentration in air rather than deposition onto the ground: Ra, = K, *K3 *(DFL)a,, *(UCLfL + Usf) *. 75*(Pj) (9.) where: K3 = the units conversion factor: 103 g/kg. H= the absolute humidity of atmospheric air, in g/m3, from Table 9-1. 0.75 = the fraction of the mass of total garden vegetation that is water (dimensionless). 0.5 = the ratio of the specific activity of tritium in garden vegetation water to that in atmospheric water (dimensionless). and other parameters are as defined above. Rev. 18 9-4 9-4 Rev. 18

VEGP ODCM TaQhl 9-1 Miscellaneous Parameters for the Garden Vegetation Pathway The following parameter values are for use in calculating RasP, for the garden vegetation pathway only. The terms themselves are defined in section 9.3. Parameter Value Reference Y 2.0 kg/M 2 Ref. 3, Table E-15 kw 5.73 x 10 s-' Ref. 1, page 33 (14-day half-life) fL 1.0 Ref. 1, page 36 fg 0.76 Ref. 1, page 33 tL 8.6 x 104 s Ref. 3, Table E-15 (1day) thv5.18 x 106 s Ref. 3, Table E-15 (60 days) H 8 g/m3 Ref. 3 Rev. 18 9-5 9-5 Rev. 18

            -     #AN+[ J4>4 t,-',          t >v,'t.^.-.-'

4.C..~4 Z t-it¢ '2Ei 4.ASjtt*tV olpP A._A ._...b 3,, I,,. 9.4 t; V$t ... )

VEGP ODCM 9.4 GRASS-COW-MILK PATHWAY FACTOR 2 For radionuclides other than tritium in the grass-cow-milk pathway, Ra,, in (m _mrem/y) per (pgCVs) is calculated as follows (Reference 1, Section 5.3.1.3): RaiP =K, AR) QF -CP *F.,.*(DL)a* (9 5) where: K, = the units conversion factor: 106 pCViCi. r= the fraction of deposited activity retained on the edible parts of vegetation (dimensionless). The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1).

                 =        the radioactive decay constant for radionuclide i, in s'. Values of X,used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 20.
                  =       the rate constant for removal of activity on leaf and plant surfaces by weathering, in s~l, from Table 9-2.

QF = the cow's consumption rate of feed, in kg/d, from Table 9-2. U= the consumption rate of cow milk by a receptor in age group a, in Uy, from Table 9-5. Fmj = the stable element transfer coefficient applicable to radionuclide i, for cow's milk, in d/L, from Table 9-6. (DFL)aj = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14. fp = the fraction of the year that the cow is on pasture (dimensionless), from Table 9-2. fs = the fraction of the cow's feed that is pasture grass while the cow is on pasture (dimensionless), from Table 9-2. Yp = the areal density (agricultural productivity) of growing pasture feed grass, in kg/M2, from Table 9-2. Y5 = the areal density (agricultural productivity) of growing stored feed, in kg/M2, from Table 9-2. t= the transport time from harvest of stored feed to its consumption by the cow, in s, from Table 9-2. Rev. 18 9-6 9-6 Rev. 18

VEGP ODCM tf = the transport time from consumption of feed by the cow, to consumption of milk by the receptor, in s, from Table 9-2. 3 For tritium in the grass-cow-milk pathway, R. in (mrem/y) per (gCVm ) is calculated as follows (Reference 1, Section 5.3.1.5), based on the concentration in air rather than deposition onto the ground: Raipj= K, *K3 *QF *Uap *'F., (D

                                                *M            75
                                                        . 'J*O'    ( 0 5 )(9.6) where:

K3 = the units conversion factor: 103 g/kg. H= the absolute humidity of atmospheric air, in giM3, from Table 9-2. 0.75 = the fraction of the mass of total vegetation that is water (dimensionless). 0.5 = the ratio of the specific activity of tritium in vegetation water to that in atmospheric water (dimensionless). and other parameters are as defined above. Rev. 18 9-7 9-7 Rev. 18

VEGP ODCM Tahbl 9-2. Miscellaneous Parameters for the Grass-Cow-Milk Pathway The following parameter values are for use in calculating Rapj for the grass-cow-milk pathway only. The terms themselves are defined in section 9.4. Parameter Value Reference 5.73 x 10' 7 s' Ref. 1, page 33 l (14-day half-life) QF 50 kg/d Ref. 3, Table E-3 fp1.0 Ref. 1,page33 f 1.0 Ref. 1, page 33 Yp0.7 kg/M 2 Ref. 3, Table E-15 YS 2.0 kg/M 2 Ref. 3, Table E-15 thm 7.78 x 106 s Ref. 3, Table E-15 (90 days) _ tf 1.73 x 105 s Ref. 3, Table E-15 (2 days) .- H 8 g/m3 Ref. 3 Rev. 18 9-8 9-8 Rev. 18

9.5 7)

VEGP ODCM 9.5 GRASS-GOAT-MILK PATHWAY FACTOR 2 For radionuclides other than tritium in the grass-goat-milk pathway, Ra,0 in (m .mremly) per (jiCi/s) is calculated as follows (Reference 1, Section 5.3.1.3): Rapj R K- Ki

• r
• QF Uap Fmi (DFL),.0(F F

                                                       *f-f (IJ-f+) e'

_ _~f

                                                                                   ]e"        (9.7) where:

K, = the units conversion factor: 106 pCVgCi. r= the fraction of deposited activity retained on the edible parts of vegetation (dimensionless). The value used for r is 1.0 for radioiodines and 02 for particulates, from (Reference 3, Table E-1).

                  =        the radioactive decay constant for radionuclide i, in s~'. Values of X, used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 20.

W= the rate constant for removal of activity on leaf and plant surfaces by weathering, in s-t, from Table 9-3. OF = the goat's consumption rate of feed, in kg/d, from Table 9-3. U'P = the consumption rate of goat milk by a receptor in age group a, in L/y, from Table 9-5. Fm 1= the stable element transfer coefficient applicable to radionuclide i, for goat's milk, in d/L, from Table 9-6. (DFL)aj = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14. fp = the fraction of the year that the goat is on pasture (dimensionless), from Table 9-3. f, = the fraction of the goat's feed that is pasture grass while the goat is on pasture (dimensionless), from Table 9-3. Yp = the areal density (agricultural productivity) of growing pasture feed grass, in kg/M2, from Table 9-3. YS = the areal density (agricultural productivity) of growing stored feed, in kgiM2 , from Table 9-3. thi, = the transport time from harvest of stored feed to its consumption by the goat, in s, from Table 9-3. Rev. 18 9-9 99 Rev. 18

VEGP ODCM tf= the transport time from consumption of feed by the goat, to consumption of milk by the receptor, in s, from Table 9-3. 3 For tritium in the grass-goat-milk pathway, Rao in (mrem/y) per (p.Cfm) is calculated as follows (Reference 1, Section 5.3.1.5), based on the concentration in air rather than deposition onto the ground: Rai; =KI' U ap

                                            *Fm; *(DFL)a    0.75-(-. H)                     (9.8) where:

K3 = the units conversion factor: 103 g/kg. H= the absolute humidity of atmospheric air, in g/m 3 , from Table 9-3. 0.75 = the fraction of the mass of total vegetation that is water (dimensionless). 0.5 = the ratio of the specific activity of tritium in vegetation water to that in atmospheric water (dimensionless). and other parameters are as defined above. Rev. 18 9-10 9-10 Rev. 18

VEGP ODCM Trnhhn I GILAU CLQ Mier-olInnaneni vi Parameters for the Grass-Goat-Milk Pathway The following parameter values are for use in calculating Raipi for the grass-goat-milk pathway only. The terms themselves are defined in section 9-5. Parameter Value Reference e 5.73 x 10-7 s-' Ref. 1, page 33 l_ (14-day half-life) QF 6 kg/d Ref. 3, Table E-3 fp1.0 Ref. 1, page 33 fS1.0 Ref. 1, page 33 Yp0.7 kg/M 2 Ref. 3, Table E-15 Y, 2.0 kg/M 2 Ref. 3, Table E-15 thi 7.78 x 106 s Ref. 3, Table E-15 (90 days) tf 1.73 x 105 s Ref. 3, Table E-15 (2 days) H 8 g/ Ref. 3 Rev. 18 9-11 9-11 Rev. 18

        ,I 9.6

) ) )

VEGP ODCM 9.6 GRASS-COW-MEAT PATHWAY FACTOR For radionuclides other than tritium in the grass-cow-meat pathway, Ran in (m2.mrem/y) per (gCi/s) is calculated as follows (Reference 1, Section 5.3.1.4): R =K *F -(DFL)i -+ e (9-9) aipj I F ap fi ayj y y where: K, = the units conversion factor: 106 pCWiCi. r= the fraction of deposited activity retained on the edible parts of vegetation (dimensionless). The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1). X= the radioactive decay constant for radionuclide i, in se. Values of X, used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 20.

                  =       the rate constant for removal of activity on leaf and plant surfaces by weathering, in e', from Table 9-4.

QF = the cow's consumption rate of feed, in kg/d, from Table 9-4. Up= the consumption rate of meat by a receptor in age group a, in kg/y, from Table 9-5. Ffi = the stable element transfer coefficient applicable to radionuclide i, for meat, in d/kg, from Table 9-6. (DFL)aj = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14. fp = the fraction of the year that the cow is on pasture (dimensionless), from Table 9-4. fs = the fraction of the cow's feed that is pasture grass while the cow is on pasture (dimensionless), from Table 9-4. Yp = the areal density (agricultural productivity) of growing pasture feed grass, in kg/M2 , from Table 9-4. YS = the areal density (agricultural productivity) of growing stored feed, in kg/m, from Table 9-4. thm = the transport time from harvest of stored feed to its consumption by the cow, in s, from Table 9-4. Rev. 18 9-12 9-12 Rev. 18

VEGP ODCM tf = the transport time from consumption of feed by the cow, to consumption of meat by the receptor, in s, from Table 9-4. 3 For tritium in the grass-cow-meat pathway, Ra,. in (mrem/y) per (CVm ) is calculated as follows (Reference 1, Section 5.3.1.4), based on the concentration in air rather than deposition onto the ground: Ralpj = K, -K3 - QF - Uap - Fad -(DFL)a, -O.75S.(5) (9.10) where: K3 = the units conversion factor: 103 g/kg. H= the absolute humidity of atmospheric air, in g/m3, from Table 9-4. 0.75 = the fraction of the mass of total vegetation that is water (dimensionless). 0.5 = the ratio of the specific activity of tritium in vegetation water to that in atmospheric water (dimensionless). and other parameters are as defined above. Rev. 18 9-13 9-13 Rev. 18

VEGP ODCM Table 9-4. Miscellaneous Parameters for the Grass-Cow-Meat Pathway . The following parameter values are for use in calculating Rapj for the grass-cow-meat pathway only. The terms themselves are defined in section 9-6. Parameter Value Reference 5.73 x 10 '7 s-lRef. 1, page 33 l (14-day half-life) QF 50 kg/d Ref. 3, Table E-3 fp 1.0 Ref. 1, page 33 l 1.0 Ref. 1, page 33 Yp0.7 kg/M 2 Ref. 3, Table E-15 Y 2.0 kg/M2 Ref. 3, Table E-15 thi 7.78 x 106 s Ref. 3, Table E-15 (90 days) t1.73 x10 6 s Ref. 3, Table E-15 (20 days) l H 8 g/m 3 Ref. 3 Rev. 18 9-14 9-14 Rev. 18

VEGP ODCM Table 9-5. Individual Usage Factors Receptor Age Group Usage Factor Infant Child Teenager Adult Milk Consumption Rate, UP 330 330 400 310 Meat Consumption Rate, U8p 0 41 65 110 (kgly) Fresh Leafy Garden Vegetation 0 26 42 64 Consumption Rate, UaL (kg fy)__ _ _ _ _ __ _ _ _ _ _ Stored Garden Vegetation 0 520 630 520 Consumption Rate, Uas (kgRy) 3 7 80 0 08 0 00 0 0 Breathing Rate, (BR), 1400 3700 8000 8000 (M 3 Iy) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ All values are from Reference 3, Table E-5. Rev. 18 9-15 Rev. 18

VEGP ODCM Tnhlk Q-A Sthlie Element Transfer Data Cow Milk Goat Milk Meat Element Fm (d/L) Fm (d/L)+ Ff (d/kg)  ! H 1.0 E-02 1.7 E-01 1.2 E-02 C 1.2 E-02 1.0 E-01 3.1 E-02 Na 4.0 E-02 4.0 E-02 3.0 E-02 P 2.5 E-02 2.5 E-01 4.6 E-02 Cr 2.2 E-03 2.2 E-03 2.4 E-03 Mn 2.5 E-04 2.5 E-04 8.0 E-04 Fe 1.2 E-03 1.3 E-04 4.0 E-02 Co 1.0 E-03 1.0 E-03 1.3 E-02 Ni 6.7 E-03 6.7 E-03 5.3 E-02 Cu 1.4 E-02 1.3 E-02 8.0 E-03 Zn 3.9 E-02 3.9 E-02 3.0 E-02 Br 5.0 E-02 5.0 E-02 2.6 E-02 Rb 3.0 E-02 3.0 E-02 3.1 E-02 Sr 8.0 E-04 1.4 E-02 6.0 E-04 Y 1.0 E-05 1.0 E-05 4.6 E-03 Zr 5.0 E-06 5.0 E-06 3.4 E-02 Nb 2.5 E-03 2.5 E-03 2.8 E-01 Mo 7.5 E-03 7.5 E-03 8.0 E-03 Tc 2.5 E-02 2.5 E-02 4.0 E-01 Ru 1.0 E-06 1.0 E-06 4.0 E-01 Rh 1.0 E-02 1.0 E-02 1.5 E-03 Ag 5.0 E-02 5.0 E-02 1.7 E-02 Sb 1.5 E-03 1.5 E-03 4.0 E-03 Te 1.0 E-03 1.0 E-03 7.7 E-02 i 6.0 E-03 6.0 E-02 2.9 E-03 Cs 1.2 E-02 3.0 E-01 4.0 E-03 Ba 4.0 E-04 4.0 E-04 3.2 E-03 La 5.0 E-06 5.0 E-06 2.0 E-04 Ce 1.0 E-04 1.0 E-04 1.2 E-03 Pr 5.0 E-06 5.0 E-06 4.7 E-03 Nd 5.0 E-06 5.0 E-06 3.3 E-03 W 5.0 E-04 5.0 E-04 1.3 E-03 Np 5.0 E-06 5.0 E-06 2.0 E-04

 *-    Values from Reference 3 (Table E-1) except as follows: Reference 2 (Table C-

5) for Br and Sb.

 +-     Values from Reference 3, Table E-2 for H, C, P, Fe, Cu, Sr, l, and Cs in goat milk, and Table E-1 for all other elements in cow milk, except as follows:

Reference 2 (Table C-5) for Br and Sb in cow milk. Rev. 18 9-16 9-16 Rev. 18

VEGP ODCM Table 9-7. Inhalation Dose Factors for the Infant Age Group Nuclide Bone Liver 1 r T.Body r - Thyroid r Kidney Lung GI-LLI H-3 No Data 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C-14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 Na-24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P-32 1.45E-03 8.03E-05 5.53E-05 No Data No Data No Data 1.15E-05 Cr-51 No Data No Data 6.39E-08 4.11 E-08 9.45E-09 9.17E-06 2.55E-07 Mn-54 No Data 1.81 E-05 3.56E-06 No Data 3.56E-06 7.14E-04 5.04E-06 Mn-56 No Data 1.10E-09 1.58E-10 No Data 7.86E-10 8.95E-06 5.12E-05 Fe-55 1.41 E-05 8.39E-06 2.38E-06 No Data No Data 6.21 E-05 7.82E-07 Fe-59 9.69E-06 1.68E-05 6.77E-06 No Data No Data 7.25E-04 1.77E-05 Co-58 No Data 8.71 E-07 1.30E-06 No Data No Data 5.55E-04 7.95E-06 Co-60 No Data 5.73E-06 8.41 E-06 No Data No Data 3.22E-03 2.28E-05 Ni-63 2.42E-04 1.46E-05 8.29E-06 No Data No Data 1.49E-04 1.73E-06 Ni-65 1.71 E-09 2.03E-1 0 8.79E-1 1 No Data No Data 5.80E-06 3.58E-05 Cu-64 No Data 1.34E-09 5.53E-10 No Data 2.84E-09 6.64E-06 1.07E-05 Zn-65 1.38E-05 4.47E-05 2.22E-05 No Data 2.32E-05 4.62E-04 3.67E-05 Zn-69 3.85E-11 6.91 E-11 5.13E-12 No Data 2.87E-11 1.05E-06 9.44E-06 Br-83 No Data No Data 2.72E-07 No Data No Data No Data No Data Br-84 No Data No Data 2.86E-07 No Data No Data No Data No Data Br-85 No Data No Data 1.46E-08 No Data No Data No Data No Data Rb-86 No Data 1.36E-04 6.30E-05 No Data No Data No Data 2.17E-06 Rb-88 No Data 3.98E-07 2.05E-07 No Data No Data No Data 2.42E-07 Rb-89 No Data 2.29E-07 1.47E-07 No Data No Data No Data 4.87E-08 Sr-89 2.84E-04 No Data 8.15E-06 No Data No Data 1.45E-03 4.57E-05 Sr-90 2.92E-02 No Data 1.85E-03 No Data No Data 8.03E-03 9.36E-05 Sr-91 6.83E-08 No Data 2.47E-09 No Data No Data 3.76E-05 5.24E-05 All values are in (mrem/pCi inhaled). They are obtained from Reference 3 (Table E-10). Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-1 24, or Sb-1 25. 9-17 Rev. 18

VEGP ODCM Table 9-7 (contd). Inhalation Dose Factors for the Infant Age Group Nuclide Bone lUver l T.Body Thyroid Kidney Lung GI-LLI Sr-92 7.50E-09 No Data 2.79E-1 0 No Data No Data 1.70E-05 1.OOE-04 Y-90 2.35E-06 No Data 6.30E-08 No Data No Data 1.92E-04 7.43E-05 Y-91m 2.91E-10 No Data 9.90E-12 No Data No Data 1.99E-06 1.68E-06 Y-91 4.20E-04 No Data 1.1 2E-05 No Data No Data 1.75E-03 5.02E-05 Y-92 1.17E-08 No Data 3.29E-10 No Data No Data 1.75E-05 9.04E-05 Y-93 1.07E-07 No Data 2.91 E-09 No Data No Data 5.46E-05 1.19E-04 Zr-95 8.24E-05 1.99E-05 1.45E-05 No Data 2.22E-05 1.25E-03 1.55E-05 Zr-97 1.07E-07 1.83E-08 8.36E-09 No Data 1.85E-08 7.88E-05 1.OOE-04 Nb-95 1.12E-05 4.59E-06 2.70E-06 No Data 3.37E-06 3.42E-04 9.05E-06 Mo-99 No Data 1.18E-07 2.31 E-08 No Data 1.89E-07 9.63E-05 3.48E-05 Tc-99m 9.98E-13 2.06E-12 2.66E-1 1 No Data 2.22E-1 1 5.79E-07 1.45E-06 Tc-101 4.65E-14 5.88E-14 5.80E-13 No Data 6.99E-13 4.17E-07 6.03E-07 Ru-103 1.44E-06 No Data 4.85E-07 No Data 3.03E-06 3.94E-04 1.15E-05 Ru-105 8.74E-10 No Data 2.93E-10 No Data 6.42E-10 1.12E-05 3.46E-05 Ru-1 06 6.20E-05 No Data 7.77E-06 No Data 7.61 E-05 8.26E-03 1.17E-04 Rh-1 05 No Data No Data No Data No Data No Data No Data No Data Ag-1 1Om 7.13E-06 5.16E-06 3.57E-06 No Data 7.80E-06 2.62E-03 2.36E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-i25 No Data No Data No Data No Data No Data No Data No Data Te-125m 3.40E-06 1.42E-06 4.70E-07 1.16E-06 No Data 3.19E-04 9.22E-06 Te-127m 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 Te-127 1.59E-09 6.81 E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 Te-129m 1.01 E-05 4.35E-06 1.59E-06 3.91 E-06 2.27E-05 1.20E-03 4.93E-05 Te-129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 Te-131m 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51 E-05 Te-131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 9-8Re.1 9-18 Rev. 18

                                                                               .VEGP ODCM Table 9-7 (contd).      Inhalation Dose Factors for the Infant Age Group Nuclide       Bone       Liver      T.Body    Thyroid       Kidney     Lung     GI-LLI Te-132     2.66E-07   1.69E-07    1.26E-07   1.99E-07     7.39E-07 2.43E-04    3.15E-05 1-130    4.54E:06   9.91 E-06   3.98E-06   1.14E-03     1.09E-05   No Data   1.42E-06 1-131    2.71 E-05 3.17E-05     1.40E-05   1.06E-02     3.70E-05   No Data   7.56E-07 1-132    1.21 E-06 2.53E-06     8.99E-07   1.21 E-04    2.82E-06   No Data   1.36E-06 1-133    9.46E-06   1.37E-05    4.OOE-06 2.54E-03       1.60E-05   No Data   1.54E-06 1-134    6.58E-07   1.34E-06    4.75E-07   3.18E-05     1.49E-06   No Data   9.21 E-07 1-135    2.76E-06   5.43E-06    1.98E-06 4.97E-04       6.05E-06   No Data   1.31 E-06 Cs-134     2.83E-04   5.02E-04 5.32E-05       No Data     1.36E-04   5.69E-05  9.53E-07 Cs-136     3.45E-05   9.61 E-05 3.78E-05      No Data     4.03E-05   8.40E-06  1.02E-06 Cs-137     3.92E-04   4.37E-04 3.25E-05       No Data     1.23E-04   5.09E-05  9.53E-07 Cs-138     3.61 E-07  5.58E-07    2.84E-07    No Data     2.93E-07 4.67E-08    6.26E-07 Ba-139    1.06E-09   7.03E-13 3.07E-1 I      No Data     4.23E-13   4.25E-06  3.64E-05 Ba-140    4.OOE-05   4.OOE-08 2.07E-06       No Data     9.59E-09   1.14E-03  2.74E-05 Ba-141    1.12E-10   7.70E-14    3.55E-12    No Data     4.64E-14   2.12E-06  3.39E-06 Ba-142    2.84E-11   2.36E-14     1.40E-12   No Data     1.36E-14   1.11 E-06 4.95E-07 La-140    3.61 E-07  1.43E-07    3.68E-08    No Data      No Data   1.20E-04  6.06E-05 La-142    7.36E-10   2.69E-10 6.46E-1 1      No Data      No Data   5.87E-06  4.25E-05 Ce-1 41    1.98E-05  1.1 9E-05    1.42E-06   No Data     3.75E-06   3.69E-04  1.54E-05 Ce-143    2.09E-07   1.38E-07     1.58E-08   No Data     4.03E-08 8.30E-05    3.55E-05 Ce-144    2.28E-03   8.65E-04     1.26E-04   No Data     3.84E-04   7.03E-03  1.06E-04 Pr-143     1.OOE-05 3.74E-06 4.99E-07        No Data      1.41 E-06 3.09E-04  2.66E-05 Pr-144     3.42E-1 1 1.32E-1 1 1.72E-12      No Data     4.80E-12   1.15E-06  3.06E-06 Nd-147     5.67E-06 5.81 E-06     3.57E-07   No Data     2.25E-06 2.30E-04    2.23E-05 W-187      9.26E-09  6.44E-09     2.23E-09   No Data      No Data   2.83E-05  2.54E-05 Np-239     2.65E-07 2.37E-08      1.34E-08   No Data     4.73E-08   4.25E-05  1.78E-05 Rev. 18 9-19                                      Rev. 18

VEGP ODCM Table 9-8. Inhalation Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C-14 9.70E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 Na-24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P-32 7.04E-04 3.09E-05 2.67E-05 No Data No Data No Data 1.14E-05 Cr-51 No Data No Data 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 Mn-54 No Data 1.1 6E-05 2.57E-06 No Data 2.71 E-06 4.26E-04 6.19E-06 Mn-56 No Data 4.48E-10 8.43E-11 No Data 4.52E-10 3.55E-06 3.33E-05 Fe-55 1.28E-05 6.80E-06 2.10E-06 No Data No Data 3.OOE-05 7.75E-07 Fe-59 5.59E-06 9.04E-06 4.51 E-06 No Data No Data 3.43E-04 1.91 E-05 Co-58 No Data 4.79E-07 8.55E-07 No Data No Data 2.99E-04 9.29E-06 Co-60 No Data 3.55E-06 6.12E-06 No Data No Data 1.91 E-03 2.60E-05 Ni-63 2.22E-04 1.25E-05 7.56E-06 No Data No Data 7.43E-05 1.71 E-06 Ni-65 8.08E-10 7.99E-1 1 4.44E-1 1 No Data No Data 2.21 E-06 2.27E-05 Cu-64 No Data 5.39E-1 0 2.90E-10 No Data 1.63E-09 2.59E-06 9.92E-06 Zn-65 1.15E-05 3.06E-05 1.90E-05 No Data 1.93E-05 2.69E-04 4.41 E-06 Zn-69 1.81 E-11 2.61 E-11 2.41 E-12 No Data 1.58E-11 3.84E-07 2.75E-06 Br-83 No Data No Data 1.28E-07 No Data No Data No Data No Data Br-84 No Data No Data 1.48E-07 No Data No Data No Data No Data Br-85 No Data No Data 6.84E-09 No Data No Data No Data No Data Rb-86 No Data 5.36E-05 3.09E-05 No Data No Data No Data 2.16E-06 Rb-88 No Data 1.52E-07 9.90E-08 No Data No Data No Data 4.66E-09 Rb-89 No Data 9.33E-08 7.83E-08 No Data No Data No Data 5.11E-10 Sr-89 1.62E-04 No Data 4.66E-06 No Data No Data 5.83E-04 4.52E-05 Sr-90 2.73E-02 No Data 1.74E-03 No Data No Data 3.99E-03 9.28E-05 Sr-91 3.28E-08 No Data 1.24E-09 No Data No Data 1.44E-05 4.70E-05 All values are in (mrem/pCi inhaled). They are obtained from Reference 3 (Table E-9). Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-125. 9-20 ev. 1 9-20 Rev. 18

VEGP ODCM Tahle Q-A 8 rnntdV

                 -I, Inhalation Dose Factors for the Child Aae Grouw Nuclide                             T.Body    Thyroid       Kidney  [    Lung   [   GI-LLI Sr-92    3.54E-09   No Data     1.42E-1 0   No Data     No Data     6.49E-06    6.55E-05 Y-90    1.11 E-06  No Data     2.99E-08    No Data     No Data     7.07E-05    7.24E-05 Y-91m     1.37E-1 0  No Data     4.98E-12    No Data     No Data     7.60E-07    4.64E-07 Y-91    2.47E-04   No Data     6.59E-06    No Data     No Data     7.1 OE-04   4.97E-05 Y-92    5.50E-09   No Data      1.57E-1 0  No Data     No Data     6.46E-06    6.46E-05 Y-93    5.04E-08   No Data      1.38E-09   No Data      No Data    2.01 E-05   1.05E-04 Zr-95    5.13E-05   1.13E-05     1.OOE-05   No Data     1.61 E-05   6.03E-04    1.65E-05 Zr-97    5.07E-08   7.34E-09 4.32E-09       No Data     1.05E-08 3.06E-05       9.49E-05 Nb-95    6.35E-06   2.48E-06     1.77E-06   No Data    2.33E-06     1.66E-04    1.OOE-05 Mo-99     No Data   4.66E-08     1.15E-08   No Data     1.06E-07    3.66E-05    3.42E-05 Tc-99m     4.81 E-1 3 9.41 E-1 3   1.56E-1 1  No Data     1.37E-1 1 2.57E-07      1.30E-06 Tc-101     2.19E-14 2.30E-14      2.91 E-13  No Data     3.92E-13    1.58E-07    4.41 E-09 Ru-1 03    7.55E-07   No Data     2.90E-07   No Data     1.90E-06    1.79E-04    1.21 E-05 Ru-105    4.13E-10   No Data     1.50E-10   No Data     3.63E-10 4.30E-06       2.69E-05 Ru-106    3.68E-05   No Data     4.57E-06   No Data     4.97E-05 3.87E-03       1.16E-04 Rh-1 05    No Data   No Data      No Data   No Data      No Data     No Data     No Data Ag-11 Om 4.56E-06      3.08E-06     2.47E-06   No Data     5.74E-06    1.48E-03    2.71 E-05 Sb-124     No Data   No Data      No Data   No Data      No Data     No Data     No Data Sb-1 25    No Data   No Data      No Data   No Data      No Data     No Data     No Data Te-125m      1.82E-06  6.29E-07     2.47E-07 5.20E-07       No Data     1.29E-04   9.13E-06 Te-127m 6.72E-06      2.31 E-06 8.16E-07      1.64E-06     1.72E-05   4.00E-04    1.93E-05 Te-127    7.49E-10  2.57E-10     1.65E-10   5.30E-10     1.91 E-09 2.71 E-06     1.52E-05 Te-129m 5.19E-06       1.85E-06    8.22E-07   1.71 E-06    1.36E-05 4.76E-04      4.91 E-05 Te-129    2.64E-1i1  9.45E-12    6.44E-12   1.93E-1 1 6.94E-1 1 7.93E-07         6.89E-06 Te-131 m 3.63E-08      1.60E-08    1.37E-08   2.64E-08     1.08E-07    5.56E-05    8.32E-05 Te-131    5.87E-12   2.28E-12     1.78E-12 4.59E-12      1.59E-11    5.55E-07    3.60E-07 Rev. 18 9-21 9-21                                          Rev. 18

VEGP ODCM Table 9-8 (contd). Inhalation Dose Factors for the Child Age Group Nuclide Bone Liver T.Body l Thyroid Kidney Lung GI-LLI Te-132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05 1-130 2.21 E-06 4.43E-06 2.28E-06 4.99E-04 6.61 E-06 No Data 1.38E-06 1-131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 No Data 7.68E-07 1-132 5.72E-07 1.1 OE-06 5.07E-07 5.23E-05 1.69E-06 No Data 8.65E-07 1-133 4.48E-06 5.49E-06 2.08E-06 1.04E-03 9.13E-06 No Data 1.48E-06 1-134 3.17E-07 5.84E-07 2.69E-07 1.37E-05 8.92E-07 No Data 2.58E-07 1-135 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 No Data 1.20E-06 Cs-134 1.76E-04 2.74E-04 6.07E-05 No Data 8.93E-05 3.27E-05 1.04E-06 Cs-136 1.76E-05 4.62E-05 3.14E-05 No Data 2.58E-05 3.93E-06 1.13E-06 Cs-137 2.45E-04 2.23E-04 3.47E-05 No Data 7.63E-05 2.81 E-05 9.78E-07 Cs-1 38 1.71 E-07 2.27E-07 1.50E-07 No Data 1.68E-07 1.84E-08 7.29E-08 Ba-139 4.98E-10 2.66E-13 1.45E-11 No Data 2.33E-13 1.56E-06 1.56E-05 Ba-140 2.OOE-05 1.75E-08 1.1 7E-06 No Data 5.71 E-09 4.71 E-04 2.75E-05 Ba-141 5.29E-1 1 2.95E-14 1.72E-12 No Data 2.56E-14 7.89E-07 7.44E-08 Ba-142 1.35E-11 9.73E-15 7.54E-13 No Data 7.87E-15 4.44E-07 7.41 E-10 La-140 1.74E-07 6.08E-08 2.04E-08 No Data No Data 4.94E-05 6.10E-05 La-142 3.50E-10 1.11E-10 3.49E-11 No Data No Data 2.35E-06 2.05E-05 Ce-141 1.06E-05 5.28E-06 7.83E-07 No Data 2.31 E-06 1.47E-04 1.53E-05 Ce-143 9.89E-08 5.37E-08 7.77E-09 No Data 2.26E-08 3.12E-05 3.44E-05 Ce-144 1.83E-03 5.72E-04 9.77E-05 No Data 3.17E-04 3.23E-03 1.05E-04 Pr-143 4.99E-06 1.50E-06 2.47E-07 No Data 8.1 iE-07 1.17E-04 2.63E-05 Pr-144 1.61 E-11 4.99E-12 8.1OE-13 No Data 2.64E-12 4.23E-07 5.32E-08 Nd-147 2.92E-06 2.36E-06 1.84E-07 No Data 1.30E-06 8.87E-05 2.22E-05 W-1 87 4.41 E-09 2.61 E-09 1.17E-09 No Data No Data 1.11 E-05 2.46E-05 Np-239 I1.26E-07 9.04E-09 6.35E-09 No Data 2.63E-08 1.57E-05 1.73E-05 Rev. 18 9-22 Rev. 18

VEGP ODCM Table 9-9. Inhalation Dose Factors for the Teenager Age Group Nuclide Bone Uver T.Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C-14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 Na-24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 P-32 2.36E-04 1.37E-08 8.95E-06 No Data No Data No Data 1.16E-05 Cr-51 No Data No Data 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 Mn-54 No Data 6.39E-06 1.05E-06 No Data 1.59E-06 2.48E-04 8.35E-06 Mn-56 No Data 2.12E-10 3.15E-11 No Data 2.24E-10 1.90E-06 7.18E-06 Fe-55 4.18E-06 2.98E-06 6.93E-07 No Data No Data 1.55E-05 7.99E-07 Fe-59 1.99E-06 4.62E-06 1.79E-06 No Data No Data 1.91 E-04 2.23E-05 Co-58 No Data 2.59E-07 3.47E-07 No Data No Data 1.68E-04 1.1 9E-05 Co-60 No Data 1.89E-06 2.48E-06 No Data No Data 1.09E-03 3.24E-05 Ni-63 7.25E-05 5.43E-06 2.47E-06 No Data No Data 3.84E-05 1.77E-06 Ni-65 2.73E-10 3.66E-1 1 1.59E-1 1 No Data No Data 1.17E-06 4.59E-06 Cu-64 No Data 2.54E-10 1.06E-10 No Data 8.01 E-10 1.39E-06 7.68E-06 Zn-65 4.82E-06 1.67E-05 7.80E-06 No Data 1.08E-05 1.55E-04 5.83E-06 Zn-69 6.04E-12 1.15E-11 8.07E-13 No Data 7.53E-12 1.98E-07 3.56E-08 Br-83 No Data No Data 4.30E-08 No Data No Data No Data No Data Br-84 No Data No Data 5.41 E-08 No Data No Data No Data No Data Br-85 No Data No Data 2.29E-09 No Data No Data No Data No Data Rb-86 No Data 2.38E-05 1.05E-05 No Data No Data No Data 2.21 E-06 Rb-88 No Data 6.82E-08 3.40E-08 No Data No Data No Data 3.65E-1 5 Rb-89 No Data 4.40E-08 2.91 E-08 No Data No Data No Data 4.22E-17 Sr-89 5.43E-05 No Data 1.56E-06 No Data No Data 3.02E-04 4.64E-05 Sr-90 1.35E-02 No Data 8.35E-04 No Data No Data 2.06E-03 9.56E-05 Sr-91 1.1OE-08 No Data 4.39E-10 No Data No Data 7.59E-06 3.24E-05

       -All values are in (mrem/pCi inhaled). They are obtained from Reference 3 (Table E-8). Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-1 25.

9-23 ev. 1 9-23 Rev. 18

VEGP ODCM Table 9-9 (contd). Inhalation Dose Factors for the Teenager Age Group Nuclide Bone Liver T.Body Thyroid Kidney Lung G'-LLI Sr-92 1.1 9E-09 No Data 5.08E-1 1 No Data No Data 3.43E-06 1.49E-05 Y-90 3.73E-07 No Data 1.OOE-08 No Data No Data 3.66E-05 6.99E-05 Y-91m 4.63E-1 1 No Data 1.77E-12 No Data No Data 4.OOE-07 3.77E-09 Y-91 8.26E-05 No Data 2.21 E-06 No Data No Data 3.67E-04 5.11 E-05 Y-92 1.84E-09 No Data 5.36E-1 1 No Data No Data 3.35E-06 2.06E-05 Y-93 1.69E-08 No Data 4.65E-1 0 No Data No Data 1.04E-05 7.24E-05 Zr-95 1.82E-05 5.73E-06 3.94E-06 No Data 8.42E-06 3.36E-04 1.86E-05 Zr-97 1.72E-08 3.40E-09 1.57E-09 No Data 5.15E-09 1.62E-05 7.88E-05 Nb-95 2.32E-06 1.29E-06 7.08E-07 No Data 1.25E-06 9.39E-05 1.21 E-05 Mo-99 No Data 2.11 E-08 4.03E-09 No Data 5.14E-08 1.92E-05 3.36E-05 Tc-99m 1.73E-13 4.83E-13 6.24E-12 No Data 7.20E-12 1.44E-07 7.66E-07 Tc-101 7.40E-15 1.05E-14 1.03E-13 No Data 1.90E-13 8.34E-08 1.09E-16 Ru-103 2.63E-07 No Data 1.12E-07 No Data 9.29E-07 9.79E-05 1.36E-05 Ru-105 1.40E-10 No Data 5.42E-11 No Data 1.76E-10 2.27E-06 1.13E-05 Ru-1 06 1.23E-05 No Data 1.55E-06 No Data 2.38E-05 2.01 E-03 1.20E-04 Rh-1 05 No Data No Data No Data No Data No Data No Data No Data Ag-11 Om 1.73E-06 1.64E-06 9.99E-07 No Data 3.13E-06 8.44E-04 3.41 E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 6.10E-07 2.80E-07 8.34E-08 1.75E-07 No Data 6.70E-05 9.38E-06 Te-127m 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 Te-127 2.51 E-I0 1.14E-10 5.52E-11 1.77E-10 9.1 OE-10 1.40E-06 1.01 E-05 Te-129m 1.74E-06 8.23E-07 2.81 E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05 Te-129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 Te-131 m 1.23E-08 7.51 E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05 Te-131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 Rev. 18 9-24 Rev. 18

VEGP ODCM Table 9-9 (contd). Inhalation Dose Factors for the Teenager Age Group Nuclide Bone J Liver T.Body Thyroid Kidney Lung GI-LLI Te-132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61 E-05 5.79E-05 1-130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 No Data 1.14E-06 1-131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 No Data 8.11 E-07 1-132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 No Data 1.59E-07 1-133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 No Data 1.29E-06 1-134 1.11 E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 No Data 2.55E-09 1-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 No Data 8.69E-07 Cs-1 34 6.28E-05 1.41 E-04 6.86E-05 No Data 4.69E-05 1.83E-05 1.22E-06 Cs-1 36 6.44E-06 2.42E-05 1.71 E-05 No Data 1.38E-05 2.22E-06 1.36E-06 Cs-i37 8.38E-05 1.06E-04 3.89E-05 No Data 3.80E-05 1.51 E-05 1.06E-06 Cs-138 5.82E-08 1.07E-07 5.58E-08 No Data 8.28E-08 9.84E-09 3.38E-1 1 Ba-139 1.67E-10 1.18E-13 4.87E-12 No Data 1.11E-13 8.08E-07 8.06E-07 Ba-140 6.84E-06 8.38E-09 4.40E-07 No Data 2.85E-09 2.54E-04 2.86E-05 Ba-141 1.78E-11 1.32E-14 5.93E-13 No Data 1.23E-14 4.11 E-07 9.33E-14 Ba-142 4.62E-12 4.63E-15 2.84E-13 No Data 3.92E-15 2.39E-07 5.99E-20 La-140 5.99E-08 2.95E-08 7.82E-09 No Data No Data 2.68E-05 6.09E-05 La-142 1.20E-10 5.31 E-11 1.32E-11 No Data No Data 1.27E-06 1.50E-06 Ce-141 3.55E-06 2.37E-06 2.71 E-07 No Data 1.11 E-06 7.67E-05 1.58E-05 Ce-143 3.32E-08 2.42E-08 2.70E-09 No Data 1.08E-08 1.63E-05 3.19E-05 Ce-144 6.11 E-04 2.53E-04 3.28E-05 No Data 1.51 E-04 1.67E-03 1.08E-04 Pr-143 1.67E-06 6.64E-07 8.28E-08 No Data 3.86E-07 6.04E-05 2.67E-05 Pr-144 5.37E-12 2.20E-12 2.72E-13 No Data 1.26E-12 2.19E-07 2.94E-14 Nd-147 9.83E-07 1.07E-06 6.41 E-08 No Data 6.28E-07 4.65E-05 2.28E-05 W-187 1.50E-09 1.22E-09 4.29E-10 No Data No Data 5.92E-06 2.21 E-05 Np-239 4.23E-08 3.99E-09 2.21 E-09 No Data 1.25E-08 8.11 E-06 1.65E-05 Rev. 18 9-25 9-25 Rev. 18

VEGP ODCM Table 9-10. Inhalation Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C-14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 Na-24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 P-32 1.65E-04 9.64E-06 6.26E-06 No Data No Data No Data 1.08E-05 Cr-51 No Data No Data 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 Mn-54 No Data 4.95E-06 7.87E-07 No Data 1.23E-06 1.75E-04 9.67E-06 Mn-56 No Data 1.55E-10 2.29E-11 No Data 1.63E-10 1.18E-06 2.53E-06 Fe-55 3.07E-06 2.12E-06 4.93E-07 No Data No Data 9.01 E-06 7.54E-07 Fe-59 1.47E-06 3.47E-06 1.32E-06 No Data No Data 1.27E-04 2.35E-05 Co-58 No Data 1.98E-07 2.59E-07 No Data No Data 1.16E-04 1.33E-05 Co-60 No Data 1.44E-06 1.85E-06 No Data No Data 7.46E-04 3.56E-05 Ni-63 5.40E-05 3.93E-06 1.81 E-06 No Data No Data 2.23E-05 1.67E-06 Ni-65 1.92E-10 2.62E-11 1.14E-11 No Data No Data 7.OOE-07 1.54E-06 Cu-64 No Data 1.83E-10 7.69E-11 No Data 5.78E-10 8.48E-07 6.12E-06 Zn-65 4.05E-06 1.29E-05 5.82E-06 No Data 8.62E-06 I.OBE-04 6.68E-06 Zn-69 4.23E-12 8.14E-12 5.65E-13 No Data 5.27E-12 1.15E-07 2.04E-09 Br-83 No Data No Data 3.01 E-08 No Data No Data No Data 2.90E-08 Br-84 No Data No Data 3.91 E-08 No Data No Data No Data 2.05E-13 Br-85 No Data No Data 1.60E-09 No Data No Data No Data No Data Rb-86 No Data 1.69E-05 7.37E-06 No Data No Data No Data 2.08E-06 Rb-88 No Data 4.84E-08 2.41E-08 No Data No Data No Data 4.18E-19 Rb-89 No Data 3.20E-08 2.12E-08 No Data No Data No Data 1.1 6E-21 Sr-89 3.80E-05 No Data 1.09E-06 No Data No Data 1.75E-04 4.37E-05 Sr-90 1.24E-02 No Data 7.62E-04 No Data No Data 1.20E-03 9.02E-05 Sr-91 7.74E-09 No Data 3.13E-10 No Data No Data 4.56E-06 2.39E-05 All values are in (mrem/pCi inhaled). They are obtained from Reference 3 (Table E-7), except as follows: Reference 2 (Table C-1) for Rh-105, Sb-124, and Sb-125. 9-26 Rev. 18

VEGP ODCM Table 9-10 (contd). Inhalation Dose Factors for the Adult Age Group Nuclide Bone l Liver T.Body Thyroid l Kidney l Lung GI-LLI Sr-92 8.43E-10 No Data 3.64E-1 1 No Data No Data 2.06E-06 5.38E-06 Y-90 2.61 E-07 No Data 7.01 E-09 No Data No Data 2.12E-05 6.32E-05 Y-91m 3.26E-11 No Data 1.27E-12 No Data No Data 2.40E-07 1.66E-10 Y-91 5.78E-05 No Data 1.55E-06 No Data No Data 2.13E-04 4.81E-05 Y-92 1.29E-09 No Data 3.77E-1I No Data No Data 1.96E-06 9.19E-06 Y-93 1.1 8E-08 No Data 3.26E-10 No Data No Data 6.06E-06 5.27E-05 Zr-95 1.34E-05 4.30E-06 2.91 E-06 No Data 6.77E-06 2.21 E-04 1.88E-05 Zr-97 1.21 E-08 2.45E-09 1.13E-09 No Data 3.71 E-09 9.84E-06 6.54E-05 Nb-95 1.76E-06 9.77E-07 5.26E-07 No Data 9.67E-07 6.31 E-05 1.30E-05 Mo-99 No Data 1.51 E-08 2.87E-09 No Data 3.64E-08 1.14E-05 3.1 OE-05 Tc-99m 1.29E-13 3.64E-1 3 4.63E-12 No Data 5.52E-12 9.55E-08 5.20E-07 Tc-101 5.22E-15 7.52E-15 7.38E-14 No Data 1.35E-13 4.99E-08 1.36E-21 Ru-1 03 1.91 E-07 No Data 8.23E-08 No Data 7.29E-07 6.31 E-05 1.38E-05 Ru-105 9.88E-1 1 No Data 3.89E-1 1 No Data 1.27E-1 0 1.37E-06 6.02E-06 Ru-106 8.64E-06 No Data 1.09E-06 No Data 1.67E-05 1.17E-03 1.14E-04 Rh-1 05 9.24E-10 6.73E-10 4.43E-10 No Data 2.86E-09 2.41 E-06 1.09E-05 Ag-110m 1.35E-06 1.25E-06 7.43E-07 No Data 2.46E-06 5.79E-04 3.78E-05 Sb-124 3.90E-06 7.36E-08 1.55E-06 9.44E-09 No Data 3.1 OE-04 5.08E-05 Sb-125 8.26E-06 8.91 E-08 1.66E-06 7.34E-09 No Data 2.75E-04 1.26E-05 Te-125m 4.27E-07 1.98E-07 5.84E-08 1.31 E-07 1.55E-06 3.92E-05 8.83E-06 Te-127m 1.58E-06 7.21 E-07 1.96E-07 4.11 E-07 5.72E-06 1.20E-04 1.87E-05 Te-127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 Te-129m 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 Te-129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-1 1 2.42E-07 1.96E-08 Te-131 m 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05 Te-131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 Rev. 18 9-27 9-27 Rev. 18

VEGP ODCM Table 9-10 (contd). Inhalation Dose Factors for the Adult Age Group Nuclide Bone Liver T.Body Thyroid Kidney Lung GI-LLI Te-1 32 3.25E-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 1-130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61 E-06 No Data 9.61 E-07 1-131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 No Data 7.85E-07 1-132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 No Data 5.08E-08 1-133 1.OBE-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 No Data 1.11 E-06 1-134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 No Data 1.26E-1 0 1-135 3.35E-07 8.73E-07 3.21 E-07 5.60E-05 1.39E-06 No Data 6.56E-07 Cs-134 4.66E-05 1.06E-04 9.10E-05 No Data 3.59E-05 1.22E-05 1.30E-06 Cs-136 4.88E-06 1.83E-05 1.38E-05 No Data 1.07E-05 1.50E-06 1.46E-06 Cs-1 37 5.98E-05 7.76E-05 5.35E-05 No Data 2.78E-05 9.40E-06 1.05E-06 Cs-138 4.14E-08 7.76E-08 4.05E-08 No Data 6.OOE-08 6.07E-09 2.33E-13 Ba-139 1.17E-10 8.32E-14 3.42E-12 No Data 7.78E-14 4.70E-07 1.12E-07 Ba-1 40 4.88E-06 6.13E-09 3.21 E-07 No Data 2.09E-09 1.59E-04 2.73E-05 Ba-141 1.25E-11 9.41 E-15 4.20E-13 No Data 8.75E-15 2.42E-07 1.45E-17 Ba-142 3.29E-12 3.38E-1 5 2.07E-13 No Data 2.86E-1 5 1.49E-07 1.96E-26 La-140 4.30E-08 2.17E-08 5.73E-09 No Data No Data 1.70E-05 5.73E-05 La-142 8.54E-11 3.88E-11 9.65E-12 No Data No Data 7.91 E-07 2.64E-07 Ce-141 2.49E-06 1.69E-06 1.91 E-07 No Data 7.83E-07 4.52E-05 1.50E-05 Ce-143 2.33E-08 1.72E-08 1.91 E-09 No Data 7.60E-09 9.97E-06 2.83E-05 Ce-144 4.29E-04 1.79E-04 2.30E-05 No Data 1.06E-04 9.72E-04 1.02E-04 Pr-143 1.17E-06 4.69E-07 5.80E-08 No Data 2.70E-07 3.51 E-05 2.50E-05 Pr-144 3.76E-12 1.56E-12 1.91E-13 No Data 8.81 E-13 1.27E-07 2.69E-18 Nd-147 6.59E-07 7.62E-07 4.56E-08 No Data 4.45E-07 2.76E-05 2.16E-05 W-187 1.06E-09 8.85E-10 3.10E-10 No Data No Data 3.63E-06 1.94E-05 Np-239 2.87E-08 2.82E-09 1.55E-09 No Data 8.75E-09 4.70E-06 1.49E-05 Rev. 18 9-28 9-28 Rev. 18

VEGP ODCM Table 9-11. Ingestion Dose Factors for the Infant Age Group Nuclide Bone Liver T.Body Thyroid Kidney Lung GI-LLI H-3 No Data 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C-14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 Na-24 1.01 E-05 1.01 E-05 1.01 E-05 1.01 E-05 1.01 E-05 1.01 E-05 1.01 E-05 P-32 1.70E-03 1.OOE-04 6.59E-05 No Data No Data No Data 2.30E-05 Cr-51 No Data No Data 1.41 E-08 9.20E-09 2.01 E-09 1.79E-08 4.11 E-07 Mn-54 No Data 1.99E-05 4.51 E-06 No Data 4.41 E-06 No Data 7.31 E-06 Mn-56 No Data 8.18E-07 1.41 E-07 No Data 7.03E-07 No Data 7.43E-05 Fe-55 1.39E-05 8.98E-06 2.40E-06 No Data No Data 4.39E-06 1.14E-06 Fe-59 3.08E-05 5.38E-05 2.12E-05 No Data No Data 1.59E-05 2.57E-05 Co-58 No Data 3.60E-06 8.98E-06 No Data No Data No Data 8.97E-06 Co-60 No Data 1.OBE-05 2.55E-05 No Data No Data No Data 2.57E-05 Ni-63 6.34E-04 3.92E-05 2.20E-05 No Data No Data No Data 1.95E-06 Ni-65 4.70E-06 5.32E-07 2.42E-07 No Data No Data No Data 4.05E-05 Cu-64 No Data 6.09E-07 2.82E-07 No Data 1.03E-06 No Data 1.25E-05 Zn-65 1.84E-05 6.31 E-05 2.91 E-05 No Data 3.06E-05 No Data 5.33E-05 Zn-69 9.33E-08 1.68E-07 1.25E-08 No Data 6.98E-08 No Data 1.37E-05 Br-83 No Data No Data 3.63E-07 No -Data No Data No Data No Data Br-84 No Data No Data 3.82E-07 No Data No Data No Data No Data Br-85 No Data No Data 1.94E-08 No Data No Data No Data No Data Rb-86 No Data 1.70E-04 8.40E-05 No Data No Data No Data 4.35E-06 Rb-88 No Data 4.98E-07 2.73E-07 No Data No Data No Data 4.85E-07 Rb-89 No Data 2.86E-07 1.97E-07 No Data No Data No Data 9.74E-08 Sr-89 2.51 E-03 No Data 7.20E-05 No Data No Data No Data 5.16E-05 Sr-90 1.85E-02 No Data 4.71 E-03 No Data No Data No Data 2.31 E-04 Sr-91 5.OOE-05 No Data 1.81 E-06 No Data No Data No Data 5.92E-05 All values are in (mrem/pCi ingested). They are obtained from Reference 3 (Table E-14). Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-1 24, or Sb-125. 1 9-29Rev. 9-29 Rev. 18

VEGP ODCM Table 9-11 (contd). Ingestion Dose Factors for the Infant Age Group _______ __ __ IT Nuclide Bone Liver T.Body Thyroid Kidney Lung GI-LLI Sr-92 1.92E-05 No Data 7.13E-07 No Data No Data No Data 2.07E-04 Y-90 8.69E-08 No Data 2.33E-09 No Data No Data No Data 1.20E-04 Y-91m 8.10E-10 No Data 2.76E-1 I No Data No Data No Data 2.70E-06 Y-91 1.13E-06 No Data 3.01 E-08 No Data No Data No Data 8.10E-05 Y-92 7.65E-09 No Data 2.15E-10 No Data No Data No Data 1.46E-04 Y-93 2.43E-08 No Data 6.62E-10 No Data No Data No Data 1.92E-04 Zr-95 2.06E-07 5.02E-08 3.56E-08 No Data 5.41 E-08 No Data 2.50E-05 Zr-97 1.48E-08 2.54E-09 1.16E-09 No Data 2.56E-09 No Data 1.62E-04 Nb-95 4.20E-08 1.73E-08 1.OOE-08 No Data 1.24E-08 No Data 1.46E-05 Mo-99 No Data 3.40E-05 6.63E-06 No Data 5.08E-05 No Data 1.12E-05 Tc-99m 1.92E-09 3.96E-09 5.1 OE-08 No Data 4.26E-08 2.07E-09 1.15E-06 Tc-101 2.27E-09 2.86E-09 2.83E-08 No Data 3.40E-08 1.56E-09 4.86E-07 Ru-i03 1.48E-06 No Data 4.95E-07 No Data 3.08E-06 No Data 1.80E-05 Ru-1 05 1.36E-07 No Data 4.58E-08 No Data 1.OOE-06 No Data 5.41 E-05 Ru-106 2.41 E-05 No Data 3.01 E-06 No Data 2.85E-05 No Data 1.83E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-1 1Om 9.96E-07 7.27E-07 4.81 E-07 No Data 1.04E-06 No Data 3.77E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 2.33E-05 7.79E-06 3.15E-06 7.84E-06 No Data No Data 1.11 E-05 Te-127m 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 No Data 2.36E-05 Te-127 1.OOE-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 No Data 2.1 OE-05 Te-129m 1.OOE-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 No Data 5.97E-05 Te-129 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 No Data 2.27E-05 Te-1 31 m 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21 E-05 No Data 1.03E-04 Te-131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 No Data 7.11 E-06 ev. 1 9-30 9-30 Rev. 18

VEGP ODCM Table 9-11 (contd). Ingestion Dose Factors for the Infant Age Group Nuclide Bone Liver T.Body Thyroid Kidney [ Lung GI-LLI Te-132 2.08E-05 1.03E-05 9.61 E-06 1.52E-05 6.44E-05 No Data 3.81 E-05 1-130 6.OOE-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 No Data 2.83E-06 1-131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 No Data 1.51 E-06 1-132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 No Data 2.73E-06 1-133 1.25E-05 1.82E-05 5.33E-06 3.31 E-03 2.14E-05 No Data 3.08E-06 1-134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 No Data 1.84E-06 1-135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 No Data 2.62E-06 Cs-134 3.77E-04 7.03E-04 7.1 OE-05 No Data 1.81 E-04 7.42E-05 1.91 E-06 Cs-136 4.59E-05 1.35E-04 5.04E-05 No Data 5.38E-05 1.1OE-05 2.05E-06 Cs-137 5.22E-04 6.11 E-04 4.33E-05 No Data 1.64E-04 6.64E-05 1.91 E-06 Cs-138 4.81 E-07 7.82E-07 3.79E-07 No Data 3.90E-07 6.09E-08 1.25E-06 Ba-139 8.81 E-07 5.84E-10 2.55E-08 No Data 3.51 E-10 3.54E-10 5.58E-05 Ba-140 1.71 E-04 1.71 E-07 8.81 E-06 No Data 4.06E-08 1.05E-07 4.20E-05 Ba-141 4.25E-07 2.91 E-I0 1.34E-08 No Data 1.75E-10 1.77E-10 5.19E-06 Ba-142 1.84E-07 1.53E-1 0 9.06E-09 No Data 8.81 E-1 1 9.26E-1 1 7.59E-07 La-140 2.11 E-08 8.32E-09 2.14E-09 No Data No Data No Data 9.77E-05 La-1 42 1.10E-09 4.04E-10 9.67E-1 1 No Data No Data No Data 6.86E-05 Ce-141 7.87E-08 4.80E-08 5.65E-09 No Data 1.48E-08 No Data 2.48E-05 Ce-143 1.48E-08 9.82E-06 1.12E-09 No Data 2.86E-09 No Data 5.73E-05 Ce-144 2.98E-06 1.22E-06 1.67E-07 No Data 4.93E-07 No Data 1.71 E-04 Pr-143 8.13E-08 3.04E-08 4.03E-09 No Data 1.13E-08 No Data 4.29E-05 Pr-144 2.74E-10 1.06E-10 1.38E-11 No Data 3.84E-11 No Data 4.93E-06 Nd-147 5.53E-08 5.68E-08 3.48E-09 No Data 2.19E-08 No Data 3.60E-05 W-187 9.03E-07 6.28E-07 2.17E-07 No Data No Data No Data 3.69E-05 Np-239 1.11 E-08 9.93E-10 5.6 E-10 No Data 1.98E-O9 No Data 2.87E-05 Rev. 18 9-31 9-31 Rev. 18

VEGP ODCM Table 9-12. Ingestion Dose Factors for the Child Age Group Nuclide Bone Liver lT. Body l Thyroid Kidney Lung GI-LLI H-3 No Data 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C-14 1.21 E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 Na-24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 P-32 8.25E-04 3.86E-05 3.18E-05 No Data No Data No Data 2.28E-05 Cr-51 No Data No Data 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 Mn-54 No Data 1.07E-05 2.85E-06 No Data 3.OOE-06 No Data 8.98E-06 Mn-56 No Data 3.34E-07 7.54E-08 No Data 4.04E-07 No Data 4.84E-05 Fe-55 1.15E-05 6.1OE-06 1.89E-06 No Data No Data 3.45E-06 1.13E-06 Fe-59 1.65E-05 2.67E-05 1.33E-05 No Data No Data 7.74E-06 2.78E-05 Co-58 No Data 1.80E-06 5.51 E-06 No Data No Data No Data 1.05E-05 Co-60 No Data 5.29E-06 1.56E-05 No Data No Data No Data 2.93E-05 Ni-63 5.38E-04 2.88E-05 1.83E-05 No Data No Data No Data 1.94E-06 Ni-65 2.22E-06 2.09E-07 1.22E-07 No Data No Data No Data 2.56E-05 Cu-64 No Data 2.45E-07 1.48E-07 No Data 5.92E-07 No Data 1.15E-05 Zn-65 1.37E-05 3.65E-05 2.27E-05 No Data 2.30E-05 No Data 6.41 E-06 Zn-69 4.38E-08 6.33E-08 5.85E-09 No Data 3.84E-08 No Data 3.99E-06 Br-83 No Data No Data 1.71 E-07 No Data No Data No Data No Data Br-84 No Data No Data 1.98E-07 No Data No Data No Data No Data Br-85 No Data No Data 9.12E-09 No Data No Data No Data No Data Rb-86 No Data 6.70E-05 4.12E-05 No Data No Data No Data 4.31 E-06 Rb-88 No Data 1.90E-07 1.32E-07 No Data No Data No Data 9.32E-09 Rb-89 No Data 1.17E-07 1.04E-07 No Data No Data No Data 1.02E-09 Sr-89 1.32E-03 No Data 3.77E-05 No Data No Data No Data 5.11 E-05 Sr-90 1.70E-02 No Data 4.31 E-03 No Data No Data No Data 2.29E-04 Sr-91 2.40E-05 No Data 9.06E-07 No Data No Data No Data 5.30E-05 All values are in (mrem/pCi ingested). They are obtained from Reference 3 (Table E-13). Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-1 24, or Sb-1 25. 9-32 Rev. 18

VEGP ODCM Table 9-12 (contd). Ingestion Dose Factors for the Child Age Group Nuclide Bone Li T.Body Thyroid Kidney Lung GI-LLI Sr-92 9.03E-06 No Data 3.62E-07 No Data No Data No Data 1.71 E-04 Y-90 4.11E-08 No Data 1.1OE-09 No Data No Data No Data 1.17E-04 Y-91 m 3.82E-1 0 No Data 1.39E-1 1 No Data No Data No Data 7.48E-07 Y-91 6.02E-07 No Data 1.61 E-08 No Data No Data No Data 8.02E-05 Y-92 3.60E-09 No Data 1.03E-10 No Data No Data No Data 1.04E-04 Y-93 1.14E-08 No Data 3.13E-10 No Data No Data No Data 1.70E-04 Zr-95 1.16E-07 2.55E-08 2.27E-08 No Data 3.65E-08 No Data 2.66E-05 Zr-97 6.99E-09 1.01 E-09 5.96E-10 No Data 1.45E-09 No Data 1.53E-04 Nb-95 2.25E-08 8.76E-09 6.26E-09 No Data 8.23E-09 No Data 1.62E-05 Mo-99 No Data 1.33E-05 3.29E-06 No Data 2.84E-05 No Data 1.10E-05 Tc-99m 9.23E-10 1.81 E-09 3.OOE-08 No Data 2.63E-08 9.19E-10 1.03E-06 Tc-101 1.07E-09 1.12E-09 1.42E-08 No Data 1.91 E-08 5.92E-10 3.56E-09 Ru-103 7.31E-07 No Data 2.81E-07 No Data 1.84E-06 No Data 1.89E-05 Ru-105 6.45E-08 No Data 2.34E-08 No Data 5.67E-07 No Data 4.21 E-05 Ru-106 1.17E-05 No Data 1.46E-06 No Data 1.58E-05 No Data 1.82E-04 Rh-1 05 No Data No Data No Data No Data No Data No Data No Data Ag-110m 5.39E-07 3.64E-07 2.91 E-07 No Data 6.78E-07 No Data 4.33E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 1.14E-05 3.09E-06 1.52E-06 3.20E-06 No Data No Data 1.10E-05 Te-127m 2.89E-05 7.78E-06 3.43E-06 6.91 E-06 8.24E-05 No Data 2.34E-05 Te-127 4.71 E-07 1.27E-07 1.01 E-07 3.26E-07 1.34E-06 No Data 1.84E-05 Te-129m 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 No Data 5.94E-05 Te-129 1.34E-07 3.74E-08 3.1 BE-08 9.56E-08 3.92E-07 No Data 8.34E-06 Te-131 m 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41 E-05 No Data 1.01 E-04 Te-131 8.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51 E-07 No Data 4.36E-07 Rev. 18 9-33 9-33 Rev. 18

VEGP ODCM Table 9-12 (contd). Ingestion Dose Factors for the Child Age Group Nuclide Bone l Liver T.Body Thyroid Kidney Lung GI-LLI Te-1 32 1.01 E-05 4.47E-06 5.40E-06 6.51 E-06 4.15E-05 No Data 4.50E-05 1-130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 No Data 2.76E-06 1-131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 No Data 1.54E-06 1-132 8.OOE-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 No Data 1.73E-06 1-133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 No Data 2.95E-06 1-134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 No Data 5.16E-07 1-135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 No Data 2.40E-06 Cs-1 34 2.34E-04 3.84E-04 8.1 OE-05 No Data 1.19E-04 4.27E-05 2.07E-06 Cs-136 2.35E-05 6.46E-05 4.18E-05 No Data 3.44E-05 5.13E-06 2.27E-06 Cs-137 3.27E-04 3.13E-04 4.62E-05 No Data 1.02E-04 3.67E-05 1.96E-06 Cs-1 38 2.28E-07 3.17E-07 2.01 E-07 No Data 2.23E-07 2.40E-08 1.46E-07 Ba-139 4.14E-07 2.21 E-10 1.20E-08 No Data 1.93E-10 1.30E-10 2.39E-05 Ba-140 8.31 E-05 7.28E-08 4.85E-06 No Data 2.37E-08 4.34E-08 4.21 E-05 Ba-141 2.OOE-07 1.12E-10 6.51 E-09 No Data 9.69E-11 6.58E-10 1.14E-07 Ba-142 8.74E-08 6.29E-11 4.88E-09 No Data 5.09E-1 3.70E-11 1.14E-09 La-140 1.01E-08 3.53E-09 1.19E-09 No Data No Data No Data 9.84E-05 La-142 5.24E-10 1.67E-10 5.23E-11 No Data No Data No Data 3.31 E-05 Ce-1 41 3.97E-08 1.98E-08 2.94E-09 No Data 8.68E-09 No Data 2.47E-05 Ce-143 6.99E-09 3.79E-06 5.49E-10 No Data 1.59E-09 No Data 5.55E-05 Ce-144 2.08E-06 6.52E-07 1.11 E-07 No Data 3.61 E-07 No Data 1.70E-04 Pr-143 3.93E-08 1.18E-08 1.95E-09 No Data 6.39E-09 No Data 4.24E-05 Pr-144 1.29E-10 3.99E-11 6.49E-12 No Data 2.11E-11 No Data 8.59E-08 Nd-147 2.79E-08 2.26E-08 1.75E-09 No Data 1.24E-08 No Data 3.58E-05 W-187 4.29E-07 2.54E-07 1.14E-07 No Data No Data No Data 3.57E-05 Np-239 5.25E-09 3.77E-10 2.65E-10 No Data 1.09E-09 No Data 2.79E-05 9-34 ev. 1 9-34 Rev. 18

VEGP ODCM Table 9-13. Ingestion Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung l GI-LLI H-3 No Data 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C-14 4.06E-06 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 Na-24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E.06 2.30E-06 2.30E-06 P-32 2.76E-04 1.71 E-05 1.07E-05 No Data No Data No Data 2.32E-05 Cr-51 No Data No Data 3.60E-09 2.OOE-09 7.89E-10 5.14E-09 6.05E-07 Mn-54 No Data 5.90E-06 1.17E-06 No Data 1.76E-06 No Data 1.21 E-05 Mn-56 No Data 1.58E-07 2.81 E-08 No Data 2.OOE-07 No Data 1.04E-05 Fe-55 3.78E-06 2.68E-06 6.25E-07 No Data No Data 1.70E-06 1.16E-06 Fe-59 5.87E-06 1.37E-05 5.29E-06 No Data No Data 4.32E-06 3.24E-05 Co-58 No Data 9.72E-07 2.24E-06 No Data No Data No Data 1.34E-05 Co-60 No Data 2.81 E-06 6.33E-06 No Data No Data No Data 3.66E-05 Ni-63 1.77E-04 1.25E-05 6.OOE-06 No Data No Data No Data 1.99E-06 Ni-65 7.49E-07 9.57E-08 4.36E-08 No Data No Data No Data 5.19E-06 Cu-64 No Data 1.15E-07 5.41E-08 No Data 2.91 E-07 No Data 8.92E-06 Zn-65 5.76E-06 2.OOE-05 9.33E-06 No Data 1.28E-05 No Data 8.47E-06 Zn-69 1.47E-08 2.80E-08 1.96E-09 No Data 1.83E-08 No Data 5.16E-08 Br-83 No Data No Data 5.74E-08 No Data No Data No Data No Data Br-84 No Data No Data 7.22E-08 No Data No Data No Data No Data Br-85 No Data No Data 3.05E-09 No Data No Data No Data No Data Rb-86 No Data 2.98E-05 1.40E-05 No Data No Data No Data 4.41 E-06 Rb-88 No Data 8.52E-08 4.54E-08 No Data No Data No Data 7.30E-15 Rb-89 No Data 5.50E-08 3.89E-08 No Data No Data No Data 8.43E-17 Sr-89 4.40E-04 No Data 1.26E-05 No Data No Data No Data 5.24E-05 Sr-90 8.30E-03 No Data 2.05E-03 No Data No Data No Data 2.33E-04 Sr-91 8.07E-06 No Data 3.21 E-07 No Data No Data No Data 3.66E-05 All values are in (mrem/pCi ingested). They are obtained from Reference 3 (Table E-12). Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-125. 9-35 Rev. 18

VEGP ODCM Table 9-13 (contd). Ingestion Dose Factors for the Teenager Age Group Nuclide Bone J Liver T.Body Thyroid Kidney J Lung GI-LLI Sr-92 3.05E-06 No Data 1.30E-07 No Data No Data No Data 7.77E-05 Y-90 1.37E-08 No Data 3.69E-10 No Data No Data No Data 1.13E-04 Y-91m 1.29E-10 No Data 4.93E-12 No Data No Data No Data 6.09E-09 Y-91 2.01 E-07 No Data 5.39E-09 No Data No Data No Data 8.24E-05 Y-92 1.21 E-09 No Data 3.50E-1 1 No Data No Data No Data 3.32E-05 Y-93 3.83E-09 No Data 1.05E-10 No Data No Data No Data 1.17E-04 Zr-95 4.12E-08 1.30E-08 8.94E-09 No Data 1.91 E-08 No Data 3.OOE-05 Zr-97 2.37E-09 4.69E-10 2.16E-10 No Data 7.11E-10 No Data 1.27E-04 Nb-95 8.22E-09 4.56E-09 2.51 E-09 No Data 4.42E-09 No Data 1.95E-05 Mo-99 No Data 6.03E-06 1.15E-06 No Data 1.38E-05 No Data 1.08E-05 Tc-99m 3.32E-10 9.26E-10 1.20E-08 No Data 1.38E-08 5.14E-10 6.08E-07 Tc-101 3.60E-10 5.12E-10 5.03E-09 No Data 9.26E-09 3.12E-10 8.75E-17 Ru-1 03 2.55E-07 No Data 1.09E-07 No Data 8.99E-07 No Data 2.13E-05 Ru-105 2.18E-08 No Data 8.46E-09 No Data 2.75E-07 No Data 1.76E-05 Ru-1 06 3.92E-06 No Data 4.94E-07 No Data 7.56E-06 No Data 1.88E-04 Rh-i 05 No Data No Data No Data No Data No Data No Data No Data Ag-110m 2.05E-07 1.94E-07 1.18E-07 No Data 3.70E-07 No Data 5.45E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 3.83E-06 1.38E-06 5.12E-07 1.07E-06 No Data No Data 1.13E-05 Te-127m 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 No Data 2.41 E-05 Te-127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 No Data 1.22E-05 Te-129m 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 No Data 6.12E-05 Te-129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 No Data 2.45E-07 Te-131 m 2.44E-06 1.1 7E-06 9.76E-07 1.76E-06 1.22E-05 No Data 9.39E-05 Te-1 31 2.79E-08 1.15E-08 8.72E-09 2.1 5E-08 1.22E-07 No Data 2.29E-09 Rev. 18 9-36 9-36 Rev. 18

VEGP ODCM Table 9-13 (contd). Ingestion Dose Factors for the Teenager Age Group Nuclide Bone l Liver T.Body JThyroid Kidney Lung [ GI-LLI Te-132 3.49E-06 2.21 E-06 2.08E-06 2.33E-06 2.12E-05 No Data 7.OOE-05 1-130 1.03E-06 2.98E-06 1.1 9E-06 2.43E-04 4.59E-06 No Data 2.29E-06 1-131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41 E-05 No Data 1.62E-06 1-132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 No Data 3.1BE-07 1-133 2.01 E-06 3.41 E-06 1.04E-06 4.76E-04 5.98E-06 No Data 2.58E-06 1-134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.1 OE-07 No Data 5.1 OE-09 1-135 6.10E-07 1.57E-06 5.82E-07 1.01 E-04 2.48E-06 No Data 1.74E-06 Cs-1 34 8.37E-05 1.97E-04 9.14E-05 No Data 6.26E-05 2.39E-05 2.45E-06 Cs-1 36 8.59E-06 3.38E-05 2.27E-05 No Data 1.84E-05 2.90E-06 2.72E-06 Cs-137 1.12E-04 1.49E-04 5.19E-05 No Data 5.07E-05 1.97E-05 2.12E-06 Cs-138 7.76E-08 1.49E-07 7.45E-08 No Data 1.1 OE-07 1.28E-08 6.76E-i 1 Ba-1 39 1.39E-07 9.78E-1 1 4.05E-09 No Data 9.22E-1 1 6.74E-1 1 1.24E-06 Ba-140 2.84E-05 3.48E-08 1.83E-06 No Data 1.18E-08 2.34E-08 4.38E-05 Ba-141 6.71 E-08 5.01 E-1 1 2.24E-09 No Data 4.65E-1 1 3.43E-1 1 1.43E-13 Ba-142 2.99E-08 2.99E-11 1.84E-09 No Data 2.53E-11 1.99E-11 9.18E-20 La-140 3.48E-09 1.71E-09 4.55E-10 No Data No Data No Data 9.82E-05 La-142 1.79E-1 0 7.95E-1 1 1.98E-1i1 No Data No Data No Data 2.42E-06 Ce-141 1.33E-08 8.88E-09 1.02E-09 No Data 4.18E-09 No Data 2.54E-05 Ce-143 2.35E-09 1.71 E-06 1.91 E-10 No Data 7.67E-10 No Data 5.14E-05 Ce-144 6.96E-07 2.88E-07 3.74E-08 No Data 1.72E-07 No Data 1.75E-04 Pr-143 1.31 E-08 5.23E-09 6.52E-10 No Data 3.04E-09 No Data 4.31 E-05 Pr-144 4.30E-11 1.76E-11 2.18E-12 No Data 1.01 E-11 No Data 4.74E-14 Nd-147 9.38E-09 1.02E-08 6.11E-10 No Data 5.99E-09 No Data 3.68E-05 W-187 1.46E-07 1.19E-07 4.17E-08 No Data No Data No Data 3.22E-05 Np-239 1.76E-09 11.66E-10 9.22E-11 No Data 5.21E-10 No Data 2.67E-05 Rev. 18 9-37 Rev. 18

VEGP ODCM Table 9-14. Ingestion Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney J Lung J GI-LLI H-3 No Data 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 Na-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P-32 1.93E-04 1.20E-05 7.46E-06 No Data No Data No Data 2.17E-05 Cr-51 No Data No Data 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 Mn-54 No Data 4.57E-06 8.72E-07 No Data 1.36E-06 No Data 1.40E-05 Mn-56 No Data 1.15E-07 2.04E-08 No Data 1.46E-07 No Data 3.67E-06 Fe-55 2.75E-06 1.90E-06 4.43E-07 No Data No Data 1.06E-06 1.09E-06 Fe-59 4.34E-06 1.02E-05 3.91 E-06 No Data No Data 2.85E-06 3.40E-05 Co-58 No Data 7.45E-07 1.67E-06 No Data No Data No Data 1.51 E-05 Co-60 No Data 2.14E-06 4.72E-06 No Data No Data No Data 4.02E-05 Ni-63 1.30E-04 9.01 E-06 4.36E-06 No Data No Data No Data 1.88E-06 Ni-65 5.28E-07 6.86E-08 3.13E-08 No Data No Data No Data 1.74E-06 Cu-64 No Data 8.33E-08 3.91 E-08 No Data 2.10E-07 No Data 7.10E-06 Zn-65 4.84E-06 1.54E-05 6.96E-06 No Data 1.03E-05 No Data 9.70E-06 Zn-69 1.03E-08 1.97E-08 1.37E-09 No Data 1.28E-08 No Data 2.96E-09 Br-83 No Data No Data 4.02E-08 No Data No Data No Data 5.79E-08 Br-84 No Data No Data 5.21 E-08 No Data No Data No Data 4.09E-13 Br-85 No Data No Data 2.14E-09 No Data No Data No Data No Data Rb-86 No Data 2.11 E-05 9.83E-06 No Data No Data No Data 4.16E-06 Rb-88 No Data 6.05E-08 3.21 E-08 No Data No Data No Data 8.36E-1 9 Rb-89 No Data 4.01 E-08 2.82E-08 No Data No Data No Data 2.33E-21 Sr-89 3.08E-04 No Data 8.84E-06 No Data No Data No Data 4.94E-05 Sr-90 7.58E-03 No Data 1.86E-03 No Data No Data No Data 2.19E-04 Sr-91 5.67E-06 No Data 2.29E-07 No Data No Data No Data 2.70E-05 All values are in (mrem/pCi ingested). They are obtained from Reference 3 (Table E-1 1), except as follows: Reference 2 (Table A-3) for Rh-1 05, Sb-124, and Sb-125. 9-38 Rev. 18

VEGP ODCM Table 9-14 (contd). Ingestion Dose Factors for the Adult Age Group Nuclide Bone Liver T.Body Thyroid Kidney Lung Gl-LLI Sr-92 2.15E-06 No Data 9.30E-08 No Data No Data No Data 4.26E-05 Y-90 9.62E-09 No Data 2.58E-1 0 No Data No Data No Data 1.02E-04 Y-91m 9.09E-11 No Data 3.52E-12 No Data No Data No Data 2.67E-10 Y-91 1.41 E-07 No Data 3.77E-09 No Data No Data No Data 7.76E-05 Y-92 8.45E-10 No Data 2.47E-11 No Data No Data No Data 1.48E-05 Y-93 2.68E-09 No Data 7.40E-1 1 No Data No Data No Data 8.50E-05 Zr-95 3.04E-08 9.75E-09 6.60E-09 No Data 1.53E-08 No Data 3.09E-05 Zr-97 1.68E-09 3.39E-10 1.55E-10 No Data 5.12E-10 No Data 1.05E-04 Nb-95 6.22E-09 3.46E-09 1.86E-09 No Data 3.42E-09 No Data 2.1 OE-05 Mo-99 No Data 4.31 E-06 8.20E-07 No Data 9.76E-06 No Data 9.99E-06 Tc-99m 2.47E-10 6.98E-1 0 8.89E-09 No Data 1.06E-08 3.42E-1 0 4.13E-07 Tc-101 2.54E-10 3.66E-10 3.59E-09 No Data 6.59E-09 1.87E-10 1.1OE-21 Ru-103 1.85E-07 No Data 7.97E-08 No Data 7.06E-07 No Data 2.16E-05 Ru-105 1.54E-08 No Data 6.08E-09 No Data 1.99E-07 No Data 9.42E-06 Ru-1 06 2.75E-06 No Data 3.48E-07 No Data 5.31 E-06 No Data 1.78E-04 Rh-1 05 1.22E-07 8.86E-08 5.83E-08 No Data 3.76E-07 No Data 1.41 E-05 Ag-i 1Om 1.60E-07 1.48E-07 8.79E-08 No Data 2.91 E-07 No Data 6.04E-05 Sb-124 2.81 E-06 5.30E-08 1.11 E-06 6.79E-09 No Data 2.1BE-06 7.95E-05 Sb-125 2.23E-06 2.40E-08 4.48E-07 1.98E-09 No Data 2.33E-04 1.97E-05 Te-125m 2.68E-06 9.71 E-07 3.59E-07 8.06E-07 1.09E-05 No Data 1.07E-05 Te-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 No Data 2.27E-05 Te-127 1.1OE-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 No Data 8.68E-06 Te-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 No Data 5.79E-05 Te-129 3.14E-08 1.18E-08 7.65E-09 2.41 E-08 1.32E-07 No Data 2.37E-08 Te-131 m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 No Data 8.40E-05 Te-1 31 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 No Data 2.79E-09 Rev. 18 9-39 9-39 Rev.1 8

VEGP ODCM Table 9-14 (contd). Ingestion Dose Factors for the Adult Age Group Nuclide Bone l Liver T.Body Thyroid Kidney Lung GI-LLI Te-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 No Data 7.71 E-05 1-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 No Data 1.92E-06 1-131 4.16E-06 5.95E-06 3.41 E-06 1.95E-03 1.02E-05 No Data 1.57E-06 1-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 No Data 1.02E-07 1-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31 E-06 No Data 2.22E-06 1-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 No Data 2.51E-10 1-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 No Data 1.31 E-06 Cs-134 6.22E-05 1.48E-04 1.21 E-04 No Data 4.79E-05 1.59E-05 2.59E-06 Cs-1 36 6.51 E-06 2.57E-05 1.85E-05 No Data 1.43E-05 1.96E-06 2.92E-06 Cs-137 7.97E-05 1.09E-04 7.14E-05 No Data 3.70E-05 1.23E-05 2.11 E-06 Cs-1 38 5.52E-08 1.09E-07 5.40E-08 No Data 8.01 E-08 7.91 E-09 4.65E-13 Ba-139 9.70E-08 6.91 E-11 2.84E-09 No Data 6.46E-11 3.92E-11 1.72E-07 Ba-140 2.03E-05 2.55E-08 1.33E-06 No Data 8.67E-09 1.46E-08 4.18E-05 Ba-141 4.71 E-08 3.56E-11 1.59E-09 No Data 3.31 E-11 2.02E-11 2.22E-17 Ba-142 2.13E-08 2.19E-1I 1.34E-09 No Data 1.85E-1I 1.24E-11 3.OOE-26 La-140 2.50E-09 1.26E-09 3.33E-10 No Data No Data No Data 9.25E-05 La-142 1.28E-10 5.82E-i1 1.45E-11 No Data No Data No Data 4.25E-07 Ce-141 9.36E-09 6.33E-09 7.18E-10 No Data 2.94E-09 No Data 2.42E-05 Ce-143 1.65E-09 1.22E-06 1.35E-10 No Data 5.37E-10 No Data 4.56E-05 Ce-144 4.88E-07 2.04E-07 2.62E-08 No Data 1.21 E-07 No Data 1.65E-04 Pr-143 9.20E-09 3.69E-09 4.56E-10 No Data 2.13E-09 No Data 4.03E-05 Pr-144 3.01 E-i1 1.25E-l1 1.53E-12 No Data 7.05E-12 No Data 4.33E-18 Nd-147 6.29E-09 7.27E-09 4.35E-1 0 No Data 4.25E-09 No Data 3.49E-05 W-187 1.03E-07 8.61 E-08 3.01 E-08 No Data No Data No Data 2.82E-05 Np-239 1.19E-09 1.17E-10 6.45E-11I No Data 3.65E-10 No Data 2.40E-05 Rev. 18 9-40 9-40 Rev. 18

VEGP ODCM Table 9-15. External Dose Factors for Standing on Contaminated Ground . Nuclide T. Body Skin Nuclide T. Body Skin H-3 0.00 0.00 Sr-91 7.1OE-09 8.30E-09 C-14 0.00 0.00 Sr-92 9.OOE-09 1.OOE-08 Na-24 2.50E-08 2.90E-08 Y-90 - 2.20E-12 2.60E-12 P-32 0.00 0.00 Y-91 m 3.80E-09 4.40E-09 Cr-51 2.20E-10 2.60E-10 Y-91 2.40E-1 1 2.70E-1 1 Mn-54 5.80E-09 6.80E-09 Y-92 1.60E-09 1.90E-09 Mn-56 1.10E-08 1.30E-08 Y-93 5.70E-10 7.80E-10 Fe-55 0.00 0.00 Zr-95 5.OOE-09 5.80E-09 Fe-59 8.OOE-09 9.40E-09 Zr-97 5.50E-09 6.40E-09 Co-58 7.OOE-09 8.20E-09 Nb-95 5.1OE-09 6.OOE-09 Co-60 1.70E-08 2.00E-08 Mo-99 1.90E-09 2.20E-09 Ni-63 0.00 0.00 Tc-99m 9.60E-10 1.1OE-09 Ni-65 3.70E-09 4.30E-09 Tc-101 2.70E-09 3.OOE-09 Cu-64 1.50E-09 1.70E-09 Ru-103 3.60E-09 4.20E-09 Zn-65 4.OOE-09 4.60E-09 Ru-105 4.50E-09 5.1OE-09 Zn-69 0.00 0.00 Ru-1 06 1.50E-09 1.80E-09 Br-83 6.40E-1 1 9.30E-1 1 Rh-105 6.60E-10 7.70E-10 Br-84 1.20E-08 1.40E-08 Ag-11 Om 1.80E-08 2.1 OE-08 Br-85 0.00 0.00 Sb-124 1.30E-08 1.50E-08 Rb-86 6.30E-10 7.20E-10 Sb-125 3.1OE-09 3.50E-09 Rb-88 3.50E-09 4.OOE-09 Te-125m 3.50E-1 1 4.80E-1 1 Rb-89 1.50E-08 1.80E-08 Te-127m 1.10E-12 1.30E-12 Sr-89 5.60E-13 6.50E-13 Te-127 1.OOE-11 1.1OE-11 Sr-90 0.00 0.00 Te-129m 7.70E-10 9.00E-10 All values are in (mrem/h) per (pCVm 2). They are obtained from Reference 3 (Table E-6), except as follows: Reference 2 (Table A-7) for Rh-105, Sb-124, and Sb-125. Rev. 18 9-41 Rev. 18

VEGP ODCM Table-9-15 (contd). External Dose Factors for Standing on Contaminated Ground Nuclide [ T.Body Skin Te-129 7.1OE-10 8.40E-10 Te-131m 8.40E-09 9.90E-09 Te-131 2.20E-09 2.60E-06 Te-132 1.70E-09 2.00E-09 1-130 1.40E-08 1.70E-08 1-131 2.80E-09 3.40E-09 1-132 1.70E-08 2.00E-08 1-133 3.70E-09 4.50E-09 1-134 1.60E-08 1.90E-08 1-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-1 36 1.50E-08 1.70E-08 Cs-1 37 4.20E-09 4.90E-09 Cs-138 2.1OE-08 2.40E-08 Ba-139 2.40E-09 2.70E-09 Ba-140 2.1 OE-09 2.40E-09 Ba-141 4.30E-09 4.90E-09 Ba-142 7.90E-09 9.OOE-09 La-1 40 1.50E-08 1.70E-08 La-142 1.50E-08 1.80E-08 Ce-141 5.50E-10 6.20E-10 Ce-143 2.20E-09 2.50E-09 Ce-144 3.20E-10 3.70E-10 Pr-143 0.00 0.00 Pr-144 2.00E-10 2.30E-10 Nd-147 1.OOE-09 1.20E-09 W-187 3.1OE-09 3.60E-09 Np-239 9.50E-10 1.1OE-09 Rev. 18 9-42 Rev. 18

                                  , . I Chapter 10 - Definitions of                  l Effluent Control Terms     '   .I       / I
  )                          )                9

10.1 VI 3

VEGP ODCM CHAPTER 10 DEFINITIONS OF EFFLUENT CONTROL TERMS The terms defined in this chapter are used in the presentation of the above chapters. These terms are shown in all capital letters to indicate that they are specifically defined. 10.1 TERMS SPECIFIC TO THE ODCM The following terms are used in the ODCM, but are not found in the Technical Specifications: ACTION(S) An ACTION shall be that part of a control that prescribes remedial measures required under designated conditions. BATCH RELEASE A BATCH RELEASE is the discharge of wastes of a discrete volume. Prior to sampling for analyses, each liquid batch shall be isolated and then thoroughly mixed by a method described in the ODCM to assure representative sampling. COMPOSITE SAMPLE A COMPOSITE SAMPLE is one which contains material from multiple waste releases, in which the quantity of sample is proportional to the quantity of waste discharged, and in which the method of sampling employed results in a specimen that is representative of the wastes released. Prior to analyses, all liquid samples that are to be aliquotted for a COMPOSITE SAMPLE shall be mixed thoroughly, in order for the COMPOSITE SAMPLE to be representative of the effluent release. When assessing the consequences of a waste release at the pre-release or post-release stage, the most recent available COMPOSITE SAMPLE results for the applicable release pathway may be used. CONTINUOUS RELEASE A CONTINUOUS RELEASE is the discharge of wastes of a non-discrete volume, e.g., from a volume within a system that has an input flow during the continuous release. To be representative of the quantities and concentrations of radioactive materials in CONTINUOUS RELEASES of liquid effluents, samples shall be collected in proportion to the rate of flow of the effluent stream or to the quantity of liquid waste discharged. FREQUENCY NOTATION The FREQUENCY NOTATION specified for the performance of surveillance requirements shall correspond to the intervals defined below, with a maximum allowable extension not to exceed 25% of the surveillance interval. NOTATION FREQUENCY

       -S (Once per shift)    At  least once per 12 hours.

D (Daily) At least once per 24 hours. W (Weekly) At least once per 7 days. M (Monthly) At least once per 31 days. Q (Quarterly) At least once per 92 days. 10-1 Rev. 18

VEGP ODCM SA (Semi-annually) At least once per 184 days. R (Refueling) At least once per 18 months. S/U (Startup) Prior to each reactor startup. NA Not applicable. P (Prior) Completed prior to each release. GASEOUS WASTE PROCESSING SYSTEM A GASEOUS WASTE PROCESSING SYSTEM shall be any system designed and installed to reduce radioactive gaseous effluents by collecting Reactor Coolant System off gases from the Reactor Coolant System and providing for delay or holdup for the purpose of reducing the total radioactivity prior to release to the environment. LIQUID RADWASTE TREATMENT SYSTEM A LIQUID RADWASTE TREATMENT SYSTEM is any system designed and installed to reduce radioactive materials in liquid effluents by systematic collection, retention, and processing through filtration, evaporation, separation and/or ion exchange treatment. This system consists of at least one collection tank, one evaporator or demineralizer system, one post-treatment tank and associated components providing for treatment flow and functional control. MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS For the purposes of the ODCM, MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS include the following changes to such systems: (1) Major changes in process equipment, components, structures, or effluent monitoring instrumentation as described in the Final Safety Analysis Report (FSAR) or as evaluated in the Nuclear Regulatory Commission staff's Safety Evaluation Report (SER) (e.g., deletion of evaporators and installation of demineralizers); (2) Changes in the design of radwaste treatment systems that could significantly increase quantities of effluents released from those previously considered in the FSAR and SER; (3) Changes in system design which may invalidate the accident analysis as described in the SER (e.g., changes in tank capacity that would alter the curies released); or (4) Changes in system design that could potentially result in a significant increase in occupational exposure of operating personnel (e.g., use of temporary equipment without adequate shielding provisions). 10-2 Rev. 18

VEGP ODCM MEMBER(S) OF THE PUBLIC' A MEMBER OF THE PUBLIC means any individual except when that individual is receiving an occupational dose2 . This category may include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant. MINIMUM DETECTABLE CONCENTRATION The MINIMUM DETECTABLE CONCENTRATION (MDC) is defined, for purposes of the controls in this ODCM, as the smallest concentration of radioactive material in a sample that will yield a net count above system background and that will be detected with 95-percent probability, with only 5-percent probability of falsely concluding that a blank observation represents a realr signal. For a particular measurement system, which may include radiochemical separation, the MDC for a given radionuclide is determined as follows (Reference 18): where: MDC = the a prioiMINIMUM DETECTABLE CONCENTRATION (giCi per unit mass or volume). 2.71 + 3.29 MDC= t S E - V

• 2.22 x Io6 Y e Rb = the background counting rate, or the counting rate of a blank sample, as appropriate (counts per minute).

ts = the length of the sample counting period (minutes). tb = the length of the background counting period (minutes). E= the counting efficiency (counts per disintegration) V= the sample size (units of mass or volume). 2.22 x 106 = the number of disintegrations per minute per ACi. Y= the fractional radiochemical yield, when applicable. X= the radioactive decay constant for the given radionuclide (h-'). Values of Xused in effluent calculations should be based on decay data from a recognized and current source, such as Reference 20. At = for effluent samples, the elapsed time between the midpoint of sample collection and the time of counting (h); for environmental samples, the elapsed time between the end of sample collection and the time of counting (h). The Italicized terms in this definition, which are not otherwise used in this ODCM, shall have the definitions assigned to them by 10 CFR 20.1003. 2 Except as delineated in other parts of 10 CFR chapter 1. Rev. 18 10-3 Rev. 18

VEGP ODCM Typical values of E, V, Y, and At should be used in the calculation. It should be recognized that the MDC is defined as an a priori (before the fact) limit representing the capability of a measurement system, and not as an a posteriori (after the fact) limit for a particular measurement. PRINCIPAL GAMMA EMITTERS The PRINCIPAL GAMMA EMITTERS for which the MINIMUM DETECTABLE CONCENTRATION (MDC) limit applies include exclusively the following radionuclides:

• For liquid radioactive effluents: Mn-64, Fe-59, Co-58, Co-0, Zn-65, Mo-99, Cs-134, Cs-137, and Ce-141. Ce-144 shall also be measured, but with an MDC of 5 x ie pCiCmL.
• For gaseous radioactive effluents: In noble gas releases, Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-138; and in particulate releases, Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-i 37, Ce-141, and Ce- 44.
• For environmental media: The gamma emitters specifically listed in Table 4-3.

These lists do not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report, the Annual Radiological Environmental Operating Report, or other applicable report(s). SITE BOUNDARY For the purpose of effluent controls defined in the ODCM, the SITE BOUNDARY shall be as shown in Figure 4-1. SOURCE CHECK A SOURCE CHECK shall be the qualitative assessment of channel response when the channel sensor is exposed to a source of increased radioactivity. UNRESTRICTED AREA The UNRESTRICTED AREA shall be any area access to which is neither limited nor controlled by the licensee, or any area within the SITE BOUNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes. VENTILATION EXHAUST TREATMENT SYSTEM The VENTILATION EXHAUST TREATMENT SYSTEM is any system designed and installed to reduce gaseous radioiodine or radioactive material in particulate form in effluents, by passing ventilation or vent exhaust gases through charcoal adsorbers and/or HEPA filters, for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to the environment. (Such a system is not considered to have any effect on any noble gas effluents). Engineered Safety Feature (ESF) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT

     -SYSTEM components.

Rev. 18 10-4 10-4 Rev. 18

I 10.2 .)

VEGP ODCM 10.2 TERMS DEFINED IN THE TECHNICAL SPECIFICATIONS The following terms are defined in the Technical Specifications, Section 1.0. Because they are used throughout the Limits of Operation sections of the ODCM, they are presented here for convenience. In the event of discrepancies between the definitions below and those in the Technical Specifications, the Technical Specification definitions shall take precedence. CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel, such that it responds within the required range and accuracy to known values of input. The CHANNEL CALIBRATION shall encompass the entire channel including the required sensor, alarm, interlock, and/or trip functions and may be performed by any series of sequential, overlapping, or total channel steps, so that the entire channel is calibrated. CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation. This determination shall include, where possible, comparison of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same parameter. CHANNEL OPERATIONAL TEST (COT) A CHANNEL OPERATIONAL TEST shall be the injection of a simulated signal into the channel as close to the sensor as practicable to verify operability of required alarm, interlock, and/or trip functions. The CHANNEL OPERATIONAL TEST shall include adjustments, as necessary, of the required alarm, interlock, and/or trip setpoints, so that the setpoints are within the required range and accuracy. DOSE EQUIVALENT 1-131 DOSE EQUIVALENT 1-131 shall be that concentration of 1-131 (fi/g) which alone would produce the same thyroid dose as the quantity and isotopic mixture of 1-131, 1-132, 1-133, 1-134, and 1-135 actually present. The thyroid dose conversion factors used for this calculation shall be those listed in Table E-7 of NRC Regulatory Guide 1.109, Revision 1, 1977. MODE (or OPERATIONAL MODE) An OPERATIONAL MODE shall correspond to any one inclusive combination of core reactivity condition, power level, average reactor coolant temperature, and reactor vessel head closure bolt tensioning specified in Section 1.0 of the Technical Specifications with fuel in the reactor vessel. OPERABLE (or OPERABILITY) OPERABILITY exists when a system, subsystem, train, component or device is capable of performing its specified function(s), and when all necessary attendant instrumentation, controls, electrical power, cooling or seal water, lubrication or other auxiliary equipment that are required for the system, subsystem, train, component or device to perform its function(s) are also capable of performing their related support function(s). Rev. 18 10-5 Rev. 18

VEGP ODCM RATED THERMAL POWER RATED THERMAL POWER shall be a total reactor core heat transfer rate to the reactor coolant of 3565 MWt. THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant. Rev. 18 10-6 Rev. 18

Effective Page Listing

        )3    )

VEGP ODCM VOGTLE ELECTRIC GENERATING PLANT OFFSITE DOSE CALCULATION MANUAL EFFECTIVE PAGE LISTING PAGE REV PAGE REV 2-33 . 18 ii.19 18 2-34. iii .. : 18 2-35. 18 iv .. 18 2-36 . 18 v.. 18 2-37 . 18 Vi . 18 2-38 . 18 vii .. 18 2-39 . 18 viii . 19 2-40 . 18 ix .. 18 2-41 . 18 x.. 18 2-42 . 18 1-1 . 18 2-43 . Deleted 2-1 . 18 2-44 ... Deleted 2 -5........................................... .D e t d 2-2 . 18 2-45 .Deleted 2-3 . 20 2-46 . Deleted 2-4 . 18 2-47 . Deleted 2-5 . 18 2-48 . Deleted 2-6 . 18 2-49 . Deleted 2-7 . 18 3-1 . 18 2-8 . 18 3-2 . 18 2-9 . 18 3-3 . 19 2-10 . 18 34 ...................................................... 1 2-11 . 18 3-5 .. 19 2-12 . 18 3-6 .. 19 2-13 . 18 3-7... 18 2-14 . 19 3-8 .. 19 2-15 . 19 3-9 .. 19 2-16 . 18 3-10 .. 18 2-17 . 18 3-11 .. 18 2-18 . 18 3-12 .. 18 2-19 . 18 3-13 .. 18 2-20 . 18 3-14 .. 19 2-21 . 18 3-15 .. 18 2-22 . 18 3-16 .. 18 2-23 . 18 3-17 .. 18 2-24 . 18 3-18 .. 18 2-25 . 18 3-19 .. 18 2-26 . 18 3-19a .. 19 2-27 . 18 3-20 .. 18 2-28 . 18 3-21 .. 18 2-29 . 18 3-22 .. 18 2-30 . 18 3-23 .. 18 2-31 . 18 3-24 .. 18 2-32 . 18 Rev. 20 I of 3 1 Rev. 20

VEGP ODCM PAGE REV PAGE REV 3-25 . 18 4-17 . 18 3-26 . 18 4-18 . 18 3-27 . 18 4-19 . Deleted 3-28 . 18 4-20 . Deleted 3-29 . 18 5-1 . 18 3-30 . 18 5-2 . 18 3-31 . 18 5-3 . 18 3-32 . 18 5-4 . 18 3-33 . 18 6-1 . 18 3-34 . 18 6-2 . 18 3-35 . 18 6-3 . Deleted 3-36 . 18 7-1 ...................................................... 18 3-37....................................................18 7-2 . 18 3-38 . 18 7-3 . 18 3-39 . 18 7-4 . 18 3-40 . 18 7-5 . 18 3-41 . 18 7-6 . 18 3-42 . 18 7-7 . Deleted 3-43 . 18 8-1 . 18 3-44 . 18 8-2 ................................................ 18 3-45 . 18 8-3 . 18 3-46 . 18 8-4 . 18 3-47 . 18 8-5 . 18 3-8 ........................................... 1 3-48.18 8-6 . 18 3-49 . 18 8-7 . 18 3-50 . Deleted 8-8 . 18 3-51 . Deleted 8-9 ................................................ 18 3-52 . Deleted 8-10 . 18 3-53 . Deleted 8-11 . 18 3-54 . Deleted 8-12 . 18 3-55 . Deleted 8-13 . 18 3-56 . Deleted 8-14 . 18 3-57 . Deleted 8-15 . 18 3-58 . Deleted 8-16 . 18 4-1 . 18 8-17 . 18 4-2 . 18 8-18.Deleted 91 .............................................. .. .. 1 4-3 . 18 9-1 . 18 4-4 . 18 9-2 . 18 4-5 . 18 9-3 . 18 46 ............................................. 1 4-6 . 18 9-4 . 18 4-7 . 18 9-5 . 18 4-8 . 18 9-6 . 18 4-94 .0..................................

       .                                            .........      118         9-7 .                                                         18 4-10 .                                                               18         9-8 .                                                         18 4-11 .                                                               18         9-9 .                                                         18 9-10 .                                                        18 4-4 ...........................................                 1 4-14    .18                                                                     9-11.18 4-15.18                                                                         9-12                                                       . 18 4-1 .................................................... 18                     9-13 .                                                        18 4-16 ......................... .............                         18         9-14 .                                                        18 Rev. 20 2 of 33                                                            Rev. 20

VEGP ODCM PAGE REV PAGE REV 9-15 . 18 9-34 . 18 9-16 . 18 9-35 . 18 9-17 . 18 9-36 . 18 9-18 . 18 9-37 . 18 9-19 . 18 9-38 . 18 9-20 . 18 9-39 . 18 9-21 . 18 9-40. 18 9-22 . 18 9-41 . 18 9-23 . 18 9-42 . 18 9-24 . 18 9-43 . Deleted 9-25 . 18 9-44 . Deleted 9-26 . 18 9-45 .Deleted 9-27 . 18 10-1 . 18 9-28 . 18 10-2 . 18 9-29 . 18 10-3 . 18 9-30 . 18 10-4 . 18 9-31 . 18 10-5 . 18 9-32 . 18 10-6 . 18 9-33 . 18 10-7 . Deleted s %vogte~odan\EpI doc Rev. 20 3 of 3 3of Rev. 20}}